
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Established and Emerging Roles of Epigenetic Regulation in Diabetic Cardiomyopathy - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="D2E480548AEEB363058054002A083435.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="blackwellopen">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12365466/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Diabetes/Metabolism Research and Reviews">
<meta name="citation_title" content="Established and Emerging Roles of Epigenetic Regulation in Diabetic Cardiomyopathy">
<meta name="citation_author" content="Adam Russell‐Hallinan">
<meta name="citation_author_institution" content="Wellcome‐Wolfson Institute for Experimental Medicine, Queen&#x27;s University Belfast, Belfast, UK">
<meta name="citation_author" content="Narainrit Karuna">
<meta name="citation_author_institution" content="Wellcome‐Wolfson Institute for Experimental Medicine, Queen&#x27;s University Belfast, Belfast, UK">
<meta name="citation_author" content="Frank Lezoualc&#x27;h">
<meta name="citation_author_institution" content="Institute of Metabolic and Cardiovascular Disease, INSERM, University Toulouse III‐Paul Sabatier, Toulouse, France">
<meta name="citation_author" content="Giuseppe Matullo">
<meta name="citation_author_institution" content="Department of Medical Sciences, University of Turin, Turin, Italy">
<meta name="citation_author" content="Hana Baker">
<meta name="citation_author_institution" content="Diabetes and Complications Research, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, USA">
<meta name="citation_author" content="Monique Bernard">
<meta name="citation_author_institution" content="Aix‐Marseille University, CNRS, CRMBM, Faculté de Médecine, Marseille, France">
<meta name="citation_author" content="Yvan Devaux">
<meta name="citation_author_institution" content="Cardiovascular Research Unit, Department of Precision Health, Luxembourg Institute of Health, Strassen, Luxembourg">
<meta name="citation_author" content="Lina Badimon">
<meta name="citation_author_institution" content="Cardiovascular Program‐ICCC, IR‐Hospital de la Santa Creu I Sant Pau, Barcelona, Spain">
<meta name="citation_author" content="Gemma Vilahur">
<meta name="citation_author_institution" content="Cardiovascular Program‐ICCC, IR‐Hospital de la Santa Creu I Sant Pau, Barcelona, Spain">
<meta name="citation_author" content="Jennifer Rieusset">
<meta name="citation_author_institution" content="Laboratoire CarMeN, UMR INSERM U1060/INRA U1397, Université Claude Bernard Lyon1, Lyon, France">
<meta name="citation_author" content="Geneviève A Derumeaux">
<meta name="citation_author_institution" content="Department of Physiology, INSERM U955, Université Paris Est Créteil (UPEC), AP‐HP, Henri Mondor Hospital, FHU SENEC, Faculté de Santé de Créteil, Créteil cedex, France">
<meta name="citation_author" content="Chris J Watson">
<meta name="citation_author_institution" content="Wellcome‐Wolfson Institute for Experimental Medicine, Queen&#x27;s University Belfast, Belfast, UK">
<meta name="citation_publication_date" content="2025 Aug 19">
<meta name="citation_volume" content="41">
<meta name="citation_issue" content="6">
<meta name="citation_firstpage" content="e70081">
<meta name="citation_doi" content="10.1002/dmrr.70081">
<meta name="citation_pmid" content="40831067">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12365466/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12365466/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12365466/pdf/DMRR-41-e70081.pdf">
<meta name="description" content="An increasing number of individuals are at high risk of type 2 diabetes (T2DM) and its cardiovascular (CV) complications, which challenges healthcare systems with an increased risk of developing CV diseases. Patients with T2DM exhibit a unique ...">
<meta name="og:title" content="Established and Emerging Roles of Epigenetic Regulation in Diabetic Cardiomyopathy">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="An increasing number of individuals are at high risk of type 2 diabetes (T2DM) and its cardiovascular (CV) complications, which challenges healthcare systems with an increased risk of developing CV diseases. Patients with T2DM exhibit a unique ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12365466/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12365466">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1002/dmrr.70081"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/DMRR-41-e70081.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12365466%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12365466/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12365466/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12365466/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-blackwellopen.png" alt="Wiley Open Access Collection logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Wiley Open Access Collection" title="Link to Wiley Open Access Collection" shape="default" href="https://doi.org/10.1002/dmrr.70081" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Diabetes Metab Res Rev</button></div>. 2025 Aug 19;41(6):e70081. doi: <a href="https://doi.org/10.1002/dmrr.70081" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1002/dmrr.70081</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22Diabetes%20Metab%20Res%20Rev%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Diabetes%20Metab%20Res%20Rev%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Diabetes%20Metab%20Res%20Rev%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Diabetes%20Metab%20Res%20Rev%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Established and Emerging Roles of Epigenetic Regulation in Diabetic Cardiomyopathy</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Russell%E2%80%90Hallinan%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Adam Russell‐Hallinan</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Adam Russell‐Hallinan</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Wellcome‐Wolfson Institute for Experimental Medicine, Queen's University Belfast, Belfast, UK</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Russell%E2%80%90Hallinan%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Adam Russell‐Hallinan</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Karuna%20N%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Narainrit Karuna</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Narainrit Karuna</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Wellcome‐Wolfson Institute for Experimental Medicine, Queen's University Belfast, Belfast, UK</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Karuna%20N%22%5BAuthor%5D" class="usa-link"><span class="name western">Narainrit Karuna</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Lezoualc'h%20F%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Frank Lezoualc'h</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Frank Lezoualc'h</span></h3>
<div class="p">
<sup>
<sup>2</sup>
</sup>Institute of Metabolic and Cardiovascular Disease, INSERM, University Toulouse III‐Paul Sabatier, Toulouse, France</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Lezoualc'h%20F%22%5BAuthor%5D" class="usa-link"><span class="name western">Frank Lezoualc'h</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Matullo%20G%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Giuseppe Matullo</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Giuseppe Matullo</span></h3>
<div class="p">
<sup>
<sup>3</sup>
</sup>Department of Medical Sciences, University of Turin, Turin, Italy</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Matullo%20G%22%5BAuthor%5D" class="usa-link"><span class="name western">Giuseppe Matullo</span></a>
</div>
</div>
<sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Baker%20H%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Hana Baker</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Hana Baker</span></h3>
<div class="p">
<sup>
<sup>4</sup>
</sup>Diabetes and Complications Research, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, USA</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Baker%20H%22%5BAuthor%5D" class="usa-link"><span class="name western">Hana Baker</span></a>
</div>
</div>
<sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Bernard%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Monique Bernard</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Monique Bernard</span></h3>
<div class="p">
<sup>
<sup>5</sup>
</sup>Aix‐Marseille University, CNRS, CRMBM, Faculté de Médecine, Marseille, France</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Bernard%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Monique Bernard</span></a>
</div>
</div>
<sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Devaux%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Yvan Devaux</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Yvan Devaux</span></h3>
<div class="p">
<sup>
<sup>6</sup>
</sup>Cardiovascular Research Unit, Department of Precision Health, Luxembourg Institute of Health, Strassen, Luxembourg</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Devaux%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Yvan Devaux</span></a>
</div>
</div>
<sup>6</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Badimon%20L%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Lina Badimon</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Lina Badimon</span></h3>
<div class="p">
<sup>
<sup>7</sup>
</sup>Cardiovascular Program‐ICCC, IR‐Hospital de la Santa Creu I Sant Pau, Barcelona, Spain</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Badimon%20L%22%5BAuthor%5D" class="usa-link"><span class="name western">Lina Badimon</span></a>
</div>
</div>
<sup>7</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Vilahur%20G%22%5BAuthor%5D" class="usa-link" aria-describedby="id9"><span class="name western">Gemma Vilahur</span></a><div hidden="hidden" id="id9">
<h3><span class="name western">Gemma Vilahur</span></h3>
<div class="p">
<sup>
<sup>7</sup>
</sup>Cardiovascular Program‐ICCC, IR‐Hospital de la Santa Creu I Sant Pau, Barcelona, Spain</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Vilahur%20G%22%5BAuthor%5D" class="usa-link"><span class="name western">Gemma Vilahur</span></a>
</div>
</div>
<sup>7</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Rieusset%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id10"><span class="name western">Jennifer Rieusset</span></a><div hidden="hidden" id="id10">
<h3><span class="name western">Jennifer Rieusset</span></h3>
<div class="p">
<sup>
<sup>8</sup>
</sup>Laboratoire CarMeN, UMR INSERM U1060/INRA U1397, Université Claude Bernard Lyon1, Lyon, France</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Rieusset%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Jennifer Rieusset</span></a>
</div>
</div>
<sup>8</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Derumeaux%20GA%22%5BAuthor%5D" class="usa-link" aria-describedby="id11"><span class="name western">Geneviève A Derumeaux</span></a><div hidden="hidden" id="id11">
<h3><span class="name western">Geneviève A Derumeaux</span></h3>
<div class="p">
<sup>
<sup>9</sup>
</sup>Department of Physiology, INSERM U955, Université Paris Est Créteil (UPEC), AP‐HP, Henri Mondor Hospital, FHU SENEC, Faculté de Santé de Créteil, Créteil cedex, France</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Derumeaux%20GA%22%5BAuthor%5D" class="usa-link"><span class="name western">Geneviève A Derumeaux</span></a>
</div>
</div>
<sup>9</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Watson%20CJ%22%5BAuthor%5D" class="usa-link" aria-describedby="id12"><span class="name western">Chris J Watson</span></a><div hidden="hidden" id="id12">
<h3><span class="name western">Chris J Watson</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Wellcome‐Wolfson Institute for Experimental Medicine, Queen's University Belfast, Belfast, UK</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Watson%20CJ%22%5BAuthor%5D" class="usa-link"><span class="name western">Chris J Watson</span></a>
</div>
</div>
<sup>1,</sup><sup>✉</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="dmrr70081-aff-0001">
<sup>
<sup>1</sup>
</sup>Wellcome‐Wolfson Institute for Experimental Medicine, Queen's University Belfast, Belfast, UK</div>
<div id="dmrr70081-aff-0002">
<sup>
<sup>2</sup>
</sup>Institute of Metabolic and Cardiovascular Disease, INSERM, University Toulouse III‐Paul Sabatier, Toulouse, France</div>
<div id="dmrr70081-aff-0003">
<sup>
<sup>3</sup>
</sup>Department of Medical Sciences, University of Turin, Turin, Italy</div>
<div id="dmrr70081-aff-0004">
<sup>
<sup>4</sup>
</sup>Diabetes and Complications Research, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, USA</div>
<div id="dmrr70081-aff-0005">
<sup>
<sup>5</sup>
</sup>Aix‐Marseille University, CNRS, CRMBM, Faculté de Médecine, Marseille, France</div>
<div id="dmrr70081-aff-0006">
<sup>
<sup>6</sup>
</sup>Cardiovascular Research Unit, Department of Precision Health, Luxembourg Institute of Health, Strassen, Luxembourg</div>
<div id="dmrr70081-aff-0007">
<sup>
<sup>7</sup>
</sup>Cardiovascular Program‐ICCC, IR‐Hospital de la Santa Creu I Sant Pau, Barcelona, Spain</div>
<div id="dmrr70081-aff-0008">
<sup>
<sup>8</sup>
</sup>Laboratoire CarMeN, UMR INSERM U1060/INRA U1397, Université Claude Bernard Lyon1, Lyon, France</div>
<div id="dmrr70081-aff-0009">
<sup>
<sup>9</sup>
</sup>Department of Physiology, INSERM U955, Université Paris Est Créteil (UPEC), AP‐HP, Henri Mondor Hospital, FHU SENEC, Faculté de Santé de Créteil, Créteil cedex, France</div>
<div class="author-notes p">
<div class="fn" id="correspondenceTo">
<sup>*</sup><p class="display-inline">

<strong>Correspondence:</strong> Chris J. Watson, 
(<span>chris.watson@qub.ac.uk</span>)
</p>
</div>
<div class="fn" id="_fncrsp93pmc__">
<sup>✉</sup><p class="display-inline">Corresponding author.</p>
</div>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Revised 2025 May 6; Received 2025 Mar 11; Accepted 2025 Aug 10; Issue date 2025 Sep.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© 2025 The Author(s). <em>Diabetes/Metabolism Research and Reviews</em> published by John Wiley &amp; Sons Ltd.</div>
<p>This is an open access article under the terms of the <a href="https://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by/4.0/</a> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12365466  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40831067/" class="usa-link">40831067</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>ABSTRACT</h2>
<p>An increasing number of individuals are at high risk of type 2 diabetes (T2DM) and its cardiovascular (CV) complications, which challenges healthcare systems with an increased risk of developing CV diseases. Patients with T2DM exhibit a unique cardiac phenotype termed diabetic cardiomyopathy (DCM). DCM usually involves complex and multifactorial pathogenic drivers, including myocardial inflammation, fibrosis, hypertrophy, and early diastolic dysfunction, which potentially evolve into systolic dysfunction and heart failure. There is a lack of effective treatments for DCM on the basis of the complexity of the disease per se and poor understanding of the mechanisms behind disease development and progression. Despite the considerable research attention on the onset of DCM development and progression, understanding of the full spectrum of pathogenic mechanisms has not yet been fully deciphered. Epigenetic alterations, including DNA methylation, histone modifications, bromodomain extra‐terminal (BET)‐containing reader proteins, and RNA‐based mechanisms (e.g., miRs, lncRNAs, circRNA), are significantly associated with the initiation and evolution of DCM, particularly in the early stage. In this review, we provide insights into the evidence of epigenetic alterations related to DCM development and progression characteristics. Furthermore, the uniqueness of epigenetic changes in DCM in specific cell types within diabetic hearts is discussed. We also review epigenetic cooperation in the context of DCM development and epigenetic biomarkers related to DCM progression. With recent advancements in technology, epitranscriptomics‐related to DCM has been uniquely discussed. Finally, this review may provide new avenues for potential implications for future research and the discovery of novel treatment targets for preventing the onset and progression of DCM.</p>
<section id="kwd-group1" class="kwd-group"><p><strong>Keywords:</strong> BET proteins, circRNAs, diabetic cardiomyopathy, DNA methylation, epigenetics, epitranscriptomics, histone modifications, lncRNA, miRNA</p></section></section><section id="dmrr70081-sec-0010"><h2 class="pmc_sec_title">1. Diabetic Cardiomyopathy and Epigenetics</h2>
<p>The prevalence of type 2 diabetes mellitus (T2DM) is increasing worldwide, and this diabetes epidemic is afflicting all ages, genders, and socioeconomic classes, leading to frailty and compromising healthy trajectories [<a href="#dmrr70081-bib-0001" class="usa-link" aria-describedby="dmrr70081-bib-0001">1</a>]. Epidemic increase in T2DM prevalence is linked to major changes in lifestyle and dietary habits, including high‐calorie and high‐fat diet (HFD) and sedentary attitudes [<a href="#dmrr70081-bib-0002" class="usa-link" aria-describedby="dmrr70081-bib-0002">2</a>]. These environmental triggers are significantly modulated by genetic predisposing factors, orchestrating epigenomic pathways that regulate gene expression and may contribute to cell and organ function modifications. For example, the control of inflammation by reprogramming immune cells has already been shown, demonstrating how epigenetic sensing leads to changes in chromatin accessibility and histone tail modification (methylation and acetylation) that favour inflammatory gene expression [<a href="#dmrr70081-bib-0003" class="usa-link" aria-describedby="dmrr70081-bib-0003">3</a>]. Thus, epigenomic mechanisms are at the interface between metabolic disorders and inflammation [<a href="#dmrr70081-bib-0004" class="usa-link" aria-describedby="dmrr70081-bib-0004">4</a>] and are implicated in inflammatory processes throughout T2DM development, which occurs when insulin secretion from pancreatic beta cells cannot sufficiently be increased to compensate for insulin resistance. Indeed, the development of T2DM is a slow process, preceded by a long and silent prediabetes phase with subtle organ complications that often remain undiagnosed and difficult to prevent at the medical level. For instance, recent data from the CARDIA study have provided good evidence for the diagnosis of diabetic cardiomyopathy (DCM), demonstrating that subtle systolic and/or diastolic myocardial abnormalities occur early in DCM development and precede the onset of overt cardiomyopathy [<a href="#dmrr70081-bib-0005" class="usa-link" aria-describedby="dmrr70081-bib-0005">5</a>]. These observations suggest that identifiable triggering factors are involved in the deterioration process, which could be subjected to interceptive actions. Notably, cardiovascular (CV) complications are the main causes of morbidity and mortality in T2DM patients, accounting for about two‐thirds of overall deaths, as evidenced by the Framingham Heart Study [<a href="#dmrr70081-bib-0006" class="usa-link" aria-describedby="dmrr70081-bib-0006">6</a>]. One of the major CV complications in T2DM is the onset of DCM, originally described as an early diastolic dysfunction leading progressively to systolic dysfunction and heart failure without hypertension, coronary artery disease and valvular or congenital heart disease [<a href="#dmrr70081-bib-0007" class="usa-link" aria-describedby="dmrr70081-bib-0007">7</a>].</p>
<p>DCM is now recognised as a distinct cardiac phenotype leading to ventricular remodelling and abnormal myocardial contractility, which correlate with multifactorial and complex molecular and cellular changes (Figure <a href="#dmrr70081-fig-0001" class="usa-link">1</a>) [<a href="#dmrr70081-bib-0005" class="usa-link" aria-describedby="dmrr70081-bib-0005">5</a>, <a href="#dmrr70081-bib-0008" class="usa-link" aria-describedby="dmrr70081-bib-0008">8</a>, <a href="#dmrr70081-bib-0009" class="usa-link" aria-describedby="dmrr70081-bib-0009">9</a>]. Both insulin resistance and chronic hyperglycaemia contribute to impaired cardiac contractility and structure via reduced Ca<sup>2+</sup> influx through L‐type Ca<sup>2+</sup> channels, impaired PI3K/Akt pathway, accumulated reactive oxygen species (ROS), increased advanced glycation end products (AGEs) formation, increased lipotoxicity, and multiple potential mechanisms such as autophagy, chronic inflammation, and epigenetic mechanisms [<a href="#dmrr70081-bib-0010" class="usa-link" aria-describedby="dmrr70081-bib-0010">10</a>]. Importantly, epigenetics associated with chronic inflammation and deregulation of the immune system play a major role in the dysregulation of glucose homeostasis, which in turn promotes gene‐activating epigenetic changes and signalling events critical in the development and progression of CV complications [<a href="#dmrr70081-bib-0011" class="usa-link" aria-describedby="dmrr70081-bib-0011">11</a>, <a href="#dmrr70081-bib-0012" class="usa-link" aria-describedby="dmrr70081-bib-0012">12</a>].</p>
<figure class="fig xbox font-sm" id="dmrr70081-fig-0001"><h3 class="obj_head">FIGURE 1.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0910/12365466/bbf869d7eeb3/DMRR-41-e70081-g001.jpg" loading="lazy" id="jats-graphic-1" height="826" width="709" alt="FIGURE 1"></p>
<div class="p text-right font-secondary"><a href="figure/dmrr70081-fig-0001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Contributing mechanisms related to cardiomyocytes that induce the pathobiology of diabetic cardiomyopathy. Type 2 diabetes mellitus with insulin resistance mediates systemic changes, including hyperglycaemia, hyperlipidaemia, and metabolic alterations. Systemic changes also interact with different signalling molecules, such as NADPH oxidase, to trigger the production of reactive oxygen species (ROS) or reactive nitrogen species. Dysfunctional mitochondria produce excess ROS, which increases oxidative stress. Oxidative stress is defined as an imbalance between inappropriate (e.g., excessive) ROS generation and the capacity for them to be degraded. Disrupted cell metabolism and oxidative stress can lead to endoplasmic reticulum (ER) stress, resulting in cardiomyocyte apoptosis and hypertrophy. Oxidative stress, ER stress, and inflammation can mutually activate and reinforce each other, driving these pathological processes. Furthermore, alterations in mitochondrial Ca<sup>2+</sup> signalling cause abnormalities in cardiomyocyte Ca<sup>2+</sup> handling and contractility. Impaired metabolic pathways, including abnormalities in substrate utilisation, mitochondrial function, AGE formation, and O‐GlcNAcylation, as well as changes at the level of insulin signalling, gene regulation, ER stress, autonomic dysfunction, and cardiac cell apoptosis, have been accepted as mediators of diabetes–induced cardiac remodelling and dysfunction. These contributing mechanisms are complex and multifactorial in the context of diabetes–induced cardiomyopathy. Collectively, these alterations contribute to cardiac impairments‐structural and functional changes, termed diabetic cardiomyopathy, potentially developing into HF over time. AGEs = Advanced glycation end products; CD36 = Cluster differentiation 36; ER = Endoplasmic reticulum; GLUT4 = Glucose transporter type 4; O‐GlcNAc = Oxygen‐linked β‐N‐acetylglucosamine; ROS = Reactive oxygen species.</p></figcaption></figure><p>The role of epigenetic modifications in DCM is currently not well deciphered, but growing evidence supports that T2DM drives an epigenetic reprogramming of cardiac metabolism, impairing both metabolic flexibility and metabolic memory [<a href="#dmrr70081-bib-0013" class="usa-link" aria-describedby="dmrr70081-bib-0013">13</a>], contributing to the development of heart failure [<a href="#dmrr70081-bib-0011" class="usa-link" aria-describedby="dmrr70081-bib-0011">11</a>]. Thus, understanding the impact of epigenetic processes in the context of DCM will provide new insights into this complex disease and guide new therapeutic strategies for preventing or reversing DCM. Indeed, as recently reviewed [<a href="#dmrr70081-bib-0014" class="usa-link" aria-describedby="dmrr70081-bib-0014">14</a>], ‘epidrugs’ may represent a viable therapeutic approach for preventing diabetic‐related heart failure, given the widespread epigenetic modifications that have been uncovered [<a href="#dmrr70081-bib-0015" class="usa-link" aria-describedby="dmrr70081-bib-0015">15</a>]. However, the numerous epigenetic regulatory proteins and chromatin modifications have yet to be fully assessed for their roles in the control of cardiac fibrosis and remodelling process in DCM. Furthermore, the utility of integrating cross‐species epigenomics needs to be addressed to demonstrate the potential relevance of this approach for human studies on DCM [<a href="#dmrr70081-bib-0016" class="usa-link" aria-describedby="dmrr70081-bib-0016">16</a>]. Taken together, understanding and investigating epigenetic factors involved in DCM development may provide promising new avenues to address DCM and slow disease progression. In the following sections, we discuss epigenetic factors related to DCM and summarise evidence of epigenetic alterations targeting pathogenic drivers of DCM.</p></section><section id="dmrr70081-sec-0020"><h2 class="pmc_sec_title">2. Epigenetic Mechanisms and Their Alterations in Diabetic Cardiomyopathy</h2>
<p>Systemic metabolic dysfunction in DM hyperglycaemia, dyslipidaemia and associated glucotoxicity, lipotoxicity and oxidative stress are the major pathological mechanisms driving the development of DCM [<a href="#dmrr70081-bib-0017" class="usa-link" aria-describedby="dmrr70081-bib-0017">17</a>, <a href="#dmrr70081-bib-0018" class="usa-link" aria-describedby="dmrr70081-bib-0018">18</a>]. These metabolic alterations are well established to predispose and influence pathological responses of resident and infiltrating myocardial immune cells that promote aberrant structural and functional cardiac changes in preclinical and clinical DCM [<a href="#dmrr70081-bib-0019" class="usa-link" aria-describedby="dmrr70081-bib-0019">19</a>, <a href="#dmrr70081-bib-0020" class="usa-link" aria-describedby="dmrr70081-bib-0020">20</a>, <a href="#dmrr70081-bib-0021" class="usa-link" aria-describedby="dmrr70081-bib-0021">21</a>, <a href="#dmrr70081-bib-0022" class="usa-link" aria-describedby="dmrr70081-bib-0022">22</a>]. Underlying this pathological cellular behaviour involves dynamic changes at the molecular level of various gene regulatory mechanisms that enable cells to respond or adapt to metabolic insults [<a href="#dmrr70081-bib-0023" class="usa-link" aria-describedby="dmrr70081-bib-0023">23</a>]. Consequently, epidemiological and clinical studies have suggested that these alterations that occur as a result of cumulative metabolic stress are retained in the form of ‘metabolic or glycaemic’ memory, which can contribute to long‐term diabetic complications [<a href="#dmrr70081-bib-0011" class="usa-link" aria-describedby="dmrr70081-bib-0011">11</a>, <a href="#dmrr70081-bib-0024" class="usa-link" aria-describedby="dmrr70081-bib-0024">24</a>, <a href="#dmrr70081-bib-0025" class="usa-link" aria-describedby="dmrr70081-bib-0025">25</a>, <a href="#dmrr70081-bib-0026" class="usa-link" aria-describedby="dmrr70081-bib-0026">26</a>]. Due to the clear association between environment, diet and transcriptional activity level on diabetes‐related complications, the influence of various epigenetic mechanisms and their contributions to dysfunctional gene regulation and subsequent aberrant cellular function in DCM is becoming increasingly apparent [<a href="#dmrr70081-bib-0027" class="usa-link" aria-describedby="dmrr70081-bib-0027">27</a>, <a href="#dmrr70081-bib-0028" class="usa-link" aria-describedby="dmrr70081-bib-0028">28</a>, <a href="#dmrr70081-bib-0029" class="usa-link" aria-describedby="dmrr70081-bib-0029">29</a>].</p>
<p>Epigenetics is defined as heritable modifications occurring in the genome resulting in a change in gene expression without affecting the DNA sequence [<a href="#dmrr70081-bib-0030" class="usa-link" aria-describedby="dmrr70081-bib-0030">30</a>]. Epigenetic mechanisms include histone modifications (e.g., acetylation, methylation), bromodomain extra‐terminal (BET)‐containing reader proteins, DNA methylation and non‐coding RNA (ncRNA)‐based mechanisms (Figure <a href="#dmrr70081-fig-0002" class="usa-link">2</a>). The latter encompasses small single‐strand ncRNA molecules named microRNAs (miRs), long non‐coding RNAs (lncRNAs), and more recently circular RNAs (circRNAs), which regulate their target genes at a post‐transcriptional level [<a href="#dmrr70081-bib-0031" class="usa-link" aria-describedby="dmrr70081-bib-0031">31</a>]. Of note, various components of the epigenetic machinery, such as the nicotinamide adenosine dinucleotide (NAD)‐dependent deacetylase, Sirtuin 1 (SIRT1), require intermediates of cellular metabolism for their enzymatic activity. In addition, changes in intracellular metabolism observed in T2DM can alter the expression of specific histone transferases, conferring widespread variations in epigenetic modification patterns [<a href="#dmrr70081-bib-0031" class="usa-link" aria-describedby="dmrr70081-bib-0031">31</a>, <a href="#dmrr70081-bib-0032" class="usa-link" aria-describedby="dmrr70081-bib-0032">32</a>]. Research in the field of ncRNA has highlighted new mechanistic links between diabetes and DCM, with evidence proving the involvement of miRs and lncRNAs in the pathogenesis of DCM [<a href="#dmrr70081-bib-0033" class="usa-link" aria-describedby="dmrr70081-bib-0033">33</a>]. Adding complexity to the matter, specific epigenetic signals affecting the three main layers of epigenetic modifications convey to alter metabolic homeostasis and cardiac function in the setting of experimental and human diabetes [<a href="#dmrr70081-bib-0034" class="usa-link" aria-describedby="dmrr70081-bib-0034">34</a>]. Therefore, the identification of these complex epigenetic alterations might lead to the development of novel therapeutics targeting pathogenic mechanisms underlying the development of DCM.</p>
<figure class="fig xbox font-sm" id="dmrr70081-fig-0002"><h3 class="obj_head">FIGURE 2.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0910/12365466/23a072933365/DMRR-41-e70081-g003.jpg" loading="lazy" id="jats-graphic-3" height="405" width="709" alt="FIGURE 2"></p>
<div class="p text-right font-secondary"><a href="figure/dmrr70081-fig-0002/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Landscape of location of epigenetic modifications. Epigenetics refers to the genetic influences that lead to altered gene expression without altering the DNA sequence. These epigenetic changes include DNA methylation, histone modifications, bromodomain and extra‐terminal domain (BET) proteins, or RNA‐based modifications (e.g., lncRNA, miR, and circRNA). (A) DNA methylation occurs predominantly at cytosine‐phosphate‐guanine (CpG) islands. This involves the addition of methyl groups to cytosines that are followed by guanine in the DNA sequence and is catalysed by DNA methyltransferases (DNMTs). DNA methylation regulates gene expression by recruiting proteins involved in gene repression or by inhibiting the binding of transcription factor(s) to DNA. (B) Histone complexes can undergo modifications at various positions on their tails, collectively forming what is known as the histone code. Histone tail acetylation by histone acetyltransferases (HATs) results in an open and accessible chromatin structure, facilitating transcription. Histone tail methylation, mediated by lysine methyltransferases (KMTs), can either activate or repress transcription. (C) Expression and activity of BET proteins are regulated at different levels, including transcription by 5‐hydroxymethylcytosine (5‐hmC) at the BRD4 promoter, messenger RNA (mRNA) stability by binding of microRNA (miRNA) to the 3′ untranslated region (UTR) of BRD4 mRNA transcripts, and translation by N<sup>6</sup>‐methyladenosine (m<sup>6</sup>A) modification of mRNA. (D) RNA‐based modifications (non‐coding RNAs; ncRNAs), including microRNAs (miRs), long ncRNAs (lncRNAs), and circular RNAs (circRNAs). These ncRNAs can govern epigenetic changes through several complex and multifactorial mechanisms as well as their sequences. miRs regulate gene expression by binding to complementary sequences on target mRNA, thereby inhibiting their translation. Expression of lncRNAs influences gene expression through diverse mechanisms, including chromatin remodelling, transcriptional co‐activation or repression, posttranscriptional modifications, and protein inhibition. circRNAs can function as miR sponges or decoys to regulate target mRNA. All these epigenetic regulations can interact with each other, indicating an intricate network to determine gene and protein expression. BET = Bromodomain and extra‐terminal domain; BRD4 = Bromodomain‐containing protein 4; DNMTs = DNA methyltransferases; HATs = Histone acetyltransferases; KMTs = Lysine methyltransferases; ncRNAs = Non‐coding RNAs.</p></figcaption></figure></section><section id="dmrr70081-sec-0030"><h2 class="pmc_sec_title">3. DNA Methylation</h2>
<p>DNA methylation is the enzymatic addition of a methyl group to the carbon 5′ position of a DNA cytosine ring, resulting in the formation of 5‐methylcytosine (5MeC) mediated by DNA methyltransferases (DNMT1, DNMT3A and DNMT3B) [<a href="#dmrr70081-bib-0029" class="usa-link" aria-describedby="dmrr70081-bib-0029">29</a>]. Regulation of gene expression by DNA methylation is primarily associated with transcriptional repression, occurring in the promoter region either directly or indirectly. DNA methylation can directly interfere with transcription factor binding to recognition sites in the promoter region or through the recruitment of co‐repressor proteins (e.g., methyl CpG‐binding protein 2 [MeCP2]) that promote the formation of a repressed chromatin state [<a href="#dmrr70081-bib-0035" class="usa-link" aria-describedby="dmrr70081-bib-0035">35</a>]. Outside of the promoter region, DNA methylation at intergenic regions and gene bodies has been widely reported to be positively correlated with enhanced gene expression [<a href="#dmrr70081-bib-0036" class="usa-link" aria-describedby="dmrr70081-bib-0036">36</a>, <a href="#dmrr70081-bib-0037" class="usa-link" aria-describedby="dmrr70081-bib-0037">37</a>]. Although this is not entirely understood, it is becoming more appreciated that DNA methylation in these regions can orchestrate gene expression by suppressing spurious transcription initiation, regulating alternative splicing, ensuring correct splicing and translation, and by the recruitment of other epigenetic modifiers, such as histone methylation modifiers [<a href="#dmrr70081-bib-0038" class="usa-link" aria-describedby="dmrr70081-bib-0038">38</a>, <a href="#dmrr70081-bib-0039" class="usa-link" aria-describedby="dmrr70081-bib-0039">39</a>]. DNA methylation is reversible in nature and methylated cytosines can be enzymatically removed by the ten‐eleven translocation proteins (TET1‐3), leading to the formation of breakdown products such as 5‐hydroxy‐methylcytosine (5H‐MeC) [<a href="#dmrr70081-bib-0040" class="usa-link" aria-describedby="dmrr70081-bib-0040">40</a>], demonstrating the dynamic and complex regulatory action on gene transcription of this epigenetic mechanism to regulate gene expression [<a href="#dmrr70081-bib-0041" class="usa-link" aria-describedby="dmrr70081-bib-0041">41</a>].</p>
<p>The influence of differential DNA methylation in patients with DM has been well documented in the literature. Follow‐on studies from the Diabetes Control and Complications Trial (DCCT) [<a href="#dmrr70081-bib-0042" class="usa-link" aria-describedby="dmrr70081-bib-0042">42</a>] and in the Epidemiology of Diabetes Interventions and Complications (EDIC) [<a href="#dmrr70081-bib-0043" class="usa-link" aria-describedby="dmrr70081-bib-0043">43</a>] studies highlighted persistent differential methylation at several genomic loci over more than a 16–17 years follow up period between cases and controls [<a href="#dmrr70081-bib-0044" class="usa-link" aria-describedby="dmrr70081-bib-0044">44</a>]. Of note, a significant reduction in methylation at the 3′ untranslated region of thioredoxin‐interacting protein (TXNIP) gene, known to be associated with oxidative stress and diabetic complications [<a href="#dmrr70081-bib-0045" class="usa-link" aria-describedby="dmrr70081-bib-0045">45</a>], was detected to persist in both whole blood and leukocytes (monocytes and lymphocytes) in the case cohort (patients with HbA1c &gt; 9.1% and significant progression of retinopathy and/or nephropathy) [<a href="#dmrr70081-bib-0046" class="usa-link" aria-describedby="dmrr70081-bib-0046">46</a>]. Reduced methylation of the TXNIP gene under hyperglycaemic conditions was validated in THP1 cells and was mirrored by a marked increase in its expression [<a href="#dmrr70081-bib-0046" class="usa-link" aria-describedby="dmrr70081-bib-0046">46</a>]. Interestingly, enhanced expression of TXNIP has also been reported in the hearts of STZ‐mice (Streptozotocin‐induced diabetic models in mice), with improved glucose uptake and preserved inotropic response to β‐adrenergic receptor stimulation reported with cardiomyocyte specific deletion of TXNIP [<a href="#dmrr70081-bib-0047" class="usa-link" aria-describedby="dmrr70081-bib-0047">47</a>], suggesting a potential mechanistic involvement of DNA methylation in regulating myocardial expression of TXNIP. Similarly, enhanced expression of liver X receptor alpha (LXRα) in the diabetic rat myocardium has also been associated with hypomethylation of 9 CpGs across a 213‐bp region in the gene promoter region. Increased myocardial expression of LXRα through hypomethylation may serve as a protective response in the heart under hyperglycaemic stress, as treatment of db/db mice with an LXR agonist (GW3965) demonstrated a reduction in myocardial inflammation and collagen deposition coupled with improvements in diastolic function [<a href="#dmrr70081-bib-0048" class="usa-link" aria-describedby="dmrr70081-bib-0048">48</a>].</p>
<p>Enrichment in DNA methylation variations at specific regions of the genome with a linkage disequilibrium association to T2DM using whole blood samples was demonstrated by Toperoff and colleagues. This study identified significant differences in methylation at intronic regions of genes such as KCNQ1, TCF7L2, JAZF1, THADA and FTO in T2DM patients compared with healthy volunteers [<a href="#dmrr70081-bib-0049" class="usa-link" aria-describedby="dmrr70081-bib-0049">49</a>]. Interestingly, subsequent bisulfite sequencing validation revealed that a specific CpG site in the first intron of FTO is hypomethylated in T2DM subjects compared with the control group. Although the functional impact of FTO hypomethylation on its expression was not examined in this study, it has been recently demonstrated that levels of FTO in diabetic murine myocardium are significantly reduced [<a href="#dmrr70081-bib-0050" class="usa-link" aria-describedby="dmrr70081-bib-0050">50</a>]. Whether or not hypomethylation at this intronic CpG site of FTO is present in the T2DM myocardium, and its relevance to reduced myocardial FTO expression in the context of DM remains to be investigated further.</p>
<p>At the tissue level, DNA methylation differences have been identified in the context of hyperglycaemia and T2DM. Nilsson and colleagues conducted genome‐wide transcriptome and CpG methylation analysis in adipose tissue from patients with T2DM versus non‐diabetic subjects and found differential methylation at sites representing candidate T2DM genes, specifically IRS1, KCNQ1, TCF7L2 and PPARG [<a href="#dmrr70081-bib-0051" class="usa-link" aria-describedby="dmrr70081-bib-0051">51</a>]. Interestingly, their work highlighted a reduced expression of PPARG, an essential regulator in adipogenesis and inflammation, in the adipose tissue from discordant twins [<a href="#dmrr70081-bib-0051" class="usa-link" aria-describedby="dmrr70081-bib-0051">51</a>]. PPARG expression has been shown to be significantly elevated in the hearts of diabetic animal models [<a href="#dmrr70081-bib-0052" class="usa-link" aria-describedby="dmrr70081-bib-0052">52</a>, <a href="#dmrr70081-bib-0053" class="usa-link" aria-describedby="dmrr70081-bib-0053">53</a>], which suggests that tissue specific changes in DNA methylation may occur and impact cellular function, metabolism and inflammation in the diabetic environment promoting tissue specific dysfunction. Within the heart itself, a recent study using methylated and hydroxymethylated DNA immunoprecipitation‐sequencing highlighted enhancement of 5MeC and 5hMeC across the genome in the hearts of STZ rat hearts that is accompanied by an increase in DNMT3B, MeCP2 and MBD2 expression [<a href="#dmrr70081-bib-0040" class="usa-link" aria-describedby="dmrr70081-bib-0040">40</a>]. Differential methylation and hydroxymethylation in the diabetic ventricular tissue were associated with pathways related to Ca<sup>2+</sup>, Rap1, phospholipase D, apelin and phosphatidylinositol signalling. Their work demonstrated that treatment with alpha‐ketoglutarate (a‐KG) blunted the increase in global 5MeC and 5hMeC and attenuated myocardial fibrosis and cardiomyocyte degeneration in diabetic animals. Mechanistically, the authors noted that in response to a‐KG treatment, lowered the enrichment of methylation and hydroxymethylation in the TGFBR2 and TGFBR3 intronic regions, which resulted in a reduction in their mRNA expression. This study demonstrates that reverting hyperglycaemic damage to cardiac tissue (e.g., promoting cardiac fibrosis) might be possible by reducing adverse epigenetic signatures by supplementing epigenetic modulators such as a‐KG along with an existing antidiabetic treatment regimen [<a href="#dmrr70081-bib-0040" class="usa-link" aria-describedby="dmrr70081-bib-0040">40</a>]. An additional study reported global DNA hypermethylation within the cardiac tissue in diabetic mice [<a href="#dmrr70081-bib-0054" class="usa-link" aria-describedby="dmrr70081-bib-0054">54</a>]. The level of DNA methylation increased further when the diabetic mice were subjected to ischaemic reperfusion injury, which coincided with alterations in mitochondrial functional genes [<a href="#dmrr70081-bib-0054" class="usa-link" aria-describedby="dmrr70081-bib-0054">54</a>].</p>
<p>Co‐repressor proteins that bind to methylated DNA have also been implicated in the pathogenesis of DCM. MeCP2 levels are significantly increased in the fibrotic myocardium of diabetic patients and STZ‐treated rats and negatively regulate Ras association domain family 1 isoform A (RASSF1A) levels to promote Ras/ERK1/2 activation and proliferation of fibroblasts in response to hyperglycaemia [<a href="#dmrr70081-bib-0055" class="usa-link" aria-describedby="dmrr70081-bib-0055">55</a>]. In addition to methylation occurring in CpG sequences of nuclear DNA, this chemical modification also takes place in mitochondrial DNA (mtDNA), regulating both mitochondrial DNA transcription and replication, termed ‘mitoepigenetics’ [<a href="#dmrr70081-bib-0056" class="usa-link" aria-describedby="dmrr70081-bib-0056">56</a>]. However, the presence of cytosine methylation in the mitochondrial genome is debated, and this requires further studies [<a href="#dmrr70081-bib-0057" class="usa-link" aria-describedby="dmrr70081-bib-0057">57</a>]. Methylation of mtDNA consists of adding a methyl group to a DNA base, usually cytosine (C) or adenine (A), from S‐Adenosyl methionine, mediated by DNMTs [<a href="#dmrr70081-bib-0056" class="usa-link" aria-describedby="dmrr70081-bib-0056">56</a>]. Importantly, compelling evidence indicates that mtDNA gene transcription is impacted by DNMTs, demonstrating that mitochondrial gene transcripts are regulated by mtDNA methylation [<a href="#dmrr70081-bib-0058" class="usa-link" aria-describedby="dmrr70081-bib-0058">58</a>]. In the heart, mtDNA methylation alteration influences mitochondrial bioenergetics and transcriptional regulatory processes involved in mitochondrial dynamics, including mitochondrial fission and fusion [<a href="#dmrr70081-bib-0059" class="usa-link" aria-describedby="dmrr70081-bib-0059">59</a>]. To underline the importance of mtDNA, studies reveal that modifications of mtDNA are associated with insulin resistance, myopathies and DM complications [<a href="#dmrr70081-bib-0060" class="usa-link" aria-describedby="dmrr70081-bib-0060">60</a>, <a href="#dmrr70081-bib-0061" class="usa-link" aria-describedby="dmrr70081-bib-0061">61</a>, <a href="#dmrr70081-bib-0062" class="usa-link" aria-describedby="dmrr70081-bib-0062">62</a>]. Changes in mtDNA methylation correlate with insulin resistance and the subsequent conditions of prediabetes and T2DM [<a href="#dmrr70081-bib-0063" class="usa-link" aria-describedby="dmrr70081-bib-0063">63</a>]. Besides, methylation of mtDNA in vascular smooth muscle cells contributes to impaired mitochondrial function and loss of contractile phenotype in vascular occlusive disease [<a href="#dmrr70081-bib-0064" class="usa-link" aria-describedby="dmrr70081-bib-0064">64</a>]. However, the role of mtDNA methylation in the progression of DCM has yet to be investigated. Interestingly, mtDNA is devoid of protective histones, and its close proximity to the ROS‐producing electron transport chain therefore increases its susceptibility to mutations [<a href="#dmrr70081-bib-0065" class="usa-link" aria-describedby="dmrr70081-bib-0065">65</a>]. In the context of diabetic retinopathy, it has been reported that epigenetic modifications promote a decrease in the expression of MutL homolog 1 (Mlh1), a key enzyme responsible for repairing base mismatches, leading to a decrease in mitochondrial accumulation and subsequent repair of mtDNA mismatches [<a href="#dmrr70081-bib-0066" class="usa-link" aria-describedby="dmrr70081-bib-0066">66</a>]. It is suggested that strategies targeting the regulation of DNA methylation could have the potential to protect mitochondrial homeostasis by preventing base mismatches and the development of diabetic retinopathy. It remains to be investigated whether and how this mechanism contributes to the development of DCM.</p></section><section id="dmrr70081-sec-0040"><h2 class="pmc_sec_title">4. Histone Modifications</h2>
<p>Histone modifications are small chemical modifications to the amino acid side chains of histone proteins that are added and removed by a multitude of highly specific enzymes, which influence chromatin structure to finely regulate gene expression [<a href="#dmrr70081-bib-0067" class="usa-link" aria-describedby="dmrr70081-bib-0067">67</a>]. Modification at specific positions within histone tails can affect both the histone‐DNA interactions and inter‐nucleosomal interactions, facilitating remodelling of the chromatin structure and influencing the accessibility of transcriptional machinery binding to the DNA to regulate gene expression [<a href="#dmrr70081-bib-0068" class="usa-link" aria-describedby="dmrr70081-bib-0068">68</a>]. Furthermore, it has become increasingly apparent that regulation of gene expression by histone modifications is mediated by the recruitment of effector modules or ‘readers’ to local chromatin sites that recognise the modifications and have a functional impact on transcriptional activity [<a href="#dmrr70081-bib-0069" class="usa-link" aria-describedby="dmrr70081-bib-0069">69</a>]. Modifications to histone proteins that are known to influence gene expression include acetylation, methylation, phosphorylation, poly‐ADP‐ribosylation, ubiquitination, deamination, sumoylation and glycosylation [<a href="#dmrr70081-bib-0070" class="usa-link" aria-describedby="dmrr70081-bib-0070">70</a>].</p>
<p>The best characterised of these modifications are lysine acetylation and deacetylation, and lysine methylation and demethylation. Histone acetylation is the process by which acetyl groups are added to ε‐amino group of lysine side chains and is catalysed by the histone acetyltransferase enzymes (such as GNAT family, p300, The MYST family) [<a href="#dmrr70081-bib-0071" class="usa-link" aria-describedby="dmrr70081-bib-0071">71</a>]. Addition of acetyl groups results in neutralisation of the charge interaction between the negatively charged DNA backbone and the positively charged lysine residues, promoting relaxed chromatin conformation and active gene transcription. Removal of acetyl groups is carried out by histone deacetylase enzymes (HDACs), which result in chromatin condensation and, therefore, repress transcriptional competence [<a href="#dmrr70081-bib-0072" class="usa-link" aria-describedby="dmrr70081-bib-0072">72</a>].</p>
<p>The process and consequences of histone methylation are more complex than acetylation. Lysine residues on histone tails can be methylated to different degrees (mono‐, di‐ or tri‐methyl) by methyltransferase enzymes (e.g., SET‐domain family and the DOT1L/KMT4 family) and subsequently removed under the action of histone demethylase enzymes LSD demethylases (e.g., LSD1 and LSD2) and the Jumonji C‐domain containing demethylases (JMJDs). Methylation at specific lysine residues on histone protein 3, H3K4 (enrichment of H3K4me1 at enhancer elements and H3K4me3 at active promoters), H3K26 and H3K79 are associated with active gene transcription, whereas methylation at H3K27, H3K9 and H3K20 is associated with transcriptionally silenced heterochromatin [<a href="#dmrr70081-bib-0073" class="usa-link" aria-describedby="dmrr70081-bib-0073">73</a>]. Protein complexes can also modify chromatin structure through regulation of histone methylation activity, such as the Trithorax group (promotes gene transcription through their H3K4 trimethylase activity) and the silencing polycomb group (enhancer of zeste homolog 2 (EZH2) has H3K27‐specific trimethylase activity) complexes, both of which have been shown to be critical for normal cardiac development and function [<a href="#dmrr70081-bib-0074" class="usa-link" aria-describedby="dmrr70081-bib-0074">74</a>].</p>
<p>Mounting evidence has highlighted the contribution of dysfunctional changes in both histone acetylation and methylation in the failing heart [<a href="#dmrr70081-bib-0075" class="usa-link" aria-describedby="dmrr70081-bib-0075">75</a>, <a href="#dmrr70081-bib-0076" class="usa-link" aria-describedby="dmrr70081-bib-0076">76</a>], with several studies describing alterations in the context of DCM. Changes in both histone acetylation and methylation have been reported to influence cardiac cell function under hyperglycaemic conditions. Culture of cardiomyoblasts (H9c2 cells) in high glucose resulted in enhanced cellular apoptosis found to be mediated by the reduction in IGFR1 expression associated with HDAC1 recruitment by p53 and lower levels of acetylation at the IGF1R promoter region [<a href="#dmrr70081-bib-0077" class="usa-link" aria-describedby="dmrr70081-bib-0077">77</a>]. Exposure of cardiomyoblasts to high glucose levels was also found to enhance the expression of IL‐6, even when cells were returned to physiological conditions. This maintained pro‐inflammatory response was associated with reduced expression of the SET‐domain methyltransferase Suv39h1 and reduced H3K9me3 marks at the IL‐6 promoter [<a href="#dmrr70081-bib-0078" class="usa-link" aria-describedby="dmrr70081-bib-0078">78</a>]. Subsequent establishment of a pro‐inflammatory cellular phenotype by hyperglycaemia‐induced changes in histone methylation was also demonstrated in human endothelial cells. Transient exposure of endothelial cells to high glucose levels promoted a Set7‐mediated increase in H3K4me1 marks at the promoter region of p65 that resulted in augmented expression of pro‐inflammatory mediators VCAM‐1 and MCP‐1, even after subsequent culture at physiological glucose levels [<a href="#dmrr70081-bib-0079" class="usa-link" aria-describedby="dmrr70081-bib-0079">79</a>, <a href="#dmrr70081-bib-0080" class="usa-link" aria-describedby="dmrr70081-bib-0080">80</a>]. Moreover, Set7 methylation of H3K4 impacted cardiac structure, function, and metabolic parameters in response to chronic stresses, such as isoproterenol‐induced cardiac hypertrophy, epigenetic hyperglycaemic memory, and glucose tolerance [<a href="#dmrr70081-bib-0081" class="usa-link" aria-describedby="dmrr70081-bib-0081">81</a>]. Targeting Set 7 may therefore serve as a therapeutic treatment in response to chronic stress, including metabolic disturbances [<a href="#dmrr70081-bib-0082" class="usa-link" aria-describedby="dmrr70081-bib-0082">82</a>, <a href="#dmrr70081-bib-0083" class="usa-link" aria-describedby="dmrr70081-bib-0083">83</a>].</p>
<p>Various studies utilising different preclinical models of DM have indicated alterations in both histone methylation and acetylation associated with pathological cardiac remodelling in vivo. Global changes in H3 histone marks reduced H3K9me2 and increased acetylation (H3K23 and H3K9), and H3K4me2 were found in cardiac tissue of db/db mice with renal complications [<a href="#dmrr70081-bib-0084" class="usa-link" aria-describedby="dmrr70081-bib-0084">84</a>]. In response to STZ‐induced hyperglycaemia in CD1 mice, increased nuclear H3K27me3 accompanied by a reduction in H3K9 acetylation, was measured in cardiac tissue after 12 weeks post‐STZ administration [<a href="#dmrr70081-bib-0085" class="usa-link" aria-describedby="dmrr70081-bib-0085">85</a>]. In spontaneously diabetic Goto‐Kakizaki rats with pronounced post‐ischaemic cardiac remodelling induced by myocardial infarction, cardiac Sirt‐1 levels (class III HDAC) were significantly upregulated and accompanied by a reduction in levels of acetylated‐p53 in the remote myocardium [<a href="#dmrr70081-bib-0086" class="usa-link" aria-describedby="dmrr70081-bib-0086">86</a>]. The associated increased expression of Sirt‐1 is postulated to be a cardioprotective response to hyperglycaemic injury, as pharmacological activation of Sirt‐1 resulted in attenuation of cardiac hypertrophy and oxidative stress through a reduction in acetylation of NF‐kB‐p65 and global cardiac H3K9 levels in fructose‐fed diabetic rats [<a href="#dmrr70081-bib-0087" class="usa-link" aria-describedby="dmrr70081-bib-0087">87</a>]. Other pharmacological intervention studies targeting HDACs have also demonstrated therapeutic benefits in the context of DCM. This includes evidence that HDAC inhibition ameliorates cardiac performance and mitigates metabolic disturbances in murine models of both type I and type II diabetes [<a href="#dmrr70081-bib-0076" class="usa-link" aria-describedby="dmrr70081-bib-0076">76</a>]. For example, administration of a selective HDAC3 inhibitor RGFP966 prevented DCM progression in diabetic OVE26 mice, with treated animals, through a sustained reduction in inflammation, oxidative stress and cardiac fibrosis. HDAC3 inhibition resulted in enhanced acetylation at the promoter region of the nuclear phosphatase DUSP5 gene, leading to increased expression and its inhibitory action on ERK1/2 activity [<a href="#dmrr70081-bib-0088" class="usa-link" aria-describedby="dmrr70081-bib-0088">88</a>]. Moreover, Hu and colleagues [<a href="#dmrr70081-bib-0089" class="usa-link" aria-describedby="dmrr70081-bib-0089">89</a>] demonstrated that PRDM16 exhibited protection of myocardial lipid metabolism and mitochondrial function in DCM mice depending on epigenetic regulation of H3K4me3 by modulating PPAR‐α and PGC‐1α. Therefore, developing a PRDM16 activator targeting PPAR‐α and PGC‐1α pathways could be a novel therapeutic strategy for treating cardiac abnormalities in T2DM [<a href="#dmrr70081-bib-0089" class="usa-link" aria-describedby="dmrr70081-bib-0089">89</a>].</p></section><section id="dmrr70081-sec-0050"><h2 class="pmc_sec_title">5. BET Proteins</h2>
<p>The bromodomain and extra‐terminal domain (BET) family of proteins (BRD2, BRD3, BRD4 and BRDT) function as epigenetic reader proteins that are now appreciated to play an essential role in gene regulation in both physiological and pathological states. These proteins mediate their regulatory function by coupling proximal signals and multi‐protein complexes to transcription factors and chromatin marks (e.g., acetylated histone marks) [<a href="#dmrr70081-bib-0090" class="usa-link" aria-describedby="dmrr70081-bib-0090">90</a>]. Mounting evidence suggests that BET proteins are key elements underlying the pathophysiology of CV complications [<a href="#dmrr70081-bib-0091" class="usa-link" aria-describedby="dmrr70081-bib-0091">91</a>, <a href="#dmrr70081-bib-0092" class="usa-link" aria-describedby="dmrr70081-bib-0092">92</a>], with reports demonstrating their alterations in response to hyperglycaemia. Among BET proteins, BRD4 is the most well‐researched BET protein, known as the ‘reader’ of lysine acetylation in the context of response to various stressed conditions, including the diabetic heart [<a href="#dmrr70081-bib-0093" class="usa-link" aria-describedby="dmrr70081-bib-0093">93</a>, <a href="#dmrr70081-bib-0094" class="usa-link" aria-describedby="dmrr70081-bib-0094">94</a>]. BRD4 expression has been shown to be significantly increased in both cardiomyoblasts [<a href="#dmrr70081-bib-0095" class="usa-link" aria-describedby="dmrr70081-bib-0095">95</a>, <a href="#dmrr70081-bib-0096" class="usa-link" aria-describedby="dmrr70081-bib-0096">96</a>] and fibroblasts [<a href="#dmrr70081-bib-0095" class="usa-link" aria-describedby="dmrr70081-bib-0095">95</a>] exposed to high concentrations of glucose in vitro. In support of the aberrant role in hyperglycaemia, elevated expression of BRD4 was demonstrated in the myocardium of several preclinical models of DCM (STZ‐mice and rats and HFD‐mice), with pharmacological inhibition of BET activity (BET inhibitor, JQ1) leading to attenuation of pathological cardiac remodelling and subsequent improvements in cardiac function [<a href="#dmrr70081-bib-0094" class="usa-link" aria-describedby="dmrr70081-bib-0094">94</a>, <a href="#dmrr70081-bib-0095" class="usa-link" aria-describedby="dmrr70081-bib-0095">95</a>, <a href="#dmrr70081-bib-0096" class="usa-link" aria-describedby="dmrr70081-bib-0096">96</a>]. Reported mechanistic benefits of inhibiting the action of BRD4 in hyperglycaemia conditions are associated with increased caveolin‐1 expression [<a href="#dmrr70081-bib-0095" class="usa-link" aria-describedby="dmrr70081-bib-0095">95</a>], reduced AKT phosphorylation [<a href="#dmrr70081-bib-0096" class="usa-link" aria-describedby="dmrr70081-bib-0096">96</a>] and most recently, activation of PINK1/Parkin‐mediated mitophagy [<a href="#dmrr70081-bib-0094" class="usa-link" aria-describedby="dmrr70081-bib-0094">94</a>] (Figure <a href="#dmrr70081-fig-0003" class="usa-link">3</a>).</p>
<figure class="fig xbox font-sm" id="dmrr70081-fig-0003"><h3 class="obj_head">FIGURE 3.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0910/12365466/ead44d212d6e/DMRR-41-e70081-g002.jpg" loading="lazy" id="jats-graphic-5" height="356" width="709" alt="FIGURE 3"></p>
<div class="p text-right font-secondary"><a href="figure/dmrr70081-fig-0003/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Bromodomain and extra‐terminal domain (BET) proteins and diabetic cardiomyopathy. (A) BRD4 is a member of the BET family of epigenetic regulators and is upregulated in diabetic cardiomyopathy, resulting in accumulation of damaged mitochondria and subsequent impairment of cardiac structure and function. (B) BET inhibitor (JQ1) alleviates the pathogenesis of diabetic cardiomyopathy with improved mitochondrial function and repaired cardiac structure and function. BET = Bromodomain and extra‐terminal domain; BRD4 = Bromodomain‐containing protein 4.</p></figcaption></figure><p>Although primarily under investigation in clinical oncology, the clinical utility of selective BET inhibitors for the treatment of CV disease has recently been examined in the recent Phase 3 BETonMACE trial. Unfortunately, treatment with the bromodomain 2 (BD2)‐specific BET inhibitor apabetalone showed no significant difference in major adverse CV events (CV death, stroke and myocardial infarction) in T2DM patients with recent acute coronary syndromes and low HDL‐c compared with placebo [<a href="#dmrr70081-bib-0097" class="usa-link" aria-describedby="dmrr70081-bib-0097">97</a>]. However, exploratory analyses of this trial have suggested that apabetalone may have CV benefits in specific at‐risk populations. Patients with T2DM, recent acute coronary disease, and a moderate likelihood of Non‐alcoholic Fatty Liver Disease were found to have a significantly lower rate of ischaemic adverse CV events and hospitalisation for heart failure after treatment with apabetalone [<a href="#dmrr70081-bib-0098" class="usa-link" aria-describedby="dmrr70081-bib-0098">98</a>]. Similarly, a reduction in hospitalisation for heart failure was also noted in T2DM patients with chronic kidney disease and lower LDL‐C levels who received apabetalone compared to placebo [<a href="#dmrr70081-bib-0099" class="usa-link" aria-describedby="dmrr70081-bib-0099">99</a>]. While further in‐depth analysis from the BETonMACE trial is still ongoing, BET inhibition in T2DM patients seems to show therapeutic impact on CV events and highlights the potential for specifically targeting other BET proteins, such as BRD4, that may prove to be an effective therapeutic strategy for patients with DCM.</p></section><section id="dmrr70081-sec-0060"><h2 class="pmc_sec_title">6. microRNAs</h2>
<p>microRNAs (miRs) are RNA molecules comprised of 18–22 nucleotides that regulate gene expression at the level of mRNA translation by binding to mRNAs and targeting them for repression or degradation. Transcriptional regulation by miRs is complex as individual miRs can control the expression of numerous target mRNAs, and each target mRNA can be regulated by multiple different miRs [<a href="#dmrr70081-bib-0100" class="usa-link" aria-describedby="dmrr70081-bib-0100">100</a>]. Considering their key roles in modulating the expression of multiple genes, it is no surprise that several candidate miRs have been highlighted in clinical samples and various preclinical diabetic models to be involved in the numerous pathophysiological processes in DCM, for instance, excessive oxidative stress (miR‐144 [<a href="#dmrr70081-bib-0101" class="usa-link" aria-describedby="dmrr70081-bib-0101">101</a>], miR‐14 [<a href="#dmrr70081-bib-0102" class="usa-link" aria-describedby="dmrr70081-bib-0102">102</a>], miR‐185 [<a href="#dmrr70081-bib-0103" class="usa-link" aria-describedby="dmrr70081-bib-0103">103</a>], miR‐673 [<a href="#dmrr70081-bib-0034" class="usa-link" aria-describedby="dmrr70081-bib-0034">34</a>]), fatty acid metabolism (miR‐320 [<a href="#dmrr70081-bib-0104" class="usa-link" aria-describedby="dmrr70081-bib-0104">104</a>]), fibrosis (miR‐29 [<a href="#dmrr70081-bib-0105" class="usa-link" aria-describedby="dmrr70081-bib-0105">105</a>], miR‐15a/b [<a href="#dmrr70081-bib-0106" class="usa-link" aria-describedby="dmrr70081-bib-0106">106</a>], miR‐200b [<a href="#dmrr70081-bib-0107" class="usa-link" aria-describedby="dmrr70081-bib-0107">107</a>]), apoptosis (miR‐30d [<a href="#dmrr70081-bib-0108" class="usa-link" aria-describedby="dmrr70081-bib-0108">108</a>], miR‐195 [<a href="#dmrr70081-bib-0109" class="usa-link" aria-describedby="dmrr70081-bib-0109">109</a>], miR‐483‐3p [<a href="#dmrr70081-bib-0110" class="usa-link" aria-describedby="dmrr70081-bib-0110">110</a>]), myocyte hypertrophy (miR‐208a [<a href="#dmrr70081-bib-0111" class="usa-link" aria-describedby="dmrr70081-bib-0111">111</a>], miR‐133a [<a href="#dmrr70081-bib-0112" class="usa-link" aria-describedby="dmrr70081-bib-0112">112</a>], miR‐451 [<a href="#dmrr70081-bib-0113" class="usa-link" aria-describedby="dmrr70081-bib-0113">113</a>]) and inflammation (miR‐146a [<a href="#dmrr70081-bib-0114" class="usa-link" aria-describedby="dmrr70081-bib-0114">114</a>], miR‐9 [<a href="#dmrr70081-bib-0115" class="usa-link" aria-describedby="dmrr70081-bib-0115">115</a>], miR‐181 [<a href="#dmrr70081-bib-0116" class="usa-link" aria-describedby="dmrr70081-bib-0116">116</a>]). In diabetic hearts, specific miR expression, such as miR‐1 was found to be upregulated [<a href="#dmrr70081-bib-0117" class="usa-link" aria-describedby="dmrr70081-bib-0117">117</a>] or downregulated [<a href="#dmrr70081-bib-0118" class="usa-link" aria-describedby="dmrr70081-bib-0118">118</a>], suggesting that the specific miR could respond differently to the trigger based on complexities and involve multiple mechanisms in the progression of DCM. Furthermore, overexpression of miR‐200a‐3p in DCM mice mitigated cardiac dysfunction, fibrosis, inflammation, cardiomyocyte apoptosis and increased autophagy [<a href="#dmrr70081-bib-0119" class="usa-link" aria-describedby="dmrr70081-bib-0119">119</a>]. miR‐494 was recently reported to upregulate expression in DCM rats and was associated with cell apoptosis and autophagy [<a href="#dmrr70081-bib-0120" class="usa-link" aria-describedby="dmrr70081-bib-0120">120</a>]. Therefore, augmenting miR‐200a‐3p and inhibiting miR‐494 may provide therapeutic effects in the context of DCM [<a href="#dmrr70081-bib-0119" class="usa-link" aria-describedby="dmrr70081-bib-0119">119</a>, <a href="#dmrr70081-bib-0120" class="usa-link" aria-describedby="dmrr70081-bib-0120">120</a>]. These results underline the complex regulation of the specific miR in response to determinants and potentially promote multiple pathogenic drivers of DCM. It also seems that changes in miR expression in response to hyperglycaemic insult may persist even after glycaemic levels return to normal, facilitating pathological development in the heart [<a href="#dmrr70081-bib-0121" class="usa-link" aria-describedby="dmrr70081-bib-0121">121</a>]. Conversely, recent reports have suggested that miR expression may be positively changed through interventional methods, such as high‐intensity exercise training, to reduce associated cardiac dysfunction with diabetes [<a href="#dmrr70081-bib-0122" class="usa-link" aria-describedby="dmrr70081-bib-0122">122</a>]. The expression of many miRs is dysregulated in the diabetic heart and may be modified in the plasma of diabetic individuals. For this reason, miRs have been proposed as potential biomarkers for the prognosis and diagnosis of patients with DCM. To enhance the understanding of the complexity of miRs involved in DCM progression, the DCM‐related miR‐mRNA network and DCM‐related competitive endogenous RNA (ceRNA) were investigated [<a href="#dmrr70081-bib-0123" class="usa-link" aria-describedby="dmrr70081-bib-0123">123</a>]. The results identified five hub genes—phospholamban (Pln), fatty acid binding protein 3 (Fabp3), tripartite motif‐containing protein 63 (Trim63), popeye domain containing 2 (Popdc2), and troponin C1 (Tnnc1)—related to ceRNA, which are accountable for the onset of DCM [<a href="#dmrr70081-bib-0123" class="usa-link" aria-describedby="dmrr70081-bib-0123">123</a>]. The involvement of miRs in the pathogenesis of DCM, as well as in the context of potential therapeutic targets, have been comprehensively summarised elsewhere [<a href="#dmrr70081-bib-0124" class="usa-link" aria-describedby="dmrr70081-bib-0124">124</a>, <a href="#dmrr70081-bib-0125" class="usa-link" aria-describedby="dmrr70081-bib-0125">125</a>, <a href="#dmrr70081-bib-0126" class="usa-link" aria-describedby="dmrr70081-bib-0126">126</a>, <a href="#dmrr70081-bib-0127" class="usa-link" aria-describedby="dmrr70081-bib-0127">127</a>, <a href="#dmrr70081-bib-0128" class="usa-link" aria-describedby="dmrr70081-bib-0128">128</a>, <a href="#dmrr70081-bib-0129" class="usa-link" aria-describedby="dmrr70081-bib-0129">129</a>, <a href="#dmrr70081-bib-0130" class="usa-link" aria-describedby="dmrr70081-bib-0130">130</a>, <a href="#dmrr70081-bib-0131" class="usa-link" aria-describedby="dmrr70081-bib-0131">131</a>] (Figure <a href="#dmrr70081-fig-0004" class="usa-link">4</a>).</p>
<figure class="fig xbox font-sm" id="dmrr70081-fig-0004"><h3 class="obj_head">FIGURE 4.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0910/12365466/7ceb6f1d4373/DMRR-41-e70081-g005.jpg" loading="lazy" id="jats-graphic-7" height="566" width="709" alt="FIGURE 4"></p>
<div class="p text-right font-secondary"><a href="figure/dmrr70081-fig-0004/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Biogenesis and function of non‐coding RNAs (miR, lncRNA, circRNA) and diabetic cardiomyopathy. (A) microRNAs (miRs) are initially transcribed as primary miRs (pri‐miRs), which have a distinct stem‐loop structure. These pri‐miRs are processed in the nucleus by Drosha and DGCR8 (also called Pasha) into precursor miRs (pre‐miRs). The pre‐miRs are then transported to the cytoplasm via Exportin 5, where they are cleaved by Dicer into a miRNA duplex. One strand of the miRs duplex is integrated into the part of the miRNA‐induced silencing complex (RISC), and the second strand is degraded. The RISC complex binds to target mRNAs through base‐pairing between the miRs and the mRNAs, leading to either suppression of translation or degradation of the mRNA. Moreover, there are unconventional/atypical miR functions such as activation of Toll‐like receptors (TLRs). (B) Most long non‐coding RNAs (lncRNAs) are processed similarly to mRNAs, involving capping, splicing, and adenylation, with some exceptions. Mature lncRNAs form complex 3D structures that enable their diverse functions, which vary by cellular location. Chromatin‐bound lncRNAs (often cis functions) typically regulate transcription, chromosome looping, and histone modifications. Cytoplasmic lncRNAs bind mRNAs, acting as decoys, guides, and scaffolds to regulate genes transcriptionally or post‐transcriptionally. They also bind proteins to alter their function and stability, code for micropeptides that are being translated, and bind other non‐coding RNAs, including miRs. (C) CircRNAs have multiple biogenesis mechanisms, but back‐splicing is a common event for all circRNAs. circRNA molecules are rich in miR‐binding sites and act as miR sponges in cells, thereby lifting the inhibition of miR on target genes and increasing the expression level of target genes. Additionally, circRNAs can also interact with proteins.</p></figcaption></figure></section><section id="dmrr70081-sec-0070"><h2 class="pmc_sec_title">7. LncRNAs</h2>
<p>Long non‐coding RNAs (lncRNAs) are diverse RNA transcripts composed of &gt; 200 nucleotides that are now appreciated to possess numerous gene regulatory roles through their interaction with diverse macromolecules, including other RNA species, proteins, and DNA [<a href="#dmrr70081-bib-0132" class="usa-link" aria-describedby="dmrr70081-bib-0132">132</a>]. As a result, dysfunctional changes in the expression of these lncRNA molecules in the pathogenesis of heart failure are under intense investigation, with myriad lncRNAs identified to be aberrantly expressed in the diabetic myocardium [<a href="#dmrr70081-bib-0133" class="usa-link" aria-describedby="dmrr70081-bib-0133">133</a>]. The study by Pant and colleagues conducted a comprehensive analysis in 20‐week‐old db/db mice with diastolic dysfunction and identified 754 lncRNAs that were differentially regulated compared to healthy control mice [<a href="#dmrr70081-bib-0134" class="usa-link" aria-describedby="dmrr70081-bib-0134">134</a>]. Co‐expression network analysis revealed 5 lncRNAs (<a href="https://www.ncbi.nlm.nih.gov/nuccore/BC038927" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">BC038927</a>, G730013B05Rik, 2700054A10Rik, <a href="https://www.ncbi.nlm.nih.gov/nuccore/AK089884" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">AK089884</a>, and Daw1) that were connected with several differentially expressed genes associated with membrane depolarisation, action potential conduction, contraction, and actin filament‐based movement of cardiac cells in the diabetic myocardium [<a href="#dmrr70081-bib-0134" class="usa-link" aria-describedby="dmrr70081-bib-0134">134</a>]. Moreover, methyltransferase‐like 14 (METTL14) expression was downregulated in DCM, mediated increased terminal differentiation‐induced lncRNA (TINCR), leading to pyroptosis processes via m6A methylation in an NLRP3‐dependent manner [<a href="#dmrr70081-bib-0135" class="usa-link" aria-describedby="dmrr70081-bib-0135">135</a>]. LncRNA TUG1 involved myocardial fibrosis in DCM development through modulating miR‐145a‐5p/Cfl2 axis, and suppression of lncRNA TUG1 demonstrated improvement of cardiac function and fibrosis [<a href="#dmrr70081-bib-0136" class="usa-link" aria-describedby="dmrr70081-bib-0136">136</a>]. Other key lncRNAs which have also been demonstrated in the myocardium and circulation in patients and preclinical models of DCM are HOTAIR [<a href="#dmrr70081-bib-0137" class="usa-link" aria-describedby="dmrr70081-bib-0137">137</a>], H19 [<a href="#dmrr70081-bib-0138" class="usa-link" aria-describedby="dmrr70081-bib-0138">138</a>, <a href="#dmrr70081-bib-0139" class="usa-link" aria-describedby="dmrr70081-bib-0139">139</a>], MALAT1 [<a href="#dmrr70081-bib-0140" class="usa-link" aria-describedby="dmrr70081-bib-0140">140</a>], MIAT [<a href="#dmrr70081-bib-0141" class="usa-link" aria-describedby="dmrr70081-bib-0141">141</a>, <a href="#dmrr70081-bib-0142" class="usa-link" aria-describedby="dmrr70081-bib-0142">142</a>, <a href="#dmrr70081-bib-0143" class="usa-link" aria-describedby="dmrr70081-bib-0143">143</a>], SENCR [<a href="#dmrr70081-bib-0141" class="usa-link" aria-describedby="dmrr70081-bib-0141">141</a>], ANRIL [<a href="#dmrr70081-bib-0144" class="usa-link" aria-describedby="dmrr70081-bib-0144">144</a>] and LIPCAR [<a href="#dmrr70081-bib-0141" class="usa-link" aria-describedby="dmrr70081-bib-0141">141</a>] (Figure <a href="#dmrr70081-fig-0004" class="usa-link">4</a>).</p></section><section id="dmrr70081-sec-0080"><h2 class="pmc_sec_title">8. Circular RNAs</h2>
<p>Circular RNAs (circRNAs) are single‐stranded RNA loops generated via back‐splicing events that do not possess either 5′ end caps or 3′ end poly‐A tails [<a href="#dmrr70081-bib-0145" class="usa-link" aria-describedby="dmrr70081-bib-0145">145</a>]. CircRNAs accumulate intracellularly due to their structural resistance to endonucleases and can competitively interact with other ncRNA molecules (e.g., miRs) and also regulate different aspects of RNA, including transcription, splicing, turnover and translation [<a href="#dmrr70081-bib-0145" class="usa-link" aria-describedby="dmrr70081-bib-0145">145</a>]. Several groups have identified a large number of circRNAs expressed in human and rodent hearts [<a href="#dmrr70081-bib-0146" class="usa-link" aria-describedby="dmrr70081-bib-0146">146</a>, <a href="#dmrr70081-bib-0147" class="usa-link" aria-describedby="dmrr70081-bib-0147">147</a>], some of which are now appreciated to play an important role in maladaptive cardiac remodelling and heart failure development [<a href="#dmrr70081-bib-0148" class="usa-link" aria-describedby="dmrr70081-bib-0148">148</a>]. A study by Dong and colleagues [<a href="#dmrr70081-bib-0149" class="usa-link" aria-describedby="dmrr70081-bib-0149">149</a>] has identified and validated 13 circRNAs differentially expressed in the myocardium of diabetic BKS‐db/db knock‐out mice, with related mRNAs associated with glucose metabolism and lipid metabolism pathways. Specifically, two circRNAs, mmu_circ_0000652 and mmu_circ_0001058, demonstrated a reduction in expression in the early stage of DCM progression and were identified as potential miR sponges to miR‐195 and miR‐2, resulting in cardiomyocytes apoptosis and interstitial fibrosis, respectively [<a href="#dmrr70081-bib-0149" class="usa-link" aria-describedby="dmrr70081-bib-0149">149</a>]. Moreover, other circRNAs have been implicated in promoting pathological cardiac dysfunction in DCM through their competitive interaction with miRs. CircRNA_000203, a circRNA transcribed from the Myo9a gene, was significantly elevated in the myocardium of db/db mice and promoted pro‐fibrotic gene expression in murine cardiac fibroblasts through its inhibitory action on miR‐26b‐5p [<a href="#dmrr70081-bib-0150" class="usa-link" aria-describedby="dmrr70081-bib-0150">150</a>]. Similarly, circRNA_010567 was also significantly upregulated in db/db diabetic myocardium and was determined to competitively inhibit the action of miR‐144 on TGFβ1‐activation of cardiac fibroblasts [<a href="#dmrr70081-bib-0151" class="usa-link" aria-describedby="dmrr70081-bib-0151">151</a>]. CircDICAR (the diabetes‐induced circulation‐associated circular RNA) showed downregulation in diabetic db/db mice and diabetic patients, promoting cardiac dysfunction, hypertrophy, fibrosis, and cardiomyocyte pyroptosis, which are the pathogenesis of DCM. Thus, circDICAR and the synthetic‐junction part may rescue diabetes‐induced cardiac impairments [<a href="#dmrr70081-bib-0152" class="usa-link" aria-describedby="dmrr70081-bib-0152">152</a>]. In a recent study, alterations of multiple circRNAs such as circPHF20L1, circCLASP1, and circSLC8A1 played significant roles in underlying cardiac fibrosis in db/db mice [<a href="#dmrr70081-bib-0153" class="usa-link" aria-describedby="dmrr70081-bib-0153">153</a>].</p>
<p>In STZ‐induced diabetic mouse models, cardiac fibrosis is evident in DCM progression, and upregulation of circAMOTL1 and circHIPK3 in diabetic mice was linked to myocardial fibrosis. Inhibition of these circRNAs ameliorated cardiac function and fibrosis, providing a therapeutic target for DCM [<a href="#dmrr70081-bib-0154" class="usa-link" aria-describedby="dmrr70081-bib-0154">154</a>, <a href="#dmrr70081-bib-0155" class="usa-link" aria-describedby="dmrr70081-bib-0155">155</a>]. CircRNA cerebellar degeneration‐related protein 1 antisense (CDR1as) was upregulated in the DCM setting and cardiomyocytes treated with high glucose, and this alteration promoted cardiomyocytes apoptosis via hippo signalling pathway, which is one of the pathogenic drivers of DCM [<a href="#dmrr70081-bib-0156" class="usa-link" aria-describedby="dmrr70081-bib-0156">156</a>]. Furthermore, circRNAs were reported to modulate the pathogenesis of DCM at a cellular level; levels of the circRNA hsa_circ_0076631 (also known as caspase‐1‐associated circRNA, CACR) were found to be increased in cardiomyocytes (AC16 cells) exposed to high glucose and promoted cell death and inflammation through increasing the expression of caspase‐1 by antagonising the action of miR‐214‐3p [<a href="#dmrr70081-bib-0157" class="usa-link" aria-describedby="dmrr70081-bib-0157">157</a>]. CircRNA mitogen‐activated protein kinase 5 (circMAP3K5) was increased in cardiomyocytes treated with high glucose conditions, promoting apoptosis processes in part of DCM progression through regulating the miR‐22‐3p/DAPK2 axis [<a href="#dmrr70081-bib-0158" class="usa-link" aria-describedby="dmrr70081-bib-0158">158</a>]. Others studied diabetes‐induced impairment of endothelial function. Alterations of circRNAs (e.g., hsa_circ_0008360, hsa_circ_0000109, hsa_circ_0002317, CircBPTF, and circHMGCS1) are associated with endothelial dysfunction in the context of HUVECs treated with high glucose conditions, and these results suggest that circRNAs considerably contribute to the initiation and development of DCM [<a href="#dmrr70081-bib-0159" class="usa-link" aria-describedby="dmrr70081-bib-0159">159</a>, <a href="#dmrr70081-bib-0160" class="usa-link" aria-describedby="dmrr70081-bib-0160">160</a>, <a href="#dmrr70081-bib-0161" class="usa-link" aria-describedby="dmrr70081-bib-0161">161</a>] (Figure <a href="#dmrr70081-fig-0004" class="usa-link">4</a>).</p></section><section id="dmrr70081-sec-0090"><h2 class="pmc_sec_title">9. Cell Type Specific Epigenetic Changes in Diabetic Cardiomyopathy</h2>
<p>Different cardiac cells have different epigenomic signatures, and understanding cell type‐specific roles of epigenetic modification is an important issue in designing epigenetic interventions for treatment [<a href="#dmrr70081-bib-0162" class="usa-link" aria-describedby="dmrr70081-bib-0162">162</a>]. Hyperglycaemia induces epigenetic changes with the expression of genes associated with endothelial dysfunction and alteration of immune cells, including macrophages, dendritic cells, mast cells, T‐cells and B‐cells. Endothelial cells are the target of early hyperglycaemia‐induced changes with epigenetic modulation and long‐term effects. Modifications of endothelial cells are key to the development of vascular alterations in DCM, including microvessels [<a href="#dmrr70081-bib-0163" class="usa-link" aria-describedby="dmrr70081-bib-0163">163</a>] with diffuse alteration of myocardial perfusion in cardiomyopathy and later on the development of atherosclerosis with macrovascular alterations [<a href="#dmrr70081-bib-0031" class="usa-link" aria-describedby="dmrr70081-bib-0031">31</a>, <a href="#dmrr70081-bib-0164" class="usa-link" aria-describedby="dmrr70081-bib-0164">164</a>]. The role of Set7, a histone methyl transferase responsible for the monomethylation of lysine 4 on histone 3 (H3K4) in glucose‐induced inflammation of endothelial cells, has been pointed out as a major actor in endothelial dysfunction [<a href="#dmrr70081-bib-0165" class="usa-link" aria-describedby="dmrr70081-bib-0165">165</a>]. Set7 regulates the transcription factor NFκB and contributes to the dysregulation of oxidant/inflammatory genes and endothelial dysfunction. Pepin et al. [<a href="#dmrr70081-bib-0166" class="usa-link" aria-describedby="dmrr70081-bib-0166">166</a>] have quantified genome‐wide DNA methylation of cultured human endothelial aortic cells and have investigated glucose‐dependent and dose‐responsive alterations in endothelial DNA methylation. They have shown glucose‐dependent methylation and gene expression of VEGF and NO signalling cascades, which could be involved in the long‐term effects of hyperglycaemia on endothelial function. The role of energy metabolism on epigenetic regulation in endothelial dysfunction has been explored as key energy metabolites typically serve as substrates or co‐factors for epigenetic modifying enzymes. In particular, the role of dysregulation of 2‐oxoglutarate‐dependent dioxygenases by hyperglycaemia has been suggested [<a href="#dmrr70081-bib-0167" class="usa-link" aria-describedby="dmrr70081-bib-0167">167</a>]. Besides this vascular role, the endothelium controls cardiomyocyte metabolism and function and mediates the transcellular flux from blood to perivascular tissues, which may be impaired by epigenetic modifications [<a href="#dmrr70081-bib-0168" class="usa-link" aria-describedby="dmrr70081-bib-0168">168</a>].</p>
<p>The endothelial‐to‐mesenchymal transition (EndMT) has been recently recognised as a major process in diabetic complications, particularly in cardiomyopathy with hyperglycaemia as an important trigger. The importance of EndMT in the pathogenesis of DCM is observed in diabetic human hearts, and this process illustrated upregulation of lncRNAs ZFAS1 and MALAT1 while decreasing several miRs (miR‐9, miR‐146a, and miR‐200b) in diabetic patients compared with non‐diabetic patients [<a href="#dmrr70081-bib-0169" class="usa-link" aria-describedby="dmrr70081-bib-0169">169</a>]. In response to different stimuli, endothelial cells are losing endothelial characteristics and developing mesenchymal traits [<a href="#dmrr70081-bib-0170" class="usa-link" aria-describedby="dmrr70081-bib-0170">170</a>]. These modifications result in cardiac fibrosis and remodelling. Epigenetic changes occur at different levels during EndMT in pathogenesis related to DCM progression involving the deacetylase HDAC3a [<a href="#dmrr70081-bib-0171" class="usa-link" aria-describedby="dmrr70081-bib-0171">171</a>], DNA methylation and methylation of RASAL1 promoter [<a href="#dmrr70081-bib-0172" class="usa-link" aria-describedby="dmrr70081-bib-0172">172</a>, <a href="#dmrr70081-bib-0173" class="usa-link" aria-describedby="dmrr70081-bib-0173">173</a>], and miRs (miR‐126‐3p, miR‐146a, miR‐9) [<a href="#dmrr70081-bib-0114" class="usa-link" aria-describedby="dmrr70081-bib-0114">114</a>, <a href="#dmrr70081-bib-0115" class="usa-link" aria-describedby="dmrr70081-bib-0115">115</a>, <a href="#dmrr70081-bib-0174" class="usa-link" aria-describedby="dmrr70081-bib-0174">174</a>]. LncRNAs are also involved, especially ANRIL, which regulates functional and structural myocardial alterations in diabetes through expressions of ECM proteins and VEGF [<a href="#dmrr70081-bib-0144" class="usa-link" aria-describedby="dmrr70081-bib-0144">144</a>] and ZFAS1 interacting with miR‐9 in mediating cardiac fibrosis in human cardiac microvascular endothelial cells [<a href="#dmrr70081-bib-0115" class="usa-link" aria-describedby="dmrr70081-bib-0115">115</a>] and circRNA [<a href="#dmrr70081-bib-0175" class="usa-link" aria-describedby="dmrr70081-bib-0175">175</a>].</p>
<p>The cardiac fibroblast is one of the key participants in alterations of ECM proteins, causing cardiac stiffness and decreased myocardial relaxation, resulting in progressive impaired cardiac function and structure [<a href="#dmrr70081-bib-0176" class="usa-link" aria-describedby="dmrr70081-bib-0176">176</a>]. Epigenetic responses in cardiac fibroblasts treated with high glucose are extensively investigated. DNMT1 expression was upregulated and subsequently suppressed the SOCS3 axis in cardiac fibroblasts treated with high glucose conditions, resulting in cardiac fibrosis through cardiac fibroblast activation [<a href="#dmrr70081-bib-0177" class="usa-link" aria-describedby="dmrr70081-bib-0177">177</a>]. Also, DNMT1 inactivation in androgen receptor axis promoted cardiac fibroblast autophagy in diabetic cardiac fibrosis [<a href="#dmrr70081-bib-0178" class="usa-link" aria-describedby="dmrr70081-bib-0178">178</a>]. miR‐150‐5p expression was upregulated and Smad7 expression decreased in cardiac fibroblasts treated with high glucose, driving cardiac inflammation and fibrosis [<a href="#dmrr70081-bib-0179" class="usa-link" aria-describedby="dmrr70081-bib-0179">179</a>]. The study by Liu et al. [<a href="#dmrr70081-bib-0180" class="usa-link" aria-describedby="dmrr70081-bib-0180">180</a>] also showed that elevated miR‐21 promoted proliferation and collagen production in rat cardiac fibroblasts treated with high glucose via the JNK/SAPK and p38 signalling pathways by repressing DUSP8 expression. Besides, increased miR‐32‐5p could repress DUSP1, contributing to cardiac fibrosis in the context of human cardiac fibroblasts in response to high glucose stimulation [<a href="#dmrr70081-bib-0181" class="usa-link" aria-describedby="dmrr70081-bib-0181">181</a>]. Conversely, miR‐495 demonstrated protective effects against inflammation, cell differentiation, and ECM accumulation in high glucose‐activated NF‐κB and TGF‐β1/Smad signalling pathways in human cardiac fibroblasts [<a href="#dmrr70081-bib-0182" class="usa-link" aria-describedby="dmrr70081-bib-0182">182</a>]. Elevated lncRNAs such as Kcnq1ot1 and <a href="https://www.ncbi.nlm.nih.gov/nuccore/AK081284" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">AK081284</a> in cardiac fibroblasts treated with high glucose contributed to cardiac fibrosis via pro‐fibrotic pathways [<a href="#dmrr70081-bib-0183" class="usa-link" aria-describedby="dmrr70081-bib-0183">183</a>, <a href="#dmrr70081-bib-0184" class="usa-link" aria-describedby="dmrr70081-bib-0184">184</a>], while increased lncRNA Airn mitigated cardiac fibrosis by inhibiting activation of cardiac fibroblasts via the m6A‐IMP2‐p53 axis [<a href="#dmrr70081-bib-0185" class="usa-link" aria-describedby="dmrr70081-bib-0185">185</a>]. These results underline the significant roles of epigenetic modifications on fibroblasts in impacting DCM progression.</p>
<p>Long‐term hyperglycaemia conditions may contribute to alternations of cardiomyocyte calcium handling, hypertrophy, autophagy, and apoptosis, which are important pathophysiological processes of DCM [<a href="#dmrr70081-bib-0186" class="usa-link" aria-describedby="dmrr70081-bib-0186">186</a>]. Under high glucose conditions, multiple miRs‐associated with cardiomyocyte hypertrophy, such as miR‐30c, miR‐133a, miR‐150, miR‐373, and miR‐203, were downregulated [<a href="#dmrr70081-bib-0112" class="usa-link" aria-describedby="dmrr70081-bib-0112">112</a>, <a href="#dmrr70081-bib-0187" class="usa-link" aria-describedby="dmrr70081-bib-0187">187</a>, <a href="#dmrr70081-bib-0188" class="usa-link" aria-describedby="dmrr70081-bib-0188">188</a>, <a href="#dmrr70081-bib-0189" class="usa-link" aria-describedby="dmrr70081-bib-0189">189</a>, <a href="#dmrr70081-bib-0190" class="usa-link" aria-describedby="dmrr70081-bib-0190">190</a>], whereas miR‐451 was increased in the diabetic heart [<a href="#dmrr70081-bib-0113" class="usa-link" aria-describedby="dmrr70081-bib-0113">113</a>]. The transcriptional co‐activator p300, histone acetyltransferase, participates in cardiomyocyte hypertrophy in the context of hyperglycaemia [<a href="#dmrr70081-bib-0187" class="usa-link" aria-describedby="dmrr70081-bib-0187">187</a>]. In addition, DCM‐related to cardiomyocyte apoptosis and mitochondria dysfunction are revealed through alterations of miRs, including miR‐34a [<a href="#dmrr70081-bib-0191" class="usa-link" aria-describedby="dmrr70081-bib-0191">191</a>], miR‐1 [<a href="#dmrr70081-bib-0192" class="usa-link" aria-describedby="dmrr70081-bib-0192">192</a>, <a href="#dmrr70081-bib-0193" class="usa-link" aria-describedby="dmrr70081-bib-0193">193</a>], miR‐206 [<a href="#dmrr70081-bib-0192" class="usa-link" aria-describedby="dmrr70081-bib-0192">192</a>], mi‐195 [<a href="#dmrr70081-bib-0194" class="usa-link" aria-describedby="dmrr70081-bib-0194">194</a>] and mi‐30d [<a href="#dmrr70081-bib-0108" class="usa-link" aria-describedby="dmrr70081-bib-0108">108</a>]. lncRNA H19 showed inhibition effects on autophagy of cardiomyocytes and cardiomyocyte apoptosis [<a href="#dmrr70081-bib-0138" class="usa-link" aria-describedby="dmrr70081-bib-0138">138</a>, <a href="#dmrr70081-bib-0139" class="usa-link" aria-describedby="dmrr70081-bib-0139">139</a>]. Recently, knockdown of lncRNA GAS5 improved high glucose‐induced cardiomyocyte inflammation, apoptosis, and oxidative stress injury [<a href="#dmrr70081-bib-0195" class="usa-link" aria-describedby="dmrr70081-bib-0195">195</a>, <a href="#dmrr70081-bib-0196" class="usa-link" aria-describedby="dmrr70081-bib-0196">196</a>]. Other epigenetic modifications, such as BET proteins (BRD4) in cardiomyocytes in the context of DCM, have previously been reviewed [<a href="#dmrr70081-bib-0094" class="usa-link" aria-describedby="dmrr70081-bib-0094">94</a>, <a href="#dmrr70081-bib-0130" class="usa-link" aria-describedby="dmrr70081-bib-0130">130</a>].</p>
<p>Moreover, the global methylation status of leukocytes and B‐cells has been shown in obesity and diabetes [<a href="#dmrr70081-bib-0197" class="usa-link" aria-describedby="dmrr70081-bib-0197">197</a>, <a href="#dmrr70081-bib-0198" class="usa-link" aria-describedby="dmrr70081-bib-0198">198</a>]. DNA methyltransferase 3B (DNMT3B) is increased in macrophages exposed to high levels of saturated fatty acids and promotes M1 macrophage polarisation [<a href="#dmrr70081-bib-0199" class="usa-link" aria-describedby="dmrr70081-bib-0199">199</a>]. Histone deacetylases (HDACs) are important in controlling inflammation; for instance, HDAC3 regulates inflammatory genes in macrophages, and HDAC2 contributes to the resolution of inflammation [<a href="#dmrr70081-bib-0200" class="usa-link" aria-describedby="dmrr70081-bib-0200">200</a>]. Numerous miRs are involved in immune cells, such as miR‐146b, resulting in monocyte activation, miR‐107 inducing increased macrophage responses, miR‐126 and miR‐193b, resulting in enhanced chemotaxis [<a href="#dmrr70081-bib-0201" class="usa-link" aria-describedby="dmrr70081-bib-0201">201</a>].</p></section><section id="dmrr70081-sec-0100"><h2 class="pmc_sec_title">10. Epigenetic Cooperation</h2>
<p>Although addressed individually in this review, it is well appreciated that epigenetic modifications not only act individually but can collectively cooperate with one another to dynamically modulate chromatin structure and gene expression in the diabetic heart. A recent study has highlighted the involvement of DNA methylation, histone modifications and miRs to regulate the expression of JunD, a member of the activated protein‐1 family that plays an important protective role against oxidative stress, inflammation and remodelling [<a href="#dmrr70081-bib-0034" class="usa-link" aria-describedby="dmrr70081-bib-0034">34</a>]. The reduction in JunD expression in the diabetic myocardium was underlined by the presence of increased DNA methylation and repressive histone marks, along with a reduction in active histone marks at the JunD promoter. Furthermore, cardiac expression of miR‐673 was reduced in the diabetic murine heart, leading to upregulation of Men1, a negative regulator of JunD activity and a known recruiter and component of histone methylation complexes, highlighting the dynamic interplay of epigenetic modifiers in regulating target gene expression in metabolic dysfunction in DCM [<a href="#dmrr70081-bib-0034" class="usa-link" aria-describedby="dmrr70081-bib-0034">34</a>]. To support targeting multiple epigenetic alterations related to DCM, flavonoids, natural epigenetic modulators, can modulate epigenetic networks with multiple mechanisms, including DNA methylation, histone modifications, ncRNA‐based modifications, and chromatin remodelling, leading to prevention of DCM development. For example, quercetin demonstrates cardioprotective benefits in diabetic hearts through modification of DNA methylation and HDAC4 inhibition [<a href="#dmrr70081-bib-0202" class="usa-link" aria-describedby="dmrr70081-bib-0202">202</a>, <a href="#dmrr70081-bib-0203" class="usa-link" aria-describedby="dmrr70081-bib-0203">203</a>, <a href="#dmrr70081-bib-0204" class="usa-link" aria-describedby="dmrr70081-bib-0204">204</a>]. Ultimately, as these epigenetic modifications are reversible and pharmacologically targetable, the concept of epigenetic therapy is currently being explored as a potential treatment strategy for DCM; however, further research is required to elucidate the contribution and cooperation of these underlying mechanisms to influence stable and hereditable pathological cellular changes that mediate diabetes‐induced dysfunction in the heart.</p></section><section id="dmrr70081-sec-0110"><h2 class="pmc_sec_title">11. Epigenetic Biomarkers and Diabetic Cardiomyopathy</h2>
<p>Early detection and management of DCM are crucial to prevent its progression to heart failure. Epigenetic biomarkers have emerged as promising tools for understanding the molecular mechanisms underlying DCM development and identifying individuals at risk. Due to their reported stability in various human fluids and their ability to be detected quantitatively, epigenetic markers have been suggested as potential diagnostic biomarkers for CV diseases such as myocardial infarction, coronary artery disease, and heart failure [<a href="#dmrr70081-bib-0124" class="usa-link" aria-describedby="dmrr70081-bib-0124">124</a>, <a href="#dmrr70081-bib-0205" class="usa-link" aria-describedby="dmrr70081-bib-0205">205</a>]. With regard to DCM, the primary associated epigenetic modifications are DNA methylation and histone modifications [<a href="#dmrr70081-bib-0206" class="usa-link" aria-describedby="dmrr70081-bib-0206">206</a>]. Changes in DNA methylation patterns of specific genes, including those involved in insulin signalling and inflammation, have been linked to DCM [<a href="#dmrr70081-bib-0207" class="usa-link" aria-describedby="dmrr70081-bib-0207">207</a>]. Aberrant histone acetylation and methylation have also been observed in DCM, affecting chromatin structure and gene expression [<a href="#dmrr70081-bib-0208" class="usa-link" aria-describedby="dmrr70081-bib-0208">208</a>]. Tao and colleagues [<a href="#dmrr70081-bib-0209" class="usa-link" aria-describedby="dmrr70081-bib-0209">209</a>] observed increased expression of methyl CpG binding protein MeCP2 and DNA hypermethylation in the RAASF1A promoter region in patients with DCM and in a T1DM rat model. These data suggest that MeCP2 plays a role in the regulation of DCM and could be a potential marker to predict DCM. It has also been reported that HiF3A mRNA expression in peripheral blood is decreased in DCM patients, which was associated with highly methylated CpG sites on HIF3A intron 1. This was consistent in patients with DCM compared with those with T2DM, suggesting that HIF3A intron 1 methylation at CpG6 could be used to identify patients with DCM from those with T2DM [<a href="#dmrr70081-bib-0210" class="usa-link" aria-describedby="dmrr70081-bib-0210">210</a>]. In addition, several groups have observed and suggested an association of hypomethylation of the KEAP1 promoter, decreased levels of H3K9me3 and increased levels of DNMT, which enhanced methylation of SERCA2a, thereby decreasing SERCA2a expression in patients with DCM [<a href="#dmrr70081-bib-0029" class="usa-link" aria-describedby="dmrr70081-bib-0029">29</a>].</p>
<p>While DNA methylation and histone modifications have been reported as primary epigenetic changes associated with DCM, studies have suggested that circulating miRs can also be altered depending on the phase of disease; therefore, in terms of evaluating the development and progression of DCM, they could be used as potential biomarkers [<a href="#dmrr70081-bib-0207" class="usa-link" aria-describedby="dmrr70081-bib-0207">207</a>]. Marked molecular changes in the heart caused by miRs have been associated with diabetes, and these changes appear to occur prior to any structural and functional changes. Additionally, the synthesis of proteins needed for normal cardiac function is inhibited in diabetic hearts by altered expression of miRs. As they are also released into the bloodstream, these CV miRs can be readily detected as biomarkers [<a href="#dmrr70081-bib-0205" class="usa-link" aria-describedby="dmrr70081-bib-0205">205</a>]. Although there have been no associations with specific miRs in patients with DCM, it is likely that circulating miRs observed in diabetes may also be associated with DCM [<a href="#dmrr70081-bib-0124" class="usa-link" aria-describedby="dmrr70081-bib-0124">124</a>]. The associated miRs which could serve as potential serum biomarkers for DCM include miR‐9, miR‐21, miR‐29, miR‐30d, miR‐34a, miR‐144, miR‐150, miR‐320 and miR‐378 [<a href="#dmrr70081-bib-0124" class="usa-link" aria-describedby="dmrr70081-bib-0124">124</a>]. Additionally, Copier et al. [<a href="#dmrr70081-bib-0211" class="usa-link" aria-describedby="dmrr70081-bib-0211">211</a>] observed an association between circulating miR‐19b‐3p and miR‐181b‐5p levels and myocardium levels during the development of DCM in obese mice on HFD. These data suggest that miR‐19b‐3p and miR‐181b‐5p could potentially serve as biomarkers for the progression of DCM in patients. While the beginning of the ‘big data’ era was marked by the accumulation of dataset integration, high‐throughput sequencing, omics‐based approaches and deep sequencing, advanced network‐based algorithms and Artificial Intelligence (e.g., machine learning) approaches may facilitate the prioritisation of molecules with functional relevance for preventing and treating the CV risk in individuals with diabetes [<a href="#dmrr70081-bib-0212" class="usa-link" aria-describedby="dmrr70081-bib-0212">212</a>]. Gadd et al. [<a href="#dmrr70081-bib-0213" class="usa-link" aria-describedby="dmrr70081-bib-0213">213</a>] developed a machine learning‐based epigenetic scoring tool using DNA methylation data to capture methylation‐proteomic signatures associated with diabetes, enabling prediction and risk stratification. This tool could hold potential for identifying diabetes‐associated CV complications. Furthermore, integrating physiological, biochemical, genetic, and epigenetic features with machine learning algorithms may improve the diagnosis and understanding of diabetes‐induced CV dysfunction. Hathaway et al. [<a href="#dmrr70081-bib-0214" class="usa-link" aria-describedby="dmrr70081-bib-0214">214</a>] identified novel cardiac biomarkers and genomic features linked to T2DM, showing that gene promoter methylation changes can serve as predictive markers for pathological processes in DCM.</p>
<p>Altogether, epigenetic biomarkers hold promise for early diagnosis, risk stratification, and therapeutic targeting of DCM. However, further research is needed to validate these biomarkers in large patient cohorts and to understand their functional significance in disease progression.</p></section><section id="dmrr70081-sec-0120"><h2 class="pmc_sec_title">12. Epitranscriptomics and Diabetic Cardiomyopathy</h2>
<p>While epigenetics has become relatively well known in the cardiovascular research field, the field of epitranscriptomics has been less explored. Similar to epigenetics, epitranscriptomics relates to the study of nucleotide modifications but at the level of RNA. RNA modifications can be chemical, at the level of alternative splicing, or through changes in base composition (‘RNA editing’). N6‐methyladenosine (m6A) RNA modification is the most prevalent and better characterised chemical modification of RNA. Its role in cardiovascular development and disease starts to be relatively well characterised [<a href="#dmrr70081-bib-0215" class="usa-link" aria-describedby="dmrr70081-bib-0215">215</a>]. Alterations in m6A profiles are associated with diabetic microvascular dysfunction [<a href="#dmrr70081-bib-0216" class="usa-link" aria-describedby="dmrr70081-bib-0216">216</a>]. Technical advances as well as the development of bioinformatics tools allow improving the knowledge of the role of RNA editing in cardiovascular disease [<a href="#dmrr70081-bib-0217" class="usa-link" aria-describedby="dmrr70081-bib-0217">217</a>]. Aberrant splicing of the CaV1.2 calcium channel mediated by the RNA‐binding protein RBFOX2 has been reported in diabetic rats developing diastolic dysfunction and cardiac hypertrophy [<a href="#dmrr70081-bib-0218" class="usa-link" aria-describedby="dmrr70081-bib-0218">218</a>, <a href="#dmrr70081-bib-0219" class="usa-link" aria-describedby="dmrr70081-bib-0219">219</a>]. Alterations and functional associations between RNA editing, splicing and DCM development remain overall poorly explored.</p></section><section id="dmrr70081-sec-0130"><h2 class="pmc_sec_title">13. Future Perspectives and Conclusions</h2>
<p>Epigenetics is a promising field, and its modifications are related to diabetes‐induced cardiac impairments. Targeting the epigenome might be a new paradigm treatment option for treating or slowing down DCM development. As the progression of DCM is unique and progressive, with distinction from other forms, epigenetic regulation plays a fundamental role in the pathogenesis of DCM. Therefore, epidrugs represent a plausible therapeutic approach to target manifestation and progression in the context of DCM. While numerous preclinical studies have shown that certain molecules have therapeutic potential, clinical trials are necessary to assess their pharmacokinetic and pharmacodynamic characteristics, safety profiles, appropriate dosages, and delivery methods. Evidence is mounting on BRD inhibitors in DCM treatments, but these studies to date are primarily from animal models [<a href="#dmrr70081-bib-0094" class="usa-link" aria-describedby="dmrr70081-bib-0094">94</a>, <a href="#dmrr70081-bib-0095" class="usa-link" aria-describedby="dmrr70081-bib-0095">95</a>]. Supporting this is the finding that treatment with the BRD inhibitor‐apabetalone in patients with T2DM and recent acute coronary syndrome was associated with reduced hospitalisation for heart failure [<a href="#dmrr70081-bib-0220" class="usa-link" aria-describedby="dmrr70081-bib-0220">220</a>]. There is biological plausibility of BRD inhibitors for DCM treatment by modulating DCM pathogenesis [<a href="#dmrr70081-bib-0094" class="usa-link" aria-describedby="dmrr70081-bib-0094">94</a>, <a href="#dmrr70081-bib-0095" class="usa-link" aria-describedby="dmrr70081-bib-0095">95</a>], and clinical trials to directly assess their effects on manifestation and progression of DCM are important. This translational approach should be considered more widely given that the majority of DCM studies to date are preclinical in nature. Greater efforts towards clinical translation are needed whilst being mindful of limitations with species conservation and preclinical models that do not fully reflect human pathogenesis. When considering the translation of epigenetic markers from preclinical studies to clinical phase, such as using lncRNAs as epigenetic drug targets or biomarkers, it is important to note that most lncRNAs are less conserved among species compared with protein‐coding mRNAs [<a href="#dmrr70081-bib-0221" class="usa-link" aria-describedby="dmrr70081-bib-0221">221</a>]. For example, the lncRNA HOTAIR was found to be associated with DCM in preclinical models [<a href="#dmrr70081-bib-0137" class="usa-link" aria-describedby="dmrr70081-bib-0137">137</a>]; however, caution is needed when translating this finding to human studies as structural and functional differences of lncRNA HOTAIR between mouse and human have been observed, indicating potential species‐specific variation in lncRNA function [<a href="#dmrr70081-bib-0222" class="usa-link" aria-describedby="dmrr70081-bib-0222">222</a>]. These highlight the importance of considering differences among species in extrapolating findings from DCM preclinical models to human biology. Moreover, screening for DCM based on epigenetic blood‐based biomarkers could be useful for identifying patients at risk of developing DCM and is considered a proactive strategy. There are currently no approved epigenetic blood‐based biomarkers for DCM diagnosis. One of the potential epigenetic blood‐based biomarker candidates for DCM is circulating miRs, which are altered in diabetes associated with cardiomyopathy and may play a pivotal role in the pathology of DCM. These miRs, including miR‐9, miR‐21, miR‐29, miR‐30d, miR‐34a, miR‐144, miR‐150, miR‐320, and miR‐378, are highly related to DCM [<a href="#dmrr70081-bib-0124" class="usa-link" aria-describedby="dmrr70081-bib-0124">124</a>]. In line with this, a clinical study by Tao et al. [<a href="#dmrr70081-bib-0223" class="usa-link" aria-describedby="dmrr70081-bib-0223">223</a>] demonstrated that circulating miR‐21 serves as a novel biomarker for the diagnosis of DCM and offers mechanistic insights supporting the potential of miRNA‐based therapeutic strategies for DCM treatment. In the future, cardio‐specific epidrugs using specific delivery methods may serve to advance therapeutic development to epigenetically target DCM. Rapid scientific research methods and technologies such as single‐cell RNA sequencing (scRNA‐seq), single‐cell assay for transposase‐accessible chromatin sequencing (scATAC‐seq), and whole genome bisulfite sequencing (WGBS) potentially support the discovery of new epigenetic modifications. With the recent development of direct RNA sequencing and other mass spectrometry‐based technologies, epitranscriptomics has entered the game, and the regulation and roles of RNA modifications, editing, and splicing in DCM deserve further investigation. Altogether, understanding the progression of DCM through epigenetic and epitranscriptomic alterations and developing novel therapies based on these alterations to prevent the onset or progression of DCM are likely on the horizon. Biomarkers and treatments based on epigenetic or epitranscriptomic marks may be useful for developing ‘theranostics’ approaches [<a href="#dmrr70081-bib-0224" class="usa-link" aria-describedby="dmrr70081-bib-0224">224</a>].</p>
<p>In summary, DCM is an important stage which is responsible for future heart failure development. Epigenetic alterations, including DNA methylation, histone modifications, and ncRNAs, can regulate multiple pathogenic drivers of DCM. Therefore, the epigenetic approach is a visible strategy to identify DCM development and slow DCM progression (Figure <a href="#dmrr70081-fig-0005" class="usa-link">5</a>). Although several challenges remain unresolved, epigenetic biomarkers and treatments are under investigation, along with advancing cutting‐edge technologies for basic, translational, and clinical studies.</p>
<figure class="fig xbox font-sm" id="dmrr70081-fig-0005"><h3 class="obj_head">FIGURE 5.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0910/12365466/5ad61dbb48ca/DMRR-41-e70081-g004.jpg" loading="lazy" id="jats-graphic-9" height="688" width="709" alt="FIGURE 5"></p>
<div class="p text-right font-secondary"><a href="figure/dmrr70081-fig-0005/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Potential epigenetic targets in diabetic cardiomyopathy. (A) DNA methylation occurs predominantly at CpG islands, and DNMT inhibitors can block the activity of DNMTs, enzymes responsible for adding methyl groups to DNA. (B) Histone acetylation depends on the writer HAT/KAT, the reader acetyl‐lysine binding proteins, and the eraser HDAC. HAT/KAT inhibitors are compounds that block the activity of acetyltransferases, which are responsible for adding acetyl groups to histone proteins, affecting DNA packaging and gene expression. HDAC inhibitors exhibit histone deacetylase inhibition by preventing HDAC from removing acetyl groups from histones. (C) BET proteins can bind to acetylated histone tails, and BET inhibitors reversibly bind BET proteins and prevent protein‐protein interaction between BET proteins and acetylated histones. (D) Histone methylation involves the addition of methyl groups to histone proteins, and KMT inhibitors block histone lysine methyltransferases (KMT), and KDM inhibitors inhibit histone lysine demethylases (KDM). (E) Non‐coding RNAs and alterations of miR, lncRNA, and circRNA. These non‐coding RNAs are functional RNA molecules that are not translated into proteins, playing crucial roles in regulating biological responses. BET = Bromodomain and extra‐terminal domain; circRNA = Circular RNA; DNMT = Deoxyribonucleic acid methyltransferase; HAT = Histone acetyltransferase; HDAC = Histone deacetylase; KAT = Lysine acetyltransferases; KDM = Lysine demethylases; KMT = Lysine methyltransferase; lncRNA = Long non‐coding RNA; miR = MicroRNA.</p></figcaption></figure></section><section id="dmrr70081-sec-0140"><h2 class="pmc_sec_title">Author Contributions</h2>
<p>All authors contributed substantially to drafting and revising the manuscript. A.R.H. and N.K. equally contributed to the work as co‐first authors.</p></section><section id="dmrr70081-sec-0160"><h2 class="pmc_sec_title">Conflicts of Interest</h2>
<p>Y.D. holds patents on RNA biomarkers of cardiovascular disease and is a member of the molecular diagnostics company, Firalis SA. C.J.W. holds patents on epigenetic therapy for cardiomyopathy. Other authors declare no conflicts of interest.</p></section><section id="dmrr70081-sec-0190"><h2 class="pmc_sec_title">Peer Review</h2>
<p>The peer review history for this article is available at <a href="https://www.webofscience.com/api/gateway/wos/peer-review/10.1002/dmrr.70081" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.webofscience.com/api/gateway/wos/peer-review/10.1002/dmrr.70081</a>.</p></section><section id="dmrr70081-sec-0150" class="ack"><h2 class="pmc_sec_title">Acknowledgements</h2>
<p>All figures were created with the aid of Bioicons (<a href="https://bioicons.com/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://bioicons.com/</a>).</p></section><section id="notes1"><p>


Russell‐Hallinan, Adam
, Karuna Narainrit, Lezoualc'h Frank, et al. 2025. “Established and Emerging Roles of Epigenetic Regulation in Diabetic Cardiomyopathy.”
Diabetes/Metabolism Research and Reviews: e70081. 10.1002/dmrr.70081.
</p>
<section id="fn-group1" class="fn-group"><div class="fn-group p font-secondary-light font-sm">
<div class="fn p" id="dmrr70081-note-0001"><p>
<strong>Funding:</strong> This project has received funding from the lnnovative Medicines lnitiative 2 Joint Undertaking (JU) under grant agreement No 821508. The JU receives support from the European Union's Horizon 2020 research and innovation programme and EFPIA. This work was also supported by the British Heart Foundation [PG/20/10424].</p></div>
<div class="fn p" id="dmrr70081-note-0002"><p>Adam Russell‐Hallinan and Narainrit Karuna contributed equally to the work.</p></div>
</div></section></section><section id="dmrr70081-sec-0180"><h2 class="pmc_sec_title">Data Availability Statement</h2>
<p>Data sharing is not applicable to this article as no new data were created or analyzed in this study.</p></section><section id="dmrr70081-bibl-0001" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="dmrr70081-bibl-0001_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="dmrr70081-bib-0001">
<span class="label">1.</span><cite>
GBD 2021 Diabetes Collaborators
, “Global, Regional, and National Burden of Diabetes From 1990 to 2021, With Projections of Prevalence to 2050: A Systematic Analysis for the Global Burden of Disease Study 2021,” Lancet
402, no. 10397 (2023): 203–234, 10.1016/s0140-6736(23)01301-6.
</cite> [<a href="https://doi.org/10.1016/s0140-6736(23)01301-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10364581/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37356446/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Global,%20Regional,%20and%20National%20Burden%20of%20Diabetes%20From%201990%20to%202021,%20With%20Projections%20of%20Prevalence%20to%202050:%20A%20Systematic%20Analysis%20for%20the%20Global%20Burden%20of%20Disease%20Study%202021&amp;volume=402&amp;issue=10397&amp;publication_year=2023&amp;pages=203-234&amp;pmid=37356446&amp;doi=10.1016/s0140-6736(23)01301-6&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0002">
<span class="label">2.</span><cite>
GBD 2019 Risk Factors Collaborators
, “Global Burden of 87 Risk Factors in 204 Countries and Territories, 1990–2019: A Systematic Analysis for the Global Burden of Disease Study 2019,” Lancet
396, no. 10258 (2020): 1223–1249, 10.1016/s0140-6736(20)30752-2.
</cite> [<a href="https://doi.org/10.1016/s0140-6736(20)30752-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7566194/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33069327/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Global%20Burden%20of%2087%20Risk%20Factors%20in%20204%20Countries%20and%20Territories,%201990%E2%80%932019:%20A%20Systematic%20Analysis%20for%20the%20Global%20Burden%20of%20Disease%20Study%202019&amp;volume=396&amp;issue=10258&amp;publication_year=2020&amp;pages=1223-1249&amp;pmid=33069327&amp;doi=10.1016/s0140-6736(20)30752-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0003">
<span class="label">3.</span><cite>
Diedisheim M., Carcarino E., Vandiedonck C., Roussel R., Gautier J. F., and Venteclef N., “Regulation of Inflammation in Diabetes: From Genetics to Epigenomics Evidence,” Molecular Metabolism
41 (2020): 101041, 10.1016/j.molmet.2020.101041.
</cite> [<a href="https://doi.org/10.1016/j.molmet.2020.101041" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7394913/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32603690/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Molecular%20Metabolism&amp;title=Regulation%20of%20Inflammation%20in%20Diabetes:%20From%20Genetics%20to%20Epigenomics%20Evidence&amp;author=M.%20Diedisheim&amp;author=E.%20Carcarino&amp;author=C.%20Vandiedonck&amp;author=R.%20Roussel&amp;author=J.%20F.%20Gautier&amp;volume=41&amp;publication_year=2020&amp;pages=101041&amp;pmid=32603690&amp;doi=10.1016/j.molmet.2020.101041&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0004">
<span class="label">4.</span><cite>
Bertero E., Dudek J., Cochain C., et al., “Immuno‐Metabolic Interfaces in Cardiac Disease and Failure,” Cardiovascular Research
118, no. 1 (2022): 37–52, 10.1093/cvr/cvab036.
</cite> [<a href="https://doi.org/10.1093/cvr/cvab036" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33537710/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cardiovascular%20Research&amp;title=Immuno%E2%80%90Metabolic%20Interfaces%20in%20Cardiac%20Disease%20and%20Failure&amp;author=E.%20Bertero&amp;author=J.%20Dudek&amp;author=C.%20Cochain&amp;volume=118&amp;issue=1&amp;publication_year=2022&amp;pages=37-52&amp;pmid=33537710&amp;doi=10.1093/cvr/cvab036&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0005">
<span class="label">5.</span><cite>
Kishi S., Gidding S. S., Reis J. P., et al., “Association of Insulin Resistance and Glycemic Metabolic Abnormalities With LV Structure and Function in Middle Age: The CARDIA Study,” JACC: Cardiovascular Imaging
10, no. 2 (2017): 105–114, 10.1016/j.jcmg.2016.02.033.
</cite> [<a href="https://doi.org/10.1016/j.jcmg.2016.02.033" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11961232/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27544896/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JACC:%20Cardiovascular%20Imaging&amp;title=Association%20of%20Insulin%20Resistance%20and%20Glycemic%20Metabolic%20Abnormalities%20With%20LV%20Structure%20and%20Function%20in%20Middle%20Age:%20The%20CARDIA%20Study&amp;author=S.%20Kishi&amp;author=S.%20S.%20Gidding&amp;author=J.%20P.%20Reis&amp;volume=10&amp;issue=2&amp;publication_year=2017&amp;pages=105-114&amp;pmid=27544896&amp;doi=10.1016/j.jcmg.2016.02.033&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0006">
<span class="label">6.</span><cite>
Kannel W. B., Hjortland M., and Castelli W. P., “Role of Diabetes in Congestive Heart Failure: The Framingham Study,” American Journal of Cardiology
34, no. 1 (1974): 29–34, 10.1016/0002-9149(74)90089-7.
</cite> [<a href="https://doi.org/10.1016/0002-9149(74)90089-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/4835750/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=American%20Journal%20of%20Cardiology&amp;title=Role%20of%20Diabetes%20in%20Congestive%20Heart%20Failure:%20The%20Framingham%20Study&amp;author=W.%20B.%20Kannel&amp;author=M.%20Hjortland&amp;author=W.%20P.%20Castelli&amp;volume=34&amp;issue=1&amp;publication_year=1974&amp;pages=29-34&amp;pmid=4835750&amp;doi=10.1016/0002-9149(74)90089-7&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0007">
<span class="label">7.</span><cite>
Falcao‐Pires I. and Leite‐Moreira A. F., “Diabetic Cardiomyopathy: Understanding the Molecular and Cellular Basis to Progress in Diagnosis and Treatment,” Heart Failure Reviews
17, no. 3 (2012): 325–344, 10.1007/s10741-011-9257-z.
</cite> [<a href="https://doi.org/10.1007/s10741-011-9257-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21626163/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Heart%20Failure%20Reviews&amp;title=Diabetic%20Cardiomyopathy:%20Understanding%20the%20Molecular%20and%20Cellular%20Basis%20to%20Progress%20in%20Diagnosis%20and%20Treatment&amp;author=I.%20Falcao%E2%80%90Pires&amp;author=A.%20F.%20Leite%E2%80%90Moreira&amp;volume=17&amp;issue=3&amp;publication_year=2012&amp;pages=325-344&amp;pmid=21626163&amp;doi=10.1007/s10741-011-9257-z&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0008">
<span class="label">8.</span><cite>
Ernande L., Thibault H., Bergerot C., et al., “Systolic Myocardial Dysfunction in Patients With Type 2 Diabetes Mellitus: Identification at MR Imaging With Cine Displacement Encoding With Stimulated Echoes,” Radiology
265, no. 2 (2012): 402–409, 10.1148/radiol.12112571.
</cite> [<a href="https://doi.org/10.1148/radiol.12112571" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3480812/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22929334/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Radiology&amp;title=Systolic%20Myocardial%20Dysfunction%20in%20Patients%20With%20Type%202%20Diabetes%20Mellitus:%20Identification%20at%20MR%20Imaging%20With%20Cine%20Displacement%20Encoding%20With%20Stimulated%20Echoes&amp;author=L.%20Ernande&amp;author=H.%20Thibault&amp;author=C.%20Bergerot&amp;volume=265&amp;issue=2&amp;publication_year=2012&amp;pages=402-409&amp;pmid=22929334&amp;doi=10.1148/radiol.12112571&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0009">
<span class="label">9.</span><cite>
Ernande L., Bergerot C., Girerd N., et al., “Longitudinal Myocardial Strain Alteration Is Associated With Left Ventricular Remodeling in Asymptomatic Patients With Type 2 Diabetes Mellitus,” Journal of the American Society of Echocardiography
27, no. 5 (2014): 479–488, 10.1016/j.echo.2014.01.001.
</cite> [<a href="https://doi.org/10.1016/j.echo.2014.01.001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24508363/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20the%20American%20Society%20of%20Echocardiography&amp;title=Longitudinal%20Myocardial%20Strain%20Alteration%20Is%20Associated%20With%20Left%20Ventricular%20Remodeling%20in%20Asymptomatic%20Patients%20With%20Type%202%20Diabetes%20Mellitus&amp;author=L.%20Ernande&amp;author=C.%20Bergerot&amp;author=N.%20Girerd&amp;volume=27&amp;issue=5&amp;publication_year=2014&amp;pages=479-488&amp;pmid=24508363&amp;doi=10.1016/j.echo.2014.01.001&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0010">
<span class="label">10.</span><cite>
Poornima I. G., Parikh P., and Shannon R. P., “Diabetic Cardiomyopathy: The Search for a Unifying Hypothesis,” Circulation Research
98, no. 5 (2006): 596–605, 10.1161/01.res.0000207406.94146.c2.
</cite> [<a href="https://doi.org/10.1161/01.res.0000207406.94146.c2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16543510/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Circulation%20Research&amp;title=Diabetic%20Cardiomyopathy:%20The%20Search%20for%20a%20Unifying%20Hypothesis&amp;author=I.%20G.%20Poornima&amp;author=P.%20Parikh&amp;author=R.%20P.%20Shannon&amp;volume=98&amp;issue=5&amp;publication_year=2006&amp;pages=596-605&amp;pmid=16543510&amp;doi=10.1161/01.res.0000207406.94146.c2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0011">
<span class="label">11.</span><cite>
Cooper M. E. and El‐Osta A., “Epigenetics: Mechanisms and Implications for Diabetic Complications,” Circulation Research
107, no. 12 (2010): 1403–1413, 10.1161/circresaha.110.223552.
</cite> [<a href="https://doi.org/10.1161/circresaha.110.223552" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21148447/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Circulation%20Research&amp;title=Epigenetics:%20Mechanisms%20and%20Implications%20for%20Diabetic%20Complications&amp;author=M.%20E.%20Cooper&amp;author=A.%20El%E2%80%90Osta&amp;volume=107&amp;issue=12&amp;publication_year=2010&amp;pages=1403-1413&amp;pmid=21148447&amp;doi=10.1161/circresaha.110.223552&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0012">
<span class="label">12.</span><cite>
Ling C. and Ronn T., “Epigenetics in Human Obesity and Type 2 Diabetes,” Cell Metabolism
29, no. 5 (2019): 1028–1044, 10.1016/j.cmet.2019.03.009.
</cite> [<a href="https://doi.org/10.1016/j.cmet.2019.03.009" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6509280/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30982733/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell%20Metabolism&amp;title=Epigenetics%20in%20Human%20Obesity%20and%20Type%202%20Diabetes&amp;author=C.%20Ling&amp;author=T.%20Ronn&amp;volume=29&amp;issue=5&amp;publication_year=2019&amp;pages=1028-1044&amp;pmid=30982733&amp;doi=10.1016/j.cmet.2019.03.009&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0013">
<span class="label">13.</span><cite>
Conte C., Terruzzi I., and Ambrosio G., “Metabolic Memory in Diabetes: Permanent Scar, Legacy, or Ongoing Domino Effect?,” Cardiovascular Research
118, no. 1 (2022): 4–6, 10.1093/cvr/cvab104.
</cite> [<a href="https://doi.org/10.1093/cvr/cvab104" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33744936/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cardiovascular%20Research&amp;title=Metabolic%20Memory%20in%20Diabetes:%20Permanent%20Scar,%20Legacy,%20or%20Ongoing%20Domino%20Effect?&amp;author=C.%20Conte&amp;author=I.%20Terruzzi&amp;author=G.%20Ambrosio&amp;volume=118&amp;issue=1&amp;publication_year=2022&amp;pages=4-6&amp;pmid=33744936&amp;doi=10.1093/cvr/cvab104&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0014">
<span class="label">14.</span><cite>
McKinsey T. A., Foo R., Anene‐Nzelu C. G., et al., “Emerging Epigenetic Therapies of Cardiac Fibrosis and Remodelling in Heart Failure: From Basic Mechanisms to Early Clinical Development,” Cardiovascular Research
118, no. 18 (2023): 3482–3498, 10.1093/cvr/cvac142.
</cite> [<a href="https://doi.org/10.1093/cvr/cvac142" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10202443/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36004821/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cardiovascular%20Research&amp;title=Emerging%20Epigenetic%20Therapies%20of%20Cardiac%20Fibrosis%20and%20Remodelling%20in%20Heart%20Failure:%20From%20Basic%20Mechanisms%20to%20Early%20Clinical%20Development&amp;author=T.%20A.%20McKinsey&amp;author=R.%20Foo&amp;author=C.%20G.%20Anene%E2%80%90Nzelu&amp;volume=118&amp;issue=18&amp;publication_year=2023&amp;pages=3482-3498&amp;pmid=36004821&amp;doi=10.1093/cvr/cvac142&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0015">
<span class="label">15.</span><cite>
Wang X., Zhao D., Beeraka N. M., et al., “A Recent Update on the Epigenetic Repertoire and Chromatin Modifying Therapy in Diabetes Mellitus: A Comprehensive Review,” Current Medicinal Chemistry
30, no. 18 (2023): 2020–2038, 10.2174/0929867329666220802090446.
</cite> [<a href="https://doi.org/10.2174/0929867329666220802090446" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35927905/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Current%20Medicinal%20Chemistry&amp;title=A%20Recent%20Update%20on%20the%20Epigenetic%20Repertoire%20and%20Chromatin%20Modifying%20Therapy%20in%20Diabetes%20Mellitus:%20A%20Comprehensive%20Review&amp;author=X.%20Wang&amp;author=D.%20Zhao&amp;author=N.%20M.%20Beeraka&amp;volume=30&amp;issue=18&amp;publication_year=2023&amp;pages=2020-2038&amp;pmid=35927905&amp;doi=10.2174/0929867329666220802090446&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0016">
<span class="label">16.</span><cite>
Multhaup M. L., Seldin M. M., Jaffe A. E., et al., “Mouse‐Human Experimental Epigenetic Analysis Unmasks Dietary Targets and Genetic Liability for Diabetic Phenotypes,” Cell Metabolism
21, no. 1 (2015): 138–149, 10.1016/j.cmet.2014.12.014.
</cite> [<a href="https://doi.org/10.1016/j.cmet.2014.12.014" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4340475/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25565211/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell%20Metabolism&amp;title=Mouse%E2%80%90Human%20Experimental%20Epigenetic%20Analysis%20Unmasks%20Dietary%20Targets%20and%20Genetic%20Liability%20for%20Diabetic%20Phenotypes&amp;author=M.%20L.%20Multhaup&amp;author=M.%20M.%20Seldin&amp;author=A.%20E.%20Jaffe&amp;volume=21&amp;issue=1&amp;publication_year=2015&amp;pages=138-149&amp;pmid=25565211&amp;doi=10.1016/j.cmet.2014.12.014&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0017">
<span class="label">17.</span><cite>
Ritchie R. H. and Abel E. D., “Basic Mechanisms of Diabetic Heart Disease,” Circulation Research
126, no. 11 (2020): 1501–1525, 10.1161/circresaha.120.315913.
</cite> [<a href="https://doi.org/10.1161/circresaha.120.315913" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7251974/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32437308/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Circulation%20Research&amp;title=Basic%20Mechanisms%20of%20Diabetic%20Heart%20Disease&amp;author=R.%20H.%20Ritchie&amp;author=E.%20D.%20Abel&amp;volume=126&amp;issue=11&amp;publication_year=2020&amp;pages=1501-1525&amp;pmid=32437308&amp;doi=10.1161/circresaha.120.315913&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0018">
<span class="label">18.</span><cite>
Maack C., Lehrke M., Backs J., et al., “Heart Failure and Diabetes: Metabolic Alterations and Therapeutic Interventions: A State‐of‐the‐Art Review From the Translational Research Committee of the Heart Failure Association‐European Society of Cardiology,” European Heart Journal
39, no. 48 (2018): 4243–4254, 10.1093/eurheartj/ehy596.
</cite> [<a href="https://doi.org/10.1093/eurheartj/ehy596" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6302261/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30295797/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=European%20Heart%20Journal&amp;title=Heart%20Failure%20and%20Diabetes:%20Metabolic%20Alterations%20and%20Therapeutic%20Interventions:%20A%20State%E2%80%90of%E2%80%90the%E2%80%90Art%20Review%20From%20the%20Translational%20Research%20Committee%20of%20the%20Heart%20Failure%20Association%E2%80%90European%20Society%20of%20Cardiology&amp;author=C.%20Maack&amp;author=M.%20Lehrke&amp;author=J.%20Backs&amp;volume=39&amp;issue=48&amp;publication_year=2018&amp;pages=4243-4254&amp;pmid=30295797&amp;doi=10.1093/eurheartj/ehy596&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0019">
<span class="label">19.</span><cite>
Dinh W., Futh R., Nickl W., et al., “Elevated Plasma Levels of TNF‐Alpha and Interleukin‐6 in Patients With Diastolic Dysfunction and Glucose Metabolism Disorders,” Cardiovascular Diabetology
8, no. 1 (2009): 58, 10.1186/1475-2840-8-58.
</cite> [<a href="https://doi.org/10.1186/1475-2840-8-58" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2778641/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19909503/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cardiovascular%20Diabetology&amp;title=Elevated%20Plasma%20Levels%20of%20TNF%E2%80%90Alpha%20and%20Interleukin%E2%80%906%20in%20Patients%20With%20Diastolic%20Dysfunction%20and%20Glucose%20Metabolism%20Disorders&amp;author=W.%20Dinh&amp;author=R.%20Futh&amp;author=W.%20Nickl&amp;volume=8&amp;issue=1&amp;publication_year=2009&amp;pages=58&amp;pmid=19909503&amp;doi=10.1186/1475-2840-8-58&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0020">
<span class="label">20.</span><cite>
Huang Z. G., Jin Q., Fan M., et al., “Myocardial Remodeling in Diabetic Cardiomyopathy Associated With Cardiac Mast Cell Activation,” PLoS One
8, no. 3 (2013): e60827, 10.1371/journal.pone.0060827.
</cite> [<a href="https://doi.org/10.1371/journal.pone.0060827" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3612033/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23556005/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20One&amp;title=Myocardial%20Remodeling%20in%20Diabetic%20Cardiomyopathy%20Associated%20With%20Cardiac%20Mast%20Cell%20Activation&amp;author=Z.%20G.%20Huang&amp;author=Q.%20Jin&amp;author=M.%20Fan&amp;volume=8&amp;issue=3&amp;publication_year=2013&amp;pages=e60827&amp;pmid=23556005&amp;doi=10.1371/journal.pone.0060827&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>] [<a href="/articles/PMC11166268/" class="text-red">Retracted</a>]</li>
<li id="dmrr70081-bib-0021">
<span class="label">21.</span><cite>
Jadhav A., Tiwari S., Lee P., and Ndisang J. F., “The Heme Oxygenase System Selectively Enhances the Anti‐Inflammatory Macrophage‐M2 Phenotype, Reduces Pericardial Adiposity, and Ameliorated Cardiac Injury in Diabetic Cardiomyopathy in Zucker Diabetic Fatty Rats,” Journal of Pharmacology and Experimental Therapeutics
345, no. 2 (2013): 239–249, 10.1124/jpet.112.200808.
</cite> [<a href="https://doi.org/10.1124/jpet.112.200808" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23442249/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Pharmacology%20and%20Experimental%20Therapeutics&amp;title=The%20Heme%20Oxygenase%20System%20Selectively%20Enhances%20the%20Anti%E2%80%90Inflammatory%20Macrophage%E2%80%90M2%20Phenotype,%20Reduces%20Pericardial%20Adiposity,%20and%20Ameliorated%20Cardiac%20Injury%20in%20Diabetic%20Cardiomyopathy%20in%20Zucker%20Diabetic%20Fatty%20Rats&amp;author=A.%20Jadhav&amp;author=S.%20Tiwari&amp;author=P.%20Lee&amp;author=J.%20F.%20Ndisang&amp;volume=345&amp;issue=2&amp;publication_year=2013&amp;pages=239-249&amp;pmid=23442249&amp;doi=10.1124/jpet.112.200808&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0022">
<span class="label">22.</span><cite>
Westermann D., Rutschow S., Van Linthout S., et al., “Inhibition of p38 Mitogen‐Activated Protein Kinase Attenuates Left Ventricular Dysfunction by Mediating Pro‐Inflammatory Cardiac Cytokine Levels in a Mouse Model of Diabetes Mellitus,” Diabetologia
49, no. 10 (2006): 2507–2513, 10.1007/s00125-006-0385-2.
</cite> [<a href="https://doi.org/10.1007/s00125-006-0385-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16937126/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabetologia&amp;title=Inhibition%20of%20p38%20Mitogen%E2%80%90Activated%20Protein%20Kinase%20Attenuates%20Left%20Ventricular%20Dysfunction%20by%20Mediating%20Pro%E2%80%90Inflammatory%20Cardiac%20Cytokine%20Levels%20in%20a%20Mouse%20Model%20of%20Diabetes%20Mellitus&amp;author=D.%20Westermann&amp;author=S.%20Rutschow&amp;author=S.%20Van%20Linthout&amp;volume=49&amp;issue=10&amp;publication_year=2006&amp;pages=2507-2513&amp;pmid=16937126&amp;doi=10.1007/s00125-006-0385-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0023">
<span class="label">23.</span><cite>
Russell‐Hallinan A., Watson C. J., O'Dwyer D., Grieve D. J., and O'Neill K. M., “Epigenetic Regulation of Endothelial Cell Function by Nucleic Acid Methylation in Cardiac Homeostasis and Disease,” Cardiovascular Drugs and Therapy
35, no. 5 (2021): 1025–1044, 10.1007/s10557-020-07019-4.
</cite> [<a href="https://doi.org/10.1007/s10557-020-07019-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8452583/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32748033/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cardiovascular%20Drugs%20and%20Therapy&amp;title=Epigenetic%20Regulation%20of%20Endothelial%20Cell%20Function%20by%20Nucleic%20Acid%20Methylation%20in%20Cardiac%20Homeostasis%20and%20Disease&amp;author=A.%20Russell%E2%80%90Hallinan&amp;author=C.%20J.%20Watson&amp;author=D.%20O'Dwyer&amp;author=D.%20J.%20Grieve&amp;author=K.%20M.%20O'Neill&amp;volume=35&amp;issue=5&amp;publication_year=2021&amp;pages=1025-1044&amp;pmid=32748033&amp;doi=10.1007/s10557-020-07019-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0024">
<span class="label">24.</span><cite>
Holman R. R., Paul S. K., Bethel M. A., Matthews D. R., and Neil H. A., “10‐Year Follow‐Up of Intensive Glucose Control in Type 2 Diabetes,” New England Journal of Medicine
359, no. 15 (2008): 1577–1589, 10.1056/nejmoa0806470.
</cite> [<a href="https://doi.org/10.1056/nejmoa0806470" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18784090/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=New%20England%20Journal%20of%20Medicine&amp;title=10%E2%80%90Year%20Follow%E2%80%90Up%20of%20Intensive%20Glucose%20Control%20in%20Type%202%20Diabetes&amp;author=R.%20R.%20Holman&amp;author=S.%20K.%20Paul&amp;author=M.%20A.%20Bethel&amp;author=D.%20R.%20Matthews&amp;author=H.%20A.%20Neil&amp;volume=359&amp;issue=15&amp;publication_year=2008&amp;pages=1577-1589&amp;pmid=18784090&amp;doi=10.1056/nejmoa0806470&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0025">
<span class="label">25.</span><cite>
Agrawal L., Azad N., Bahn G. D., et al., “Long‐Term Follow‐Up of Intensive Glycaemic Control on Renal Outcomes in the Veterans Affairs Diabetes Trial (VADT),” Diabetologia
61, no. 2 (2018): 295–299, 10.1007/s00125-017-4473-2.
</cite> [<a href="https://doi.org/10.1007/s00125-017-4473-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5747983/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29101421/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabetologia&amp;title=Long%E2%80%90Term%20Follow%E2%80%90Up%20of%20Intensive%20Glycaemic%20Control%20on%20Renal%20Outcomes%20in%20the%20Veterans%20Affairs%20Diabetes%20Trial%20(VADT)&amp;author=L.%20Agrawal&amp;author=N.%20Azad&amp;author=G.%20D.%20Bahn&amp;volume=61&amp;issue=2&amp;publication_year=2018&amp;pages=295-299&amp;pmid=29101421&amp;doi=10.1007/s00125-017-4473-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0026">
<span class="label">26.</span><cite>
Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group
, “Sustained Effect of Intensive Treatment of Type 1 Diabetes Mellitus on Development and Progression of Diabetic Nephropathy: The Epidemiology of Diabetes Interventions and Complications (EDIC) Study,” JAMA
290, no. 16 (2003): 2159–2167, 10.1001/jama.290.16.2159.
</cite> [<a href="https://doi.org/10.1001/jama.290.16.2159" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2622725/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/14570951/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JAMA&amp;title=Sustained%20Effect%20of%20Intensive%20Treatment%20of%20Type%201%20Diabetes%20Mellitus%20on%20Development%20and%20Progression%20of%20Diabetic%20Nephropathy:%20The%20Epidemiology%20of%20Diabetes%20Interventions%20and%20Complications%20(EDIC)%20Study&amp;volume=290&amp;issue=16&amp;publication_year=2003&amp;pages=2159-2167&amp;pmid=14570951&amp;doi=10.1001/jama.290.16.2159&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0027">
<span class="label">27.</span><cite>
Sarkozy M., Szucs G., Fekete V., et al., “Transcriptomic Alterations in the Heart of Non‐Obese Type 2 Diabetic Goto‐Kakizaki Rats,” Cardiovascular Diabetology
15, no. 1 (2016): 110, 10.1186/s12933-016-0424-3.
</cite> [<a href="https://doi.org/10.1186/s12933-016-0424-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4975916/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27496100/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cardiovascular%20Diabetology&amp;title=Transcriptomic%20Alterations%20in%20the%20Heart%20of%20Non%E2%80%90Obese%20Type%202%20Diabetic%20Goto%E2%80%90Kakizaki%20Rats&amp;author=M.%20Sarkozy&amp;author=G.%20Szucs&amp;author=V.%20Fekete&amp;volume=15&amp;issue=1&amp;publication_year=2016&amp;pages=110&amp;pmid=27496100&amp;doi=10.1186/s12933-016-0424-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0028">
<span class="label">28.</span><cite>
Kesherwani V., Shahshahan H. R., and Mishra P. K., “Cardiac Transcriptome Profiling of Diabetic Akita Mice Using Microarray and Next Generation Sequencing,” PLoS One
12, no. 8 (2017): e0182828, 10.1371/journal.pone.0182828.
</cite> [<a href="https://doi.org/10.1371/journal.pone.0182828" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5570368/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28837672/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20One&amp;title=Cardiac%20Transcriptome%20Profiling%20of%20Diabetic%20Akita%20Mice%20Using%20Microarray%20and%20Next%20Generation%20Sequencing&amp;author=V.%20Kesherwani&amp;author=H.%20R.%20Shahshahan&amp;author=P.%20K.%20Mishra&amp;volume=12&amp;issue=8&amp;publication_year=2017&amp;pages=e0182828&amp;pmid=28837672&amp;doi=10.1371/journal.pone.0182828&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0029">
<span class="label">29.</span><cite>
Hao J. and Liu Y., “Epigenetics of Methylation Modifications in Diabetic Cardiomyopathy,” Frontiers in Endocrinology
14 (2023): 1119765, 10.3389/fendo.2023.1119765.
</cite> [<a href="https://doi.org/10.3389/fendo.2023.1119765" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10050754/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37008904/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Frontiers%20in%20Endocrinology&amp;title=Epigenetics%20of%20Methylation%20Modifications%20in%20Diabetic%20Cardiomyopathy&amp;author=J.%20Hao&amp;author=Y.%20Liu&amp;volume=14&amp;publication_year=2023&amp;pages=1119765&amp;pmid=37008904&amp;doi=10.3389/fendo.2023.1119765&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0030">
<span class="label">30.</span><cite>
Jaenisch R. and Bird A., “Epigenetic Regulation of Gene Expression: How the Genome Integrates Intrinsic and Environmental Signals,” supplement, Nature Genetics
33, no. Sl (2003): 245–254, 10.1038/ng1089.
</cite> [<a href="https://doi.org/10.1038/ng1089" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12610534/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature%20Genetics&amp;title=Epigenetic%20Regulation%20of%20Gene%20Expression:%20How%20the%20Genome%20Integrates%20Intrinsic%20and%20Environmental%20Signals&amp;author=R.%20Jaenisch&amp;author=A.%20Bird&amp;volume=33&amp;issue=Sl&amp;publication_year=2003&amp;pages=245-254&amp;pmid=12610534&amp;doi=10.1038/ng1089&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0031">
<span class="label">31.</span><cite>
Keating S. T., Plutzky J., and El‐Osta A., “Epigenetic Changes in Diabetes and Cardiovascular Risk,” Circulation Research
118, no. 11 (2016): 1706–1722, 10.1161/circresaha.116.306819.
</cite> [<a href="https://doi.org/10.1161/circresaha.116.306819" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5593074/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27230637/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Circulation%20Research&amp;title=Epigenetic%20Changes%20in%20Diabetes%20and%20Cardiovascular%20Risk&amp;author=S.%20T.%20Keating&amp;author=J.%20Plutzky&amp;author=A.%20El%E2%80%90Osta&amp;volume=118&amp;issue=11&amp;publication_year=2016&amp;pages=1706-1722&amp;pmid=27230637&amp;doi=10.1161/circresaha.116.306819&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0032">
<span class="label">32.</span><cite>
Wang A. J., Wang S., Wang B. J., et al., “Epigenetic Regulation Associated With Sirtuin 1 in Complications of Diabetes Mellitus,” Frontiers in Endocrinology
11 (2020): 598012, 10.3389/fendo.2020.598012.
</cite> [<a href="https://doi.org/10.3389/fendo.2020.598012" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7848207/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33537003/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Frontiers%20in%20Endocrinology&amp;title=Epigenetic%20Regulation%20Associated%20With%20Sirtuin%201%20in%20Complications%20of%20Diabetes%20Mellitus&amp;author=A.%20J.%20Wang&amp;author=S.%20Wang&amp;author=B.%20J.%20Wang&amp;volume=11&amp;publication_year=2020&amp;pages=598012&amp;pmid=33537003&amp;doi=10.3389/fendo.2020.598012&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0033">
<span class="label">33.</span><cite>
Xia L. and Song M., “Role of Non‐Coding RNA in Diabetic Cardiomyopathy,” Advances in Experimental Medicine and Biology
1229 (2020): 181–195, 10.1007/978-981-15-1671-9_10.
</cite> [<a href="https://doi.org/10.1007/978-981-15-1671-9_10" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32285412/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Advances%20in%20Experimental%20Medicine%20and%20Biology&amp;title=Role%20of%20Non%E2%80%90Coding%20RNA%20in%20Diabetic%20Cardiomyopathy&amp;author=L.%20Xia&amp;author=M.%20Song&amp;volume=1229&amp;publication_year=2020&amp;pages=181-195&amp;pmid=32285412&amp;doi=10.1007/978-981-15-1671-9_10&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0034">
<span class="label">34.</span><cite>
Hussain S., Khan A. W., Akhmedov A., et al., “Hyperglycemia Induces Myocardial Dysfunction via Epigenetic Regulation of JunD,” Circulation Research
127, no. 10 (2020): 1261–1273, 10.1161/circresaha.120.317132.
</cite> [<a href="https://doi.org/10.1161/circresaha.120.317132" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32815777/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Circulation%20Research&amp;title=Hyperglycemia%20Induces%20Myocardial%20Dysfunction%20via%20Epigenetic%20Regulation%20of%20JunD&amp;author=S.%20Hussain&amp;author=A.%20W.%20Khan&amp;author=A.%20Akhmedov&amp;volume=127&amp;issue=10&amp;publication_year=2020&amp;pages=1261-1273&amp;pmid=32815777&amp;doi=10.1161/circresaha.120.317132&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0035">
<span class="label">35.</span><cite>
Das P. M. and Singal R., “DNA Methylation and Cancer,” Journal of Clinical Oncology
22, no. 22 (2004): 4632–4642, 10.1200/jco.2004.07.151.
</cite> [<a href="https://doi.org/10.1200/jco.2004.07.151" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15542813/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Clinical%20Oncology&amp;title=DNA%20Methylation%20and%20Cancer&amp;author=P.%20M.%20Das&amp;author=R.%20Singal&amp;volume=22&amp;issue=22&amp;publication_year=2004&amp;pages=4632-4642&amp;pmid=15542813&amp;doi=10.1200/jco.2004.07.151&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0036">
<span class="label">36.</span><cite>
Arechederra M., Daian F., Yim A., et al., “Hypermethylation of Gene Body CpG Islands Predicts High Dosage of Functional Oncogenes in Liver Cancer,” Nature Communications
9, no. 1 (2018): 3164, 10.1038/s41467-018-05550-5.</cite> [<a href="https://doi.org/10.1038/s41467-018-05550-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6082886/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30089774/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature%20Communications&amp;title=Hypermethylation%20of%20Gene%20Body%20CpG%20Islands%20Predicts%20High%20Dosage%20of%20Functional%20Oncogenes%20in%20Liver%20Cancer&amp;author=M.%20Arechederra&amp;author=F.%20Daian&amp;author=A.%20Yim&amp;volume=9&amp;issue=1&amp;publication_year=2018&amp;pages=3164&amp;pmid=30089774&amp;doi=10.1038/s41467-018-05550-5&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0037">
<span class="label">37.</span><cite>
Yang X., Han H., De Carvalho D. D., Lay F. D., Jones P. A., and Liang G., “Gene Body Methylation Can Alter Gene Expression and Is a Therapeutic Target in Cancer,” Cancer Cell
26, no. 4 (2014): 577–590, 10.1016/j.ccr.2014.07.028.
</cite> [<a href="https://doi.org/10.1016/j.ccr.2014.07.028" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4224113/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25263941/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Cell&amp;title=Gene%20Body%20Methylation%20Can%20Alter%20Gene%20Expression%20and%20Is%20a%20Therapeutic%20Target%20in%20Cancer&amp;author=X.%20Yang&amp;author=H.%20Han&amp;author=D.%20D.%20De%20Carvalho&amp;author=F.%20D.%20Lay&amp;author=P.%20A.%20Jones&amp;volume=26&amp;issue=4&amp;publication_year=2014&amp;pages=577-590&amp;pmid=25263941&amp;doi=10.1016/j.ccr.2014.07.028&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0038">
<span class="label">38.</span><cite>
Wang Q., Xiong F., Wu G., et al., “Gene Body Methylation in Cancer: Molecular Mechanisms and Clinical Applications,” Clinical Epigenetics
14, no. 1 (2022): 154, 10.1186/s13148-022-01382-9.
</cite> [<a href="https://doi.org/10.1186/s13148-022-01382-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9706891/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36443876/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clinical%20Epigenetics&amp;title=Gene%20Body%20Methylation%20in%20Cancer:%20Molecular%20Mechanisms%20and%20Clinical%20Applications&amp;author=Q.%20Wang&amp;author=F.%20Xiong&amp;author=G.%20Wu&amp;volume=14&amp;issue=1&amp;publication_year=2022&amp;pages=154&amp;pmid=36443876&amp;doi=10.1186/s13148-022-01382-9&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0039">
<span class="label">39.</span><cite>
Neri F., Rapelli S., Krepelova A., et al., “Intragenic DNA Methylation Prevents Spurious Transcription Initiation,” Nature
543, no. 7643 (2017): 72–77, 10.1038/nature21373.
</cite> [<a href="https://doi.org/10.1038/nature21373" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28225755/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Intragenic%20DNA%20Methylation%20Prevents%20Spurious%20Transcription%20Initiation&amp;author=F.%20Neri&amp;author=S.%20Rapelli&amp;author=A.%20Krepelova&amp;volume=543&amp;issue=7643&amp;publication_year=2017&amp;pages=72-77&amp;pmid=28225755&amp;doi=10.1038/nature21373&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0040">
<span class="label">40.</span><cite>
Dhat R., Mongad D., Raji S., et al., “Epigenetic Modifier Alpha‐Ketoglutarate Modulates Aberrant Gene Body Methylation and Hydroxymethylation Marks in Diabetic Heart,” Epigenetics &amp; Chromatin
16, no. 1 (2023): 12, 10.1186/s13072-023-00489-4.
</cite> [<a href="https://doi.org/10.1186/s13072-023-00489-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10134649/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37101286/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Epigenetics%20&amp;%20Chromatin&amp;title=Epigenetic%20Modifier%20Alpha%E2%80%90Ketoglutarate%20Modulates%20Aberrant%20Gene%20Body%20Methylation%20and%20Hydroxymethylation%20Marks%20in%20Diabetic%20Heart&amp;author=R.%20Dhat&amp;author=D.%20Mongad&amp;author=S.%20Raji&amp;volume=16&amp;issue=1&amp;publication_year=2023&amp;pages=12&amp;pmid=37101286&amp;doi=10.1186/s13072-023-00489-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0041">
<span class="label">41.</span><cite>
Kohli R. M. and Zhang Y., “TET Enzymes, TDG and the Dynamics of DNA Demethylation,” Nature
502, no. 7472 (2013): 472–479, 10.1038/nature12750.
</cite> [<a href="https://doi.org/10.1038/nature12750" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4046508/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24153300/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=TET%20Enzymes,%20TDG%20and%20the%20Dynamics%20of%20DNA%20Demethylation&amp;author=R.%20M.%20Kohli&amp;author=Y.%20Zhang&amp;volume=502&amp;issue=7472&amp;publication_year=2013&amp;pages=472-479&amp;pmid=24153300&amp;doi=10.1038/nature12750&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0042">
<span class="label">42.</span><cite>
Diabetes Control and Complications Trial (DCCT): Results of Feasibility Study. The DCCT Research Group,” Diabetes Care
10, no. 1 (1987): 1–19.
</cite> [<a href="https://doi.org/10.2337/diacare.10.1.1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/2882967/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes%20Care&amp;title=Diabetes%20Control%20and%20Complications%20Trial%20(DCCT):%20Results%20of%20Feasibility%20Study.%20The%20DCCT%20Research%20Group&amp;volume=10&amp;issue=1&amp;publication_year=1987&amp;pages=1-19&amp;pmid=2882967&amp;doi=10.2337/diacare.10.1.1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0043">
<span class="label">43.</span><cite>
Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group
, “Epidemiology of Diabetes Interventions and Complications (EDIC). Design, Implementation, and Preliminary Results of a Long‐Term Follow‐Up of the Diabetes Control and Complications Trial Cohort,” Diabetes Care
22, no. 1 (1999): 99–111, 10.2337/diacare.22.1.99.
</cite> [<a href="https://doi.org/10.2337/diacare.22.1.99" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2745938/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10333910/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes%20Care&amp;title=Epidemiology%20of%20Diabetes%20Interventions%20and%20Complications%20(EDIC).%20Design,%20Implementation,%20and%20Preliminary%20Results%20of%20a%20Long%E2%80%90Term%20Follow%E2%80%90Up%20of%20the%20Diabetes%20Control%20and%20Complications%20Trial%20Cohort&amp;volume=22&amp;issue=1&amp;publication_year=1999&amp;pages=99-111&amp;pmid=10333910&amp;doi=10.2337/diacare.22.1.99&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0044">
<span class="label">44.</span><cite>
Chen Z., Miao F., Braffett B. H., et al., “DNA Methylation Mediates Development of HbA1c‐Associated Complications in Type 1 Diabetes,” Nature Metabolism
2, no. 8 (2020): 744–762, 10.1038/s42255-020-0231-8.</cite> [<a href="https://doi.org/10.1038/s42255-020-0231-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7590966/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32694834/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature%20Metabolism&amp;title=DNA%20Methylation%20Mediates%20Development%20of%20HbA1c%E2%80%90Associated%20Complications%20in%20Type%201%20Diabetes&amp;author=Z.%20Chen&amp;author=F.%20Miao&amp;author=B.%20H.%20Braffett&amp;volume=2&amp;issue=8&amp;publication_year=2020&amp;pages=744-762&amp;pmid=32694834&amp;doi=10.1038/s42255-020-0231-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0045">
<span class="label">45.</span><cite>
Chong C. R., Clarke K., and Levelt E., “Metabolic Remodeling in Diabetic Cardiomyopathy,” Cardiovascular Research
113, no. 4 (2017): 422–430, 10.1093/cvr/cvx018.
</cite> [<a href="https://doi.org/10.1093/cvr/cvx018" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5412022/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28177068/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cardiovascular%20Research&amp;title=Metabolic%20Remodeling%20in%20Diabetic%20Cardiomyopathy&amp;author=C.%20R.%20Chong&amp;author=K.%20Clarke&amp;author=E.%20Levelt&amp;volume=113&amp;issue=4&amp;publication_year=2017&amp;pages=422-430&amp;pmid=28177068&amp;doi=10.1093/cvr/cvx018&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0046">
<span class="label">46.</span><cite>
Chen Z., Miao F., Paterson A. D., et al., “Epigenomic Profiling Reveals an Association Between Persistence of DNA Methylation and Metabolic Memory in the DCCT/EDIC Type 1 Diabetes Cohort,” Proceedings of the National Academy of Sciences of the USA
113, no. 21 (2016): E3002–E3011, 10.1073/pnas.1603712113.
</cite> [<a href="https://doi.org/10.1073/pnas.1603712113" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4890596/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27162351/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Proceedings%20of%20the%20National%20Academy%20of%20Sciences%20of%20the%20USA&amp;title=Epigenomic%20Profiling%20Reveals%20an%20Association%20Between%20Persistence%20of%20DNA%20Methylation%20and%20Metabolic%20Memory%20in%20the%20DCCT/EDIC%20Type%201%20Diabetes%20Cohort&amp;author=Z.%20Chen&amp;author=F.%20Miao&amp;author=A.%20D.%20Paterson&amp;volume=113&amp;issue=21&amp;publication_year=2016&amp;pages=E3002-E3011&amp;pmid=27162351&amp;doi=10.1073/pnas.1603712113&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0047">
<span class="label">47.</span><cite>
Myers R. B., Fomovsky G. M., Lee S., et al., “Deletion of Thioredoxin‐Interacting Protein Improves Cardiac Inotropic Reserve in the Streptozotocin‐Induced Diabetic Heart,” American Journal of Physiology—Heart and Circulatory Physiology
310, no. 11 (2016): H1748–H1759, 10.1152/ajpheart.00051.2016.
</cite> [<a href="https://doi.org/10.1152/ajpheart.00051.2016" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4935523/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27037370/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=American%20Journal%20of%20Physiology%E2%80%94Heart%20and%20Circulatory%20Physiology&amp;title=Deletion%20of%20Thioredoxin%E2%80%90Interacting%20Protein%20Improves%20Cardiac%20Inotropic%20Reserve%20in%20the%20Streptozotocin%E2%80%90Induced%20Diabetic%20Heart&amp;author=R.%20B.%20Myers&amp;author=G.%20M.%20Fomovsky&amp;author=S.%20Lee&amp;volume=310&amp;issue=11&amp;publication_year=2016&amp;pages=H1748-H1759&amp;pmid=27037370&amp;doi=10.1152/ajpheart.00051.2016&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0048">
<span class="label">48.</span><cite>
He Q., Pu J., Yuan A., et al., “Liver X Receptor Agonist Treatment Attenuates Cardiac Dysfunction in Type 2 Diabetic db/db Mice,” Cardiovascular Diabetology
13, no. 1 (2014): 149, 10.1186/s12933-014-0149-0.
</cite> [<a href="https://doi.org/10.1186/s12933-014-0149-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4245833/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25416469/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cardiovascular%20Diabetology&amp;title=Liver%20X%20Receptor%20Agonist%20Treatment%20Attenuates%20Cardiac%20Dysfunction%20in%20Type%202%20Diabetic%20db/db%20Mice&amp;author=Q.%20He&amp;author=J.%20Pu&amp;author=A.%20Yuan&amp;volume=13&amp;issue=1&amp;publication_year=2014&amp;pages=149&amp;pmid=25416469&amp;doi=10.1186/s12933-014-0149-0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0049">
<span class="label">49.</span><cite>
Toperoff G., Aran D., Kark J. D., et al., “Genome‐Wide Survey Reveals Predisposing Diabetes Type 2‐Related DNA Methylation Variations in Human Peripheral Blood,” Human Molecular Genetics
21, no. 2 (2012): 371–383, 10.1093/hmg/ddr472.
</cite> [<a href="https://doi.org/10.1093/hmg/ddr472" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3276288/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21994764/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Human%20Molecular%20Genetics&amp;title=Genome%E2%80%90Wide%20Survey%20Reveals%20Predisposing%20Diabetes%20Type%202%E2%80%90Related%20DNA%20Methylation%20Variations%20in%20Human%20Peripheral%20Blood&amp;author=G.%20Toperoff&amp;author=D.%20Aran&amp;author=J.%20D.%20Kark&amp;volume=21&amp;issue=2&amp;publication_year=2012&amp;pages=371-383&amp;pmid=21994764&amp;doi=10.1093/hmg/ddr472&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0050">
<span class="label">50.</span><cite>
Ju W., Liu K., Ouyang S., Liu Z., He F., and Wu J., “Changes in N6‐Methyladenosine Modification Modulate Diabetic Cardiomyopathy by Reducing Myocardial Fibrosis and Myocyte Hypertrophy,” Frontiers in Cell and Developmental Biology
9 (2021): 702579, 10.3389/fcell.2021.702579.
</cite> [<a href="https://doi.org/10.3389/fcell.2021.702579" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8334868/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34368154/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Frontiers%20in%20Cell%20and%20Developmental%20Biology&amp;title=Changes%20in%20N6%E2%80%90Methyladenosine%20Modification%20Modulate%20Diabetic%20Cardiomyopathy%20by%20Reducing%20Myocardial%20Fibrosis%20and%20Myocyte%20Hypertrophy&amp;author=W.%20Ju&amp;author=K.%20Liu&amp;author=S.%20Ouyang&amp;author=Z.%20Liu&amp;author=F.%20He&amp;volume=9&amp;publication_year=2021&amp;pages=702579&amp;pmid=34368154&amp;doi=10.3389/fcell.2021.702579&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0051">
<span class="label">51.</span><cite>
Nilsson E., Vavakova M., Perfilyev A., et al., “Differential DNA Methylation and Expression of miRNAs in Adipose Tissue From Twin Pairs Discordant for Type 2 Diabetes,” Diabetes
70, no. 10 (2021): 2402–2418, 10.2337/db20-0324.
</cite> [<a href="https://doi.org/10.2337/db20-0324" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34315727/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes&amp;title=Differential%20DNA%20Methylation%20and%20Expression%20of%20miRNAs%20in%20Adipose%20Tissue%20From%20Twin%20Pairs%20Discordant%20for%20Type%202%20Diabetes&amp;author=E.%20Nilsson&amp;author=M.%20Vavakova&amp;author=A.%20Perfilyev&amp;volume=70&amp;issue=10&amp;publication_year=2021&amp;pages=2402-2418&amp;pmid=34315727&amp;doi=10.2337/db20-0324&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0052">
<span class="label">52.</span><cite>
Lee T. I., Kao Y. H., Chen Y. C., Pan N. H., Lin Y. K., and Chen Y. J., “Cardiac Peroxisome‐Proliferator‐Activated Receptor Expression in Hypertension Co‐Existing With Diabetes,” Clinical Science
121, no. 7 (2011): 305–312, 10.1042/cs20100529.
</cite> [<a href="https://doi.org/10.1042/cs20100529" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21501116/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clinical%20Science&amp;title=Cardiac%20Peroxisome%E2%80%90Proliferator%E2%80%90Activated%20Receptor%20Expression%20in%20Hypertension%20Co%E2%80%90Existing%20With%20Diabetes&amp;author=T.%20I.%20Lee&amp;author=Y.%20H.%20Kao&amp;author=Y.%20C.%20Chen&amp;author=N.%20H.%20Pan&amp;author=Y.%20K.%20Lin&amp;volume=121&amp;issue=7&amp;publication_year=2011&amp;pages=305-312&amp;pmid=21501116&amp;doi=10.1042/cs20100529&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0053">
<span class="label">53.</span><cite>
Lee T. I., Kao Y. H., Chen Y. C., Pan N. H., and Chen Y. J., “Oxidative Stress and Inflammation Modulate Peroxisome Proliferator‐Activated Receptors With Regional Discrepancy in Diabetic Heart,” European Journal of Clinical Investigation
40, no. 8 (2010): 692–699, 10.1111/j.1365-2362.2010.02318.x.
</cite> [<a href="https://doi.org/10.1111/j.1365-2362.2010.02318.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20561028/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=European%20Journal%20of%20Clinical%20Investigation&amp;title=Oxidative%20Stress%20and%20Inflammation%20Modulate%20Peroxisome%20Proliferator%E2%80%90Activated%20Receptors%20With%20Regional%20Discrepancy%20in%20Diabetic%20Heart&amp;author=T.%20I.%20Lee&amp;author=Y.%20H.%20Kao&amp;author=Y.%20C.%20Chen&amp;author=N.%20H.%20Pan&amp;author=Y.%20J.%20Chen&amp;volume=40&amp;issue=8&amp;publication_year=2010&amp;pages=692-699&amp;pmid=20561028&amp;doi=10.1111/j.1365-2362.2010.02318.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0054">
<span class="label">54.</span><cite>
Boovarahan S. R., Chellappan D. R., Ali N., et al., “Diabetic Hearts Exhibit Global DNA Hypermethylation That Alter the Mitochondrial Functional Genes to Enhance the Sensitivity of the Heart to Ischemia Reperfusion Injury,” Biomedicines
10, no. 12 (2022): 3065, 10.3390/biomedicines10123065.
</cite> [<a href="https://doi.org/10.3390/biomedicines10123065" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9776053/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36551820/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biomedicines&amp;title=Diabetic%20Hearts%20Exhibit%20Global%20DNA%20Hypermethylation%20That%20Alter%20the%20Mitochondrial%20Functional%20Genes%20to%20Enhance%20the%20Sensitivity%20of%20the%20Heart%20to%20Ischemia%20Reperfusion%20Injury&amp;author=S.%20R.%20Boovarahan&amp;author=D.%20R.%20Chellappan&amp;author=N.%20Ali&amp;volume=10&amp;issue=12&amp;publication_year=2022&amp;pages=3065&amp;pmid=36551820&amp;doi=10.3390/biomedicines10123065&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0055">
<span class="label">55.</span><cite>
Tao H., Tao J. Y., Song Z. Y., et al., “MeCP2 Triggers Diabetic Cardiomyopathy and Cardiac Fibroblast Proliferation by Inhibiting RASSF1A,” Cellular Signalling
63 (2019): 109387, 10.1016/j.cellsig.2019.109387.
</cite> [<a href="https://doi.org/10.1016/j.cellsig.2019.109387" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31398393/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cellular%20Signalling&amp;title=MeCP2%20Triggers%20Diabetic%20Cardiomyopathy%20and%20Cardiac%20Fibroblast%20Proliferation%20by%20Inhibiting%20RASSF1A&amp;author=H.%20Tao&amp;author=J.%20Y.%20Tao&amp;author=Z.%20Y.%20Song&amp;volume=63&amp;publication_year=2019&amp;pages=109387&amp;pmid=31398393&amp;doi=10.1016/j.cellsig.2019.109387&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0056">
<span class="label">56.</span><cite>
Stoccoro A. and Coppede F., “Mitochondrial DNA Methylation and Human Diseases,” International Journal of Molecular Sciences
22, no. 9 (2021): 4594, 10.3390/ijms22094594.
</cite> [<a href="https://doi.org/10.3390/ijms22094594" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8123858/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33925624/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=International%20Journal%20of%20Molecular%20Sciences&amp;title=Mitochondrial%20DNA%20Methylation%20and%20Human%20Diseases&amp;author=A.%20Stoccoro&amp;author=F.%20Coppede&amp;volume=22&amp;issue=9&amp;publication_year=2021&amp;pages=4594&amp;pmid=33925624&amp;doi=10.3390/ijms22094594&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0057">
<span class="label">57.</span><cite>
Mechta M., Ingerslev L. R., Fabre O., Picard M., and Barres R., “Evidence Suggesting Absence of Mitochondrial DNA Methylation,” Frontiers in Genetics
8 (2017): 166, 10.3389/fgene.2017.00166.
</cite> [<a href="https://doi.org/10.3389/fgene.2017.00166" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5671948/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29163634/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Frontiers%20in%20Genetics&amp;title=Evidence%20Suggesting%20Absence%20of%20Mitochondrial%20DNA%20Methylation&amp;author=M.%20Mechta&amp;author=L.%20R.%20Ingerslev&amp;author=O.%20Fabre&amp;author=M.%20Picard&amp;author=R.%20Barres&amp;volume=8&amp;publication_year=2017&amp;pages=166&amp;pmid=29163634&amp;doi=10.3389/fgene.2017.00166&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0058">
<span class="label">58.</span><cite>
Mposhi A., Van der Wijst M. G., Faber K. N., and Rots M. G., “Regulation of Mitochondrial Gene Expression, the Epigenetic Enigma,” Frontiers in Bioscience
22, no. 7 (2017): 1099–1113, 10.2741/4535.</cite> [<a href="https://doi.org/10.2741/4535" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28199194/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Frontiers%20in%20Bioscience&amp;title=Regulation%20of%20Mitochondrial%20Gene%20Expression,%20the%20Epigenetic%20Enigma&amp;author=A.%20Mposhi&amp;author=M.%20G.%20Van%20der%20Wijst&amp;author=K.%20N.%20Faber&amp;author=M.%20G.%20Rots&amp;volume=22&amp;issue=7&amp;publication_year=2017&amp;pages=1099-1113&amp;pmid=28199194&amp;doi=10.2741/4535&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0059">
<span class="label">59.</span><cite>
Rehman A., Kumari R., Kamthan A., et al., “Cell‐Free Circulating Mitochondrial DNA: An Emerging Biomarker for Airborne Particulate Matter Associated With Cardiovascular Diseases,” Free Radical Biology and Medicine
195 (2023): 103–120, 10.1016/j.freeradbiomed.2022.12.083.
</cite> [<a href="https://doi.org/10.1016/j.freeradbiomed.2022.12.083" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36584454/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Free%20Radical%20Biology%20and%20Medicine&amp;title=Cell%E2%80%90Free%20Circulating%20Mitochondrial%20DNA:%20An%20Emerging%20Biomarker%20for%20Airborne%20Particulate%20Matter%20Associated%20With%20Cardiovascular%20Diseases&amp;author=A.%20Rehman&amp;author=R.%20Kumari&amp;author=A.%20Kamthan&amp;volume=195&amp;publication_year=2023&amp;pages=103-120&amp;pmid=36584454&amp;doi=10.1016/j.freeradbiomed.2022.12.083&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0060">
<span class="label">60.</span><cite>
Zheng L. D., Linarelli L. E., Liu L., et al., “Insulin Resistance Is Associated With Epigenetic and Genetic Regulation of Mitochondrial DNA in Obese Humans,” Clinical Epigenetics
7, no. 1 (2015): 60, 10.1186/s13148-015-0093-1.
</cite> [<a href="https://doi.org/10.1186/s13148-015-0093-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4479353/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26110043/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clinical%20Epigenetics&amp;title=Insulin%20Resistance%20Is%20Associated%20With%20Epigenetic%20and%20Genetic%20Regulation%20of%20Mitochondrial%20DNA%20in%20Obese%20Humans&amp;author=L.%20D.%20Zheng&amp;author=L.%20E.%20Linarelli&amp;author=L.%20Liu&amp;volume=7&amp;issue=1&amp;publication_year=2015&amp;pages=60&amp;pmid=26110043&amp;doi=10.1186/s13148-015-0093-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0061">
<span class="label">61.</span><cite>
Cao K., Lv W., Wang X., et al., “Hypermethylation of Hepatic Mitochondrial ND6 Provokes Systemic Insulin Resistance,” Advanced Science
8, no. 11 (2021): 2004507, 10.1002/advs.202004507.
</cite> [<a href="https://doi.org/10.1002/advs.202004507" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8188198/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34141522/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Advanced%20Science&amp;title=Hypermethylation%20of%20Hepatic%20Mitochondrial%20ND6%20Provokes%20Systemic%20Insulin%20Resistance&amp;author=K.%20Cao&amp;author=W.%20Lv&amp;author=X.%20Wang&amp;volume=8&amp;issue=11&amp;publication_year=2021&amp;pages=2004507&amp;pmid=34141522&amp;doi=10.1002/advs.202004507&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0062">
<span class="label">62.</span><cite>
Mposhi A., Liang L., Mennega K. P., et al., “The Mitochondrial Epigenome: An Unexplored Avenue to Explain Unexplained Myopathies?,” International Journal of Molecular Sciences
23, no. 4 (2022): 2197, 10.3390/ijms23042197.
</cite> [<a href="https://doi.org/10.3390/ijms23042197" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8879787/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35216315/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=International%20Journal%20of%20Molecular%20Sciences&amp;title=The%20Mitochondrial%20Epigenome:%20An%20Unexplored%20Avenue%20to%20Explain%20Unexplained%20Myopathies?&amp;author=A.%20Mposhi&amp;author=L.%20Liang&amp;author=K.%20P.%20Mennega&amp;volume=23&amp;issue=4&amp;publication_year=2022&amp;pages=2197&amp;pmid=35216315&amp;doi=10.3390/ijms23042197&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0063">
<span class="label">63.</span><cite>
Rautenberg E. K., Hamzaoui Y., and Coletta D. K., “Mini‐Review: Mitochondrial DNA Methylation in Type 2 Diabetes and Obesity,” Frontiers in Endocrinology
13 (2022): 968268, 10.3389/fendo.2022.968268.
</cite> [<a href="https://doi.org/10.3389/fendo.2022.968268" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9453027/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36093112/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Frontiers%20in%20Endocrinology&amp;title=Mini%E2%80%90Review:%20Mitochondrial%20DNA%20Methylation%20in%20Type%202%20Diabetes%20and%20Obesity&amp;author=E.%20K.%20Rautenberg&amp;author=Y.%20Hamzaoui&amp;author=D.%20K.%20Coletta&amp;volume=13&amp;publication_year=2022&amp;pages=968268&amp;pmid=36093112&amp;doi=10.3389/fendo.2022.968268&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0064">
<span class="label">64.</span><cite>
Liu Y. F., Zhu J. J., Yu T. X., et al., “Hypermethylation of Mitochondrial DNA in Vascular Smooth Muscle Cells Impairs Cell Contractility,” Cell Death &amp; Disease
11, no. 1 (2020): 35, 10.1038/s41419-020-2240-7.
</cite> [<a href="https://doi.org/10.1038/s41419-020-2240-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6971246/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31959742/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell%20Death%20&amp;%20Disease&amp;title=Hypermethylation%20of%20Mitochondrial%20DNA%20in%20Vascular%20Smooth%20Muscle%20Cells%20Impairs%20Cell%20Contractility&amp;author=Y.%20F.%20Liu&amp;author=J.%20J.%20Zhu&amp;author=T.%20X.%20Yu&amp;volume=11&amp;issue=1&amp;publication_year=2020&amp;pages=35&amp;pmid=31959742&amp;doi=10.1038/s41419-020-2240-7&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0065">
<span class="label">65.</span><cite>
Scarpulla R. C., “Nucleus‐Encoded Regulators of Mitochondrial Function: Integration of Respiratory Chain Expression, Nutrient Sensing and Metabolic Stress,” Biochimica et Biophysica Acta
1819, no. 9–10 (2012): 1088–1097, 10.1016/j.bbagrm.2011.10.011.
</cite> [<a href="https://doi.org/10.1016/j.bbagrm.2011.10.011" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3306451/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22080153/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biochimica%20et%20Biophysica%20Acta&amp;title=Nucleus%E2%80%90Encoded%20Regulators%20of%20Mitochondrial%20Function:%20Integration%20of%20Respiratory%20Chain%20Expression,%20Nutrient%20Sensing%20and%20Metabolic%20Stress&amp;author=R.%20C.%20Scarpulla&amp;volume=1819&amp;issue=9%E2%80%9310&amp;publication_year=2012&amp;pages=1088-1097&amp;pmid=22080153&amp;doi=10.1016/j.bbagrm.2011.10.011&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0066">
<span class="label">66.</span><cite>
Mohammad G., Radhakrishnan R., and Kowluru R. A., “Epigenetic Modifications Compromise Mitochondrial DNA Quality Control in the Development of Diabetic Retinopathy,” Investigative Ophthalmology &amp; Visual Science
60, no. 12 (2019): 3943–3951, 10.1167/iovs.19-27602.
</cite> [<a href="https://doi.org/10.1167/iovs.19-27602" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6759036/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31546260/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Investigative%20Ophthalmology%20&amp;%20Visual%20Science&amp;title=Epigenetic%20Modifications%20Compromise%20Mitochondrial%20DNA%20Quality%20Control%20in%20the%20Development%20of%20Diabetic%20Retinopathy&amp;author=G.%20Mohammad&amp;author=R.%20Radhakrishnan&amp;author=R.%20A.%20Kowluru&amp;volume=60&amp;issue=12&amp;publication_year=2019&amp;pages=3943-3951&amp;pmid=31546260&amp;doi=10.1167/iovs.19-27602&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0067">
<span class="label">67.</span><cite>
Bannister A. J. and Kouzarides T., “Regulation of Chromatin by Histone Modifications,” Cell Research
21, no. 3 (2011): 381–395, 10.1038/cr.2011.22.
</cite> [<a href="https://doi.org/10.1038/cr.2011.22" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3193420/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21321607/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell%20Research&amp;title=Regulation%20of%20Chromatin%20by%20Histone%20Modifications&amp;author=A.%20J.%20Bannister&amp;author=T.%20Kouzarides&amp;volume=21&amp;issue=3&amp;publication_year=2011&amp;pages=381-395&amp;pmid=21321607&amp;doi=10.1038/cr.2011.22&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0068">
<span class="label">68.</span><cite>
Bernstein B. E., Meissner A., and Lander E. S., “The Mammalian Epigenome,” Cell
128, no. 4 (2007): 669–681, 10.1016/j.cell.2007.01.033.
</cite> [<a href="https://doi.org/10.1016/j.cell.2007.01.033" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17320505/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell&amp;title=The%20Mammalian%20Epigenome&amp;author=B.%20E.%20Bernstein&amp;author=A.%20Meissner&amp;author=E.%20S.%20Lander&amp;volume=128&amp;issue=4&amp;publication_year=2007&amp;pages=669-681&amp;pmid=17320505&amp;doi=10.1016/j.cell.2007.01.033&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0069">
<span class="label">69.</span><cite>
Yun M., Wu J., Workman J. L., and Li B., “Readers of Histone Modifications,” Cell Research
21, no. 4 (2011): 564–578, 10.1038/cr.2011.42.
</cite> [<a href="https://doi.org/10.1038/cr.2011.42" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3131977/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21423274/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell%20Research&amp;title=Readers%20of%20Histone%20Modifications&amp;author=M.%20Yun&amp;author=J.%20Wu&amp;author=J.%20L.%20Workman&amp;author=B.%20Li&amp;volume=21&amp;issue=4&amp;publication_year=2011&amp;pages=564-578&amp;pmid=21423274&amp;doi=10.1038/cr.2011.42&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0070">
<span class="label">70.</span><cite>
Yerra V. G. and Advani A., “Histones and Heart Failure in Diabetes,” Cellular and Molecular Life Sciences
75, no. 17 (2018): 3193–3213, 10.1007/s00018-018-2857-1.
</cite> [<a href="https://doi.org/10.1007/s00018-018-2857-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6063320/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29934664/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cellular%20and%20Molecular%20Life%20Sciences&amp;title=Histones%20and%20Heart%20Failure%20in%20Diabetes&amp;author=V.%20G.%20Yerra&amp;author=A.%20Advani&amp;volume=75&amp;issue=17&amp;publication_year=2018&amp;pages=3193-3213&amp;pmid=29934664&amp;doi=10.1007/s00018-018-2857-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0071">
<span class="label">71.</span><cite>
Marmorstein R., “Structure and Function of Histone Acetyltransferases,” Cellular and Molecular Life Sciences
58, no. 5–6 (2001): 693–703, 10.1007/pl00000893.
</cite> [<a href="https://doi.org/10.1007/pl00000893" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11337361/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11437231/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cellular%20and%20Molecular%20Life%20Sciences&amp;title=Structure%20and%20Function%20of%20Histone%20Acetyltransferases&amp;author=R.%20Marmorstein&amp;volume=58&amp;issue=5%E2%80%936&amp;publication_year=2001&amp;pages=693-703&amp;pmid=11437231&amp;doi=10.1007/pl00000893&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0072">
<span class="label">72.</span><cite>
Verdone L., Caserta M., and Di Mauro E., “Role of Histone Acetylation in the Control of Gene Expression,” Biochemistry and Cell Biology
83, no. 3 (2005): 344–353, 10.1139/o05-041.
</cite> [<a href="https://doi.org/10.1139/o05-041" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15959560/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biochemistry%20and%20Cell%20Biology&amp;title=Role%20of%20Histone%20Acetylation%20in%20the%20Control%20of%20Gene%20Expression&amp;author=L.%20Verdone&amp;author=M.%20Caserta&amp;author=E.%20Di%20Mauro&amp;volume=83&amp;issue=3&amp;publication_year=2005&amp;pages=344-353&amp;pmid=15959560&amp;doi=10.1139/o05-041&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0073">
<span class="label">73.</span><cite>
Kooistra S. M. and Helin K., “Molecular Mechanisms and Potential Functions of Histone Demethylases,” Nature Reviews Molecular Cell Biology
13, no. 5 (2012): 297–311, 10.1038/nrm3327.
</cite> [<a href="https://doi.org/10.1038/nrm3327" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22473470/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature%20Reviews%20Molecular%20Cell%20Biology&amp;title=Molecular%20Mechanisms%20and%20Potential%20Functions%20of%20Histone%20Demethylases&amp;author=S.%20M.%20Kooistra&amp;author=K.%20Helin&amp;volume=13&amp;issue=5&amp;publication_year=2012&amp;pages=297-311&amp;pmid=22473470&amp;doi=10.1038/nrm3327&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0074">
<span class="label">74.</span><cite>
Wang Q. T., “Epigenetic Regulation of Cardiac Development and Function by Polycomb Group and Trithorax Group Proteins,” Developmental Dynamics
241, no. 6 (2012): 1021–1033, 10.1002/dvdy.23796.
</cite> [<a href="https://doi.org/10.1002/dvdy.23796" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3426356/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22514007/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Developmental%20Dynamics&amp;title=Epigenetic%20Regulation%20of%20Cardiac%20Development%20and%20Function%20by%20Polycomb%20Group%20and%20Trithorax%20Group%20Proteins&amp;author=Q.%20T.%20Wang&amp;volume=241&amp;issue=6&amp;publication_year=2012&amp;pages=1021-1033&amp;pmid=22514007&amp;doi=10.1002/dvdy.23796&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0075">
<span class="label">75.</span><cite>
Russell‐Hallinan A., Watson C. J., and Baugh J. A., “Epigenetics of Aberrant Cardiac Wound Healing,” Comprehensive Physiology
8, no. 2 (2018): 451–491, 10.1002/j.2040-4603.2018.tb00023.x.
</cite> [<a href="https://doi.org/10.1002/j.2040-4603.2018.tb00023.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29687888/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Comprehensive%20Physiology&amp;title=Epigenetics%20of%20Aberrant%20Cardiac%20Wound%20Healing&amp;author=A.%20Russell%E2%80%90Hallinan&amp;author=C.%20J.%20Watson&amp;author=J.%20A.%20Baugh&amp;volume=8&amp;issue=2&amp;publication_year=2018&amp;pages=451-491&amp;pmid=29687888&amp;doi=10.1002/j.2040-4603.2018.tb00023.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0076">
<span class="label">76.</span><cite>
Bagchi R. A. and Weeks K. L., “Histone Deacetylases in Cardiovascular and Metabolic Diseases,” Journal of Molecular and Cellular Cardiology
130 (2019): 151–159, 10.1016/j.yjmcc.2019.04.003.
</cite> [<a href="https://doi.org/10.1016/j.yjmcc.2019.04.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30978343/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Molecular%20and%20Cellular%20Cardiology&amp;title=Histone%20Deacetylases%20in%20Cardiovascular%20and%20Metabolic%20Diseases&amp;author=R.%20A.%20Bagchi&amp;author=K.%20L.%20Weeks&amp;volume=130&amp;publication_year=2019&amp;pages=151-159&amp;pmid=30978343&amp;doi=10.1016/j.yjmcc.2019.04.003&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0077">
<span class="label">77.</span><cite>
Yu X. Y., Geng Y. J., Liang J. L., et al., “High Levels of Glucose Induce Apoptosis in Cardiomyocyte via Epigenetic Regulation of the Insulin‐Like Growth Factor Receptor,” Experimental Cell Research
316, no. 17 (2010): 2903–2909, 10.1016/j.yexcr.2010.07.004.
</cite> [<a href="https://doi.org/10.1016/j.yexcr.2010.07.004" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20633551/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Experimental%20Cell%20Research&amp;title=High%20Levels%20of%20Glucose%20Induce%20Apoptosis%20in%20Cardiomyocyte%20via%20Epigenetic%20Regulation%20of%20the%20Insulin%E2%80%90Like%20Growth%20Factor%20Receptor&amp;author=X.%20Y.%20Yu&amp;author=Y.%20J.%20Geng&amp;author=J.%20L.%20Liang&amp;volume=316&amp;issue=17&amp;publication_year=2010&amp;pages=2903-2909&amp;pmid=20633551&amp;doi=10.1016/j.yexcr.2010.07.004&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0078">
<span class="label">78.</span><cite>
Yu X. Y., Geng Y. J., Liang J. L., et al., “High Levels of Glucose Induce ‘Metabolic Memory’ in Cardiomyocyte via Epigenetic Histone H3 Lysine 9 Methylation,” Molecular Biology Reports
39, no. 9 (2012): 8891–8898, 10.1007/s11033-012-1756-z.
</cite> [<a href="https://doi.org/10.1007/s11033-012-1756-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22707199/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Molecular%20Biology%20Reports&amp;title=High%20Levels%20of%20Glucose%20Induce%20%E2%80%98Metabolic%20Memory%E2%80%99%20in%20Cardiomyocyte%20via%20Epigenetic%20Histone%20H3%20Lysine%209%20Methylation&amp;author=X.%20Y.%20Yu&amp;author=Y.%20J.%20Geng&amp;author=J.%20L.%20Liang&amp;volume=39&amp;issue=9&amp;publication_year=2012&amp;pages=8891-8898&amp;pmid=22707199&amp;doi=10.1007/s11033-012-1756-z&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0079">
<span class="label">79.</span><cite>
El‐Osta A., Brasacchio D., Yao D., et al., “Transient High Glucose Causes Persistent Epigenetic Changes and Altered Gene Expression During Subsequent Normoglycemia,” Journal of Experimental Medicine
205, no. 10 (2008): 2409–2417, 10.1084/jem.20081188092608c.
</cite> [<a href="https://doi.org/10.1084/jem.20081188092608c" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2556800/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18809715/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Experimental%20Medicine&amp;title=Transient%20High%20Glucose%20Causes%20Persistent%20Epigenetic%20Changes%20and%20Altered%20Gene%20Expression%20During%20Subsequent%20Normoglycemia&amp;author=A.%20El%E2%80%90Osta&amp;author=D.%20Brasacchio&amp;author=D.%20Yao&amp;volume=205&amp;issue=10&amp;publication_year=2008&amp;pages=2409-2417&amp;pmid=18809715&amp;doi=10.1084/jem.20081188092608c&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0080">
<span class="label">80.</span><cite>
Brasacchio D., Okabe J., Tikellis C., et al., “Hyperglycemia Induces a Dynamic Cooperativity of Histone Methylase and Demethylase Enzymes Associated With Gene‐Activating Epigenetic Marks That Coexist on the Lysine Tail,” Diabetes
58, no. 5 (2009): 1229–1236, 10.2337/db08-1666.
</cite> [<a href="https://doi.org/10.2337/db08-1666" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2671038/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19208907/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes&amp;title=Hyperglycemia%20Induces%20a%20Dynamic%20Cooperativity%20of%20Histone%20Methylase%20and%20Demethylase%20Enzymes%20Associated%20With%20Gene%E2%80%90Activating%20Epigenetic%20Marks%20That%20Coexist%20on%20the%20Lysine%20Tail&amp;author=D.%20Brasacchio&amp;author=J.%20Okabe&amp;author=C.%20Tikellis&amp;volume=58&amp;issue=5&amp;publication_year=2009&amp;pages=1229-1236&amp;pmid=19208907&amp;doi=10.2337/db08-1666&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0081">
<span class="label">81.</span><cite>
Pearson J. T., “Set7 Methyltransferase Roles in Myocardial Protection From Chronic Stressors,” Clinical Science
137, no. 1 (2023): 105–108, 10.1042/cs20220773.
</cite> [<a href="https://doi.org/10.1042/cs20220773" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36601782/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clinical%20Science&amp;title=Set7%20Methyltransferase%20Roles%20in%20Myocardial%20Protection%20From%20Chronic%20Stressors&amp;author=J.%20T.%20Pearson&amp;volume=137&amp;issue=1&amp;publication_year=2023&amp;pages=105-108&amp;pmid=36601782&amp;doi=10.1042/cs20220773&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0082">
<span class="label">82.</span><cite>
Siebel A. L., Fernandez A. Z., and El‐Osta A., “Glycemic Memory Associated Epigenetic Changes,” Biochemical Pharmacology
80, no. 12 (2010): 1853–1859, 10.1016/j.bcp.2010.06.005.
</cite> [<a href="https://doi.org/10.1016/j.bcp.2010.06.005" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20599797/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biochemical%20Pharmacology&amp;title=Glycemic%20Memory%20Associated%20Epigenetic%20Changes&amp;author=A.%20L.%20Siebel&amp;author=A.%20Z.%20Fernandez&amp;author=A.%20El%E2%80%90Osta&amp;volume=80&amp;issue=12&amp;publication_year=2010&amp;pages=1853-1859&amp;pmid=20599797&amp;doi=10.1016/j.bcp.2010.06.005&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0083">
<span class="label">83.</span><cite>
Miranda J. B., Lunardon G., Lima V. M., et al., “Set7 Deletion Prevents Glucose Intolerance and Improves the Recovery of Cardiac Function After Ischemia and Reperfusion in Obese Female Mice,” Cellular Physiology and Biochemistry
56, no. 3 (2022): 293–309, 10.33594/000000535.
</cite> [<a href="https://doi.org/10.33594/000000535" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35781359/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cellular%20Physiology%20and%20Biochemistry&amp;title=Set7%20Deletion%20Prevents%20Glucose%20Intolerance%20and%20Improves%20the%20Recovery%20of%20Cardiac%20Function%20After%20Ischemia%20and%20Reperfusion%20in%20Obese%20Female%20Mice&amp;author=J.%20B.%20Miranda&amp;author=G.%20Lunardon&amp;author=V.%20M.%20Lima&amp;volume=56&amp;issue=3&amp;publication_year=2022&amp;pages=293-309&amp;pmid=35781359&amp;doi=10.33594/000000535&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0084">
<span class="label">84.</span><cite>
Gaikwad A. B., Sayyed S. G., Lichtnekert J., Tikoo K., and Anders H. J., “Renal Failure Increases Cardiac Histone h3 Acetylation, Dimethylation, and Phosphorylation and the Induction of Cardiomyopathy‐Related Genes in Type 2 Diabetes,” American Journal Of Pathology
176, no. 3 (2010): 1079–1083, 10.2353/ajpath.2010.090528.
</cite> [<a href="https://doi.org/10.2353/ajpath.2010.090528" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2832129/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20075197/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=American%20Journal%20Of%20Pathology&amp;title=Renal%20Failure%20Increases%20Cardiac%20Histone%20h3%20Acetylation,%20Dimethylation,%20and%20Phosphorylation%20and%20the%20Induction%20of%20Cardiomyopathy%E2%80%90Related%20Genes%20in%20Type%202%20Diabetes&amp;author=A.%20B.%20Gaikwad&amp;author=S.%20G.%20Sayyed&amp;author=J.%20Lichtnekert&amp;author=K.%20Tikoo&amp;author=H.%20J.%20Anders&amp;volume=176&amp;issue=3&amp;publication_year=2010&amp;pages=1079-1083&amp;pmid=20075197&amp;doi=10.2353/ajpath.2010.090528&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0085">
<span class="label">85.</span><cite>
Barbati S. A., Colussi C., Bacci L., et al., “Transcription Factor CREM Mediates High Glucose Response in Cardiomyocytes and in a Male Mouse Model of Prolonged Hyperglycemia,” Endocrinology
158, no. 7 (2017): 2391–2405, 10.1210/en.2016-1960.
</cite> [<a href="https://doi.org/10.1210/en.2016-1960" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28368536/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Endocrinology&amp;title=Transcription%20Factor%20CREM%20Mediates%20High%20Glucose%20Response%20in%20Cardiomyocytes%20and%20in%20a%20Male%20Mouse%20Model%20of%20Prolonged%20Hyperglycemia&amp;author=S.%20A.%20Barbati&amp;author=C.%20Colussi&amp;author=L.%20Bacci&amp;volume=158&amp;issue=7&amp;publication_year=2017&amp;pages=2391-2405&amp;pmid=28368536&amp;doi=10.1210/en.2016-1960&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0086">
<span class="label">86.</span><cite>
Vahtola E., Louhelainen M., Forsten H., et al., “Sirtuin1‐p53, Forkhead Box O3a, p38 and Post‐Infarct Cardiac Remodeling in the Spontaneously Diabetic Goto‐Kakizaki Rat,” Cardiovascular Diabetology
9, no. 1 (2010): 5, 10.1186/1475-2840-9-5.
</cite> [<a href="https://doi.org/10.1186/1475-2840-9-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2835668/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20105289/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cardiovascular%20Diabetology&amp;title=Sirtuin1%E2%80%90p53,%20Forkhead%20Box%20O3a,%20p38%20and%20Post%E2%80%90Infarct%20Cardiac%20Remodeling%20in%20the%20Spontaneously%20Diabetic%20Goto%E2%80%90Kakizaki%20Rat&amp;author=E.%20Vahtola&amp;author=M.%20Louhelainen&amp;author=H.%20Forsten&amp;volume=9&amp;issue=1&amp;publication_year=2010&amp;pages=5&amp;pmid=20105289&amp;doi=10.1186/1475-2840-9-5&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0087">
<span class="label">87.</span><cite>
Bagul P. K., Deepthi N., Sultana R., and Banerjee S. K., “Resveratrol Ameliorates Cardiac Oxidative Stress in Diabetes Through Deacetylation of NFkB‐p65 and Histone 3,” Journal of Nutritional Biochemistry
26, no. 11 (2015): 1298–1307, 10.1016/j.jnutbio.2015.06.006.
</cite> [<a href="https://doi.org/10.1016/j.jnutbio.2015.06.006" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26298192/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Nutritional%20Biochemistry&amp;title=Resveratrol%20Ameliorates%20Cardiac%20Oxidative%20Stress%20in%20Diabetes%20Through%20Deacetylation%20of%20NFkB%E2%80%90p65%20and%20Histone%203&amp;author=P.%20K.%20Bagul&amp;author=N.%20Deepthi&amp;author=R.%20Sultana&amp;author=S.%20K.%20Banerjee&amp;volume=26&amp;issue=11&amp;publication_year=2015&amp;pages=1298-1307&amp;pmid=26298192&amp;doi=10.1016/j.jnutbio.2015.06.006&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0088">
<span class="label">88.</span><cite>
Xu Z., Tong Q., Zhang Z., et al., “Inhibition of HDAC3 Prevents Diabetic Cardiomyopathy in OVE26 Mice via Epigenetic Regulation of DUSP5‐ERK1/2 Pathway,” Clinical Science
131, no. 15 (2017): 1841–1857, 10.1042/cs20170064.
</cite> [<a href="https://doi.org/10.1042/cs20170064" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5737625/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28533215/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clinical%20Science&amp;title=Inhibition%20of%20HDAC3%20Prevents%20Diabetic%20Cardiomyopathy%20in%20OVE26%20Mice%20via%20Epigenetic%20Regulation%20of%20DUSP5%E2%80%90ERK1/2%20Pathway&amp;author=Z.%20Xu&amp;author=Q.%20Tong&amp;author=Z.%20Zhang&amp;volume=131&amp;issue=15&amp;publication_year=2017&amp;pages=1841-1857&amp;pmid=28533215&amp;doi=10.1042/cs20170064&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0089">
<span class="label">89.</span><cite>
Hu T., Wu Q., Yao Q., et al., “PRDM16 Exerts Critical Role in Myocardial Metabolism and Energetics in Type 2 Diabetes Induced Cardiomyopathy,” Metabolism
146 (2023): 155658, 10.1016/j.metabol.2023.155658.
</cite> [<a href="https://doi.org/10.1016/j.metabol.2023.155658" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37433344/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Metabolism&amp;title=PRDM16%20Exerts%20Critical%20Role%20in%20Myocardial%20Metabolism%20and%20Energetics%20in%20Type%202%20Diabetes%20Induced%20Cardiomyopathy&amp;author=T.%20Hu&amp;author=Q.%20Wu&amp;author=Q.%20Yao&amp;volume=146&amp;publication_year=2023&amp;pages=155658&amp;pmid=37433344&amp;doi=10.1016/j.metabol.2023.155658&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0090">
<span class="label">90.</span><cite>
Shi J. and Vakoc C. R., “The Mechanisms Behind the Therapeutic Activity of BET Bromodomain Inhibition,” Molecular Cell
54, no. 5 (2014): 728–736, 10.1016/j.molcel.2014.05.016.
</cite> [<a href="https://doi.org/10.1016/j.molcel.2014.05.016" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4236231/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24905006/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Molecular%20Cell&amp;title=The%20Mechanisms%20Behind%20the%20Therapeutic%20Activity%20of%20BET%20Bromodomain%20Inhibition&amp;author=J.%20Shi&amp;author=C.%20R.%20Vakoc&amp;volume=54&amp;issue=5&amp;publication_year=2014&amp;pages=728-736&amp;pmid=24905006&amp;doi=10.1016/j.molcel.2014.05.016&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0091">
<span class="label">91.</span><cite>
Duan Q., McMahon S., Anand P., et al., “BET Bromodomain Inhibition Suppresses Innate Inflammatory and Profibrotic Transcriptional Networks in Heart Failure,” Science Translational Medicine
9, no. 390 (2017): eaah5084, 10.1126/scitranslmed.aah5084.
</cite> [<a href="https://doi.org/10.1126/scitranslmed.aah5084" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5544253/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28515341/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Science%20Translational%20Medicine&amp;title=BET%20Bromodomain%20Inhibition%20Suppresses%20Innate%20Inflammatory%20and%20Profibrotic%20Transcriptional%20Networks%20in%20Heart%20Failure&amp;author=Q.%20Duan&amp;author=S.%20McMahon&amp;author=P.%20Anand&amp;volume=9&amp;issue=390&amp;publication_year=2017&amp;pages=eaah5084&amp;pmid=28515341&amp;doi=10.1126/scitranslmed.aah5084&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0092">
<span class="label">92.</span><cite>
Borck P. C., Guo L. W., and Plutzky J., “BET Epigenetic Reader Proteins in Cardiovascular Transcriptional Programs,” Circulation Research
126, no. 9 (2020): 1190–1208, 10.1161/circresaha.120.315929.
</cite> [<a href="https://doi.org/10.1161/circresaha.120.315929" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8111334/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32324495/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Circulation%20Research&amp;title=BET%20Epigenetic%20Reader%20Proteins%20in%20Cardiovascular%20Transcriptional%20Programs&amp;author=P.%20C.%20Borck&amp;author=L.%20W.%20Guo&amp;author=J.%20Plutzky&amp;volume=126&amp;issue=9&amp;publication_year=2020&amp;pages=1190-1208&amp;pmid=32324495&amp;doi=10.1161/circresaha.120.315929&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0093">
<span class="label">93.</span><cite>
Wang N., Wu R., Tang D., and Kang R., “The BET Family in Immunity and Disease,” Signal Transduction and Targeted Therapy
6, no. 1 (2021): 23, 10.1038/s41392-020-00384-4.
</cite> [<a href="https://doi.org/10.1038/s41392-020-00384-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7813845/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33462181/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Signal%20Transduction%20and%20Targeted%20Therapy&amp;title=The%20BET%20Family%20in%20Immunity%20and%20Disease&amp;author=N.%20Wang&amp;author=R.%20Wu&amp;author=D.%20Tang&amp;author=R.%20Kang&amp;volume=6&amp;issue=1&amp;publication_year=2021&amp;pages=23&amp;pmid=33462181&amp;doi=10.1038/s41392-020-00384-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0094">
<span class="label">94.</span><cite>
Mu J., Zhang D., Tian Y., Xie Z., and Zou M. H., “BRD4 Inhibition by JQ1 Prevents High‐Fat Diet‐Induced Diabetic Cardiomyopathy by Activating PINK1/Parkin‐Mediated Mitophagy in Vivo,” Journal of Molecular and Cellular Cardiology
149 (2020): 1–14, 10.1016/j.yjmcc.2020.09.003.
</cite> [<a href="https://doi.org/10.1016/j.yjmcc.2020.09.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7736123/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32941882/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Molecular%20and%20Cellular%20Cardiology&amp;title=BRD4%20Inhibition%20by%20JQ1%20Prevents%20High%E2%80%90Fat%20Diet%E2%80%90Induced%20Diabetic%20Cardiomyopathy%20by%20Activating%20PINK1/Parkin%E2%80%90Mediated%20Mitophagy%20in%20Vivo&amp;author=J.%20Mu&amp;author=D.%20Zhang&amp;author=Y.%20Tian&amp;author=Z.%20Xie&amp;author=M.%20H.%20Zou&amp;volume=149&amp;publication_year=2020&amp;pages=1-14&amp;pmid=32941882&amp;doi=10.1016/j.yjmcc.2020.09.003&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0095">
<span class="label">95.</span><cite>
Guo M., Wang H. X., and Chen W. J., “BET‐Inhibition by JQ1 Alleviates Streptozotocin‐Induced Diabetic Cardiomyopathy,” Toxicology and Applied Pharmacology
352 (2018): 9–18, 10.1016/j.taap.2018.05.018.
</cite> [<a href="https://doi.org/10.1016/j.taap.2018.05.018" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29782963/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Toxicology%20and%20Applied%20Pharmacology&amp;title=BET%E2%80%90Inhibition%20by%20JQ1%20Alleviates%20Streptozotocin%E2%80%90Induced%20Diabetic%20Cardiomyopathy&amp;author=M.%20Guo&amp;author=H.%20X.%20Wang&amp;author=W.%20J.%20Chen&amp;volume=352&amp;publication_year=2018&amp;pages=9-18&amp;pmid=29782963&amp;doi=10.1016/j.taap.2018.05.018&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0096">
<span class="label">96.</span><cite>
Wang Q., Sun Y., Li T., et al., “Function of BRD4 in the Pathogenesis of High Glucose‐Induced Cardiac Hypertrophy,” Molecular Medicine Reports
19, no. 1 (2019): 499–507, 10.3892/mmr.2018.9681.
</cite> [<a href="https://doi.org/10.3892/mmr.2018.9681" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6297744/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30483785/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Molecular%20Medicine%20Reports&amp;title=Function%20of%20BRD4%20in%20the%20Pathogenesis%20of%20High%20Glucose%E2%80%90Induced%20Cardiac%20Hypertrophy&amp;author=Q.%20Wang&amp;author=Y.%20Sun&amp;author=T.%20Li&amp;volume=19&amp;issue=1&amp;publication_year=2019&amp;pages=499-507&amp;pmid=30483785&amp;doi=10.3892/mmr.2018.9681&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0097">
<span class="label">97.</span><cite>
Ray K. K., Nicholls S. J., Buhr K. A., et al., “Effect of Apabetalone Added to Standard Therapy on Major Adverse Cardiovascular Events in Patients With Recent Acute Coronary Syndrome and Type 2 Diabetes: A Randomized Clinical Trial,” JAMA
323, no. 16 (2020): 1565–1573, 10.1001/jama.2020.3308.
</cite> [<a href="https://doi.org/10.1001/jama.2020.3308" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7101505/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32219359/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JAMA&amp;title=Effect%20of%20Apabetalone%20Added%20to%20Standard%20Therapy%20on%20Major%20Adverse%20Cardiovascular%20Events%20in%20Patients%20With%20Recent%20Acute%20Coronary%20Syndrome%20and%20Type%202%20Diabetes:%20A%20Randomized%20Clinical%20Trial&amp;author=K.%20K.%20Ray&amp;author=S.%20J.%20Nicholls&amp;author=K.%20A.%20Buhr&amp;volume=323&amp;issue=16&amp;publication_year=2020&amp;pages=1565-1573&amp;pmid=32219359&amp;doi=10.1001/jama.2020.3308&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0098">
<span class="label">98.</span><cite>
Toth P. P., Schwartz G. G., Nicholls S. J., et al., “Reduction in the Risk of Major Adverse Cardiovascular Events With the BET Protein Inhibitor Apabetalone in Patients With Recent Acute Coronary Syndrome, Type 2 Diabetes, and Moderate to High Likelihood of Non‐Alcoholic Fatty Liver Disease,” American Journal of Preventive Cardiology
11 (2022): 100372, 10.1016/j.ajpc.2022.100372.
</cite> [<a href="https://doi.org/10.1016/j.ajpc.2022.100372" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9419281/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36039183/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=American%20Journal%20of%20Preventive%20Cardiology&amp;title=Reduction%20in%20the%20Risk%20of%20Major%20Adverse%20Cardiovascular%20Events%20With%20the%20BET%20Protein%20Inhibitor%20Apabetalone%20in%20Patients%20With%20Recent%20Acute%20Coronary%20Syndrome,%20Type%202%20Diabetes,%20and%20Moderate%20to%20High%20Likelihood%20of%20Non%E2%80%90Alcoholic%20Fatty%20Liver%20Disease&amp;author=P.%20P.%20Toth&amp;author=G.%20G.%20Schwartz&amp;author=S.%20J.%20Nicholls&amp;volume=11&amp;publication_year=2022&amp;pages=100372&amp;pmid=36039183&amp;doi=10.1016/j.ajpc.2022.100372&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0099">
<span class="label">99.</span><cite>
Kalantar‐Zadeh K., Schwartz G. G., Nicholls S. J., et al., “Effect of Apabetalone on Cardiovascular Events in Diabetes, CKD, and Recent Acute Coronary Syndrome: Results From the BETonMACE Randomized Controlled Trial,” Clinical Journal of the American Society of Nephrology
16, no. 5 (2021): 705–716, 10.2215/cjn.16751020.
</cite> [<a href="https://doi.org/10.2215/cjn.16751020" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8259488/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33906908/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clinical%20Journal%20of%20the%20American%20Society%20of%20Nephrology&amp;title=Effect%20of%20Apabetalone%20on%20Cardiovascular%20Events%20in%20Diabetes,%20CKD,%20and%20Recent%20Acute%20Coronary%20Syndrome:%20Results%20From%20the%20BETonMACE%20Randomized%20Controlled%20Trial&amp;author=K.%20Kalantar%E2%80%90Zadeh&amp;author=G.%20G.%20Schwartz&amp;author=S.%20J.%20Nicholls&amp;volume=16&amp;issue=5&amp;publication_year=2021&amp;pages=705-716&amp;pmid=33906908&amp;doi=10.2215/cjn.16751020&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0100">
<span class="label">100.</span><cite>
Shang R., Lee S., Senavirathne G., and Lai E. C., “microRNAs in Action: Biogenesis, Function and Regulation,” Nature Reviews Genetics
24, no. 12 (2023): 816–833, 10.1038/s41576-023-00611-y.</cite> [<a href="https://doi.org/10.1038/s41576-023-00611-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11087887/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37380761/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature%20Reviews%20Genetics&amp;title=microRNAs%20in%20Action:%20Biogenesis,%20Function%20and%20Regulation&amp;author=R.%20Shang&amp;author=S.%20Lee&amp;author=G.%20Senavirathne&amp;author=E.%20C.%20Lai&amp;volume=24&amp;issue=12&amp;publication_year=2023&amp;pages=816-833&amp;pmid=37380761&amp;doi=10.1038/s41576-023-00611-y&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0101">
<span class="label">101.</span><cite>
Yu M., Liu Y., Zhang B., Shi Y., Cui L., and Zhao X., “Inhibiting microRNA‐144 Abates Oxidative Stress and Reduces Apoptosis in Hearts of Streptozotocin‐Induced Diabetic Mice,” Cardiovascular Pathology
24, no. 6 (2015): 375–381, 10.1016/j.carpath.2015.06.003.
</cite> [<a href="https://doi.org/10.1016/j.carpath.2015.06.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26164195/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cardiovascular%20Pathology&amp;title=Inhibiting%20microRNA%E2%80%90144%20Abates%20Oxidative%20Stress%20and%20Reduces%20Apoptosis%20in%20Hearts%20of%20Streptozotocin%E2%80%90Induced%20Diabetic%20Mice&amp;author=M.%20Yu&amp;author=Y.%20Liu&amp;author=B.%20Zhang&amp;author=Y.%20Shi&amp;author=L.%20Cui&amp;volume=24&amp;issue=6&amp;publication_year=2015&amp;pages=375-381&amp;pmid=26164195&amp;doi=10.1016/j.carpath.2015.06.003&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0102">
<span class="label">102.</span><cite>
Baseler W. A., Thapa D., Jagannathan R., Dabkowski E. R., Croston T. L., and Hollander J. M., “miR‐141 as a Regulator of the Mitochondrial Phosphate Carrier (Slc25a3) in the Type 1 Diabetic Heart,” American Journal of Physiology—Cell Physiology
303, no. 12 (2012): C1244–C1251, 10.1152/ajpcell.00137.2012.
</cite> [<a href="https://doi.org/10.1152/ajpcell.00137.2012" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3532490/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23034391/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=American%20Journal%20of%20Physiology%E2%80%94Cell%20Physiology&amp;title=miR%E2%80%90141%20as%20a%20Regulator%20of%20the%20Mitochondrial%20Phosphate%20Carrier%20(Slc25a3)%20in%20the%20Type%201%20Diabetic%20Heart&amp;author=W.%20A.%20Baseler&amp;author=D.%20Thapa&amp;author=R.%20Jagannathan&amp;author=E.%20R.%20Dabkowski&amp;author=T.%20L.%20Croston&amp;volume=303&amp;issue=12&amp;publication_year=2012&amp;pages=C1244-C1251&amp;pmid=23034391&amp;doi=10.1152/ajpcell.00137.2012&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0103">
<span class="label">103.</span><cite>
La Sala L., Cattaneo M., De Nigris V., et al., “Oscillating Glucose Induces microRNA‐185 and Impairs an Efficient Antioxidant Response in Human Endothelial Cells,” Cardiovascular Diabetology
15, no. 1 (2016): 71, 10.1186/s12933-016-0390-9.
</cite> [<a href="https://doi.org/10.1186/s12933-016-0390-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4852407/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27137793/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cardiovascular%20Diabetology&amp;title=Oscillating%20Glucose%20Induces%20microRNA%E2%80%90185%20and%20Impairs%20an%20Efficient%20Antioxidant%20Response%20in%20Human%20Endothelial%20Cells&amp;author=L.%20La%20Sala&amp;author=M.%20Cattaneo&amp;author=V.%20De%20Nigris&amp;volume=15&amp;issue=1&amp;publication_year=2016&amp;pages=71&amp;pmid=27137793&amp;doi=10.1186/s12933-016-0390-9&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0104">
<span class="label">104.</span><cite>
Li H., Fan J., Zhao Y., et al., “Nuclear miR‐320 Mediates Diabetes‐Induced Cardiac Dysfunction by Activating Transcription of Fatty Acid Metabolic Genes to Cause Lipotoxicity in the Heart,” Circulation Research
125, no. 12 (2019): 1106–1120, 10.1161/circresaha.119.314898.
</cite> [<a href="https://doi.org/10.1161/circresaha.119.314898" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6903355/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31638474/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Circulation%20Research&amp;title=Nuclear%20miR%E2%80%90320%20Mediates%20Diabetes%E2%80%90Induced%20Cardiac%20Dysfunction%20by%20Activating%20Transcription%20of%20Fatty%20Acid%20Metabolic%20Genes%20to%20Cause%20Lipotoxicity%20in%20the%20Heart&amp;author=H.%20Li&amp;author=J.%20Fan&amp;author=Y.%20Zhao&amp;volume=125&amp;issue=12&amp;publication_year=2019&amp;pages=1106-1120&amp;pmid=31638474&amp;doi=10.1161/circresaha.119.314898&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0105">
<span class="label">105.</span><cite>
van Rooij E., Sutherland L. B., Thatcher J. E., et al., “Dysregulation of microRNAs After Myocardial Infarction Reveals a Role of miR‐29 in Cardiac Fibrosis,” Proceedings of the National Academy of Sciences of the USA
105, no. 35 (2008): 13027–13032, 10.1073/pnas.0805038105.
</cite> [<a href="https://doi.org/10.1073/pnas.0805038105" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2529064/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18723672/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Proceedings%20of%20the%20National%20Academy%20of%20Sciences%20of%20the%20USA&amp;title=Dysregulation%20of%20microRNAs%20After%20Myocardial%20Infarction%20Reveals%20a%20Role%20of%20miR%E2%80%9029%20in%20Cardiac%20Fibrosis&amp;author=E.%20van%20Rooij&amp;author=L.%20B.%20Sutherland&amp;author=J.%20E.%20Thatcher&amp;volume=105&amp;issue=35&amp;publication_year=2008&amp;pages=13027-13032&amp;pmid=18723672&amp;doi=10.1073/pnas.0805038105&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0106">
<span class="label">106.</span><cite>
Rawal S., Munasinghe P. E., Nagesh P. T., et al., “Down‐Regulation of miR‐15a/b Accelerates Fibrotic Remodelling in the Type 2 Diabetic Human and Mouse Heart,” Clinical Science
131, no. 9 (2017): 847–863, 10.1042/cs20160916.
</cite> [<a href="https://doi.org/10.1042/cs20160916" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28289072/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clinical%20Science&amp;title=Down%E2%80%90Regulation%20of%20miR%E2%80%9015a/b%20Accelerates%20Fibrotic%20Remodelling%20in%20the%20Type%202%20Diabetic%20Human%20and%20Mouse%20Heart&amp;author=S.%20Rawal&amp;author=P.%20E.%20Munasinghe&amp;author=P.%20T.%20Nagesh&amp;volume=131&amp;issue=9&amp;publication_year=2017&amp;pages=847-863&amp;pmid=28289072&amp;doi=10.1042/cs20160916&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0107">
<span class="label">107.</span><cite>
Feng B., Cao Y., Chen S., Chu X., Chu Y., and Chakrabarti S., “miR‐200b Mediates Endothelial‐to‐Mesenchymal Transition in Diabetic Cardiomyopathy,” Diabetes
65, no. 3 (2016): 768–779, 10.2337/db15-1033.
</cite> [<a href="https://doi.org/10.2337/db15-1033" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26718496/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes&amp;title=miR%E2%80%90200b%20Mediates%20Endothelial%E2%80%90to%E2%80%90Mesenchymal%20Transition%20in%20Diabetic%20Cardiomyopathy&amp;author=B.%20Feng&amp;author=Y.%20Cao&amp;author=S.%20Chen&amp;author=X.%20Chu&amp;author=Y.%20Chu&amp;volume=65&amp;issue=3&amp;publication_year=2016&amp;pages=768-779&amp;pmid=26718496&amp;doi=10.2337/db15-1033&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0108">
<span class="label">108.</span><cite>
Li X., Du N., Zhang Q., et al., “MicroRNA‐30d Regulates Cardiomyocyte Pyroptosis by Directly Targeting foxo3a in Diabetic Cardiomyopathy,” Cell Death &amp; Disease
5, no. 10 (2014): e1479, 10.1038/cddis.2014.430.
</cite> [<a href="https://doi.org/10.1038/cddis.2014.430" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4237254/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25341033/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell%20Death%20&amp;%20Disease&amp;title=MicroRNA%E2%80%9030d%20Regulates%20Cardiomyocyte%20Pyroptosis%20by%20Directly%20Targeting%20foxo3a%20in%20Diabetic%20Cardiomyopathy&amp;author=X.%20Li&amp;author=N.%20Du&amp;author=Q.%20Zhang&amp;volume=5&amp;issue=10&amp;publication_year=2014&amp;pages=e1479&amp;pmid=25341033&amp;doi=10.1038/cddis.2014.430&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0109">
<span class="label">109.</span><cite>
Zhu H., Yang Y., Wang Y., Li J., Schiller P. W., and Peng T., “MicroRNA‐195 Promotes Palmitate‐Induced Apoptosis in Cardiomyocytes by Down‐Regulating Sirt1,” Cardiovascular Research
92, no. 1 (2011): 75–84, 10.1093/cvr/cvr145.
</cite> [<a href="https://doi.org/10.1093/cvr/cvr145" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21622680/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cardiovascular%20Research&amp;title=MicroRNA%E2%80%90195%20Promotes%20Palmitate%E2%80%90Induced%20Apoptosis%20in%20Cardiomyocytes%20by%20Down%E2%80%90Regulating%20Sirt1&amp;author=H.%20Zhu&amp;author=Y.%20Yang&amp;author=Y.%20Wang&amp;author=J.%20Li&amp;author=P.%20W.%20Schiller&amp;volume=92&amp;issue=1&amp;publication_year=2011&amp;pages=75-84&amp;pmid=21622680&amp;doi=10.1093/cvr/cvr145&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0110">
<span class="label">110.</span><cite>
Qiao Y., Zhao Y., Liu Y., et al., “miR‐483‐3p Regulates Hyperglycaemia‐Induced Cardiomyocyte Apoptosis in Transgenic Mice,” Biochemical and Biophysical Research Communications
477, no. 4 (2016): 541–547, 10.1016/j.bbrc.2016.06.051.
</cite> [<a href="https://doi.org/10.1016/j.bbrc.2016.06.051" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27346130/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biochemical%20and%20Biophysical%20Research%20Communications&amp;title=miR%E2%80%90483%E2%80%903p%20Regulates%20Hyperglycaemia%E2%80%90Induced%20Cardiomyocyte%20Apoptosis%20in%20Transgenic%20Mice&amp;author=Y.%20Qiao&amp;author=Y.%20Zhao&amp;author=Y.%20Liu&amp;volume=477&amp;issue=4&amp;publication_year=2016&amp;pages=541-547&amp;pmid=27346130&amp;doi=10.1016/j.bbrc.2016.06.051&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0111">
<span class="label">111.</span><cite>
Callis T. E., Pandya K., Seok H. Y., et al., “MicroRNA‐208a Is a Regulator of Cardiac Hypertrophy and Conduction in Mice,” Journal of Clinical Investigation
119, no. 9 (2009): 2772–2786, 10.1172/jci36154.
</cite> [<a href="https://doi.org/10.1172/jci36154" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2735902/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19726871/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Clinical%20Investigation&amp;title=MicroRNA%E2%80%90208a%20Is%20a%20Regulator%20of%20Cardiac%20Hypertrophy%20and%20Conduction%20in%20Mice&amp;author=T.%20E.%20Callis&amp;author=K.%20Pandya&amp;author=H.%20Y.%20Seok&amp;volume=119&amp;issue=9&amp;publication_year=2009&amp;pages=2772-2786&amp;pmid=19726871&amp;doi=10.1172/jci36154&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0112">
<span class="label">112.</span><cite>
Feng B., Chen S., George B., Feng Q., and Chakrabarti S., “miR133a Regulates Cardiomyocyte Hypertrophy in Diabetes,” Diabetes/Metabolism Research and Reviews
26, no. 1 (2010): 40–49, 10.1002/dmrr.1054.
</cite> [<a href="https://doi.org/10.1002/dmrr.1054" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20013939/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes/Metabolism%20Research%20and%20Reviews&amp;title=miR133a%20Regulates%20Cardiomyocyte%20Hypertrophy%20in%20Diabetes&amp;author=B.%20Feng&amp;author=S.%20Chen&amp;author=B.%20George&amp;author=Q.%20Feng&amp;author=S.%20Chakrabarti&amp;volume=26&amp;issue=1&amp;publication_year=2010&amp;pages=40-49&amp;pmid=20013939&amp;doi=10.1002/dmrr.1054&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0113">
<span class="label">113.</span><cite>
Kuwabara Y., Horie T., Baba O., et al., “MicroRNA‐451 Exacerbates Lipotoxicity in Cardiac Myocytes and High‐Fat Diet‐Induced Cardiac Hypertrophy in Mice Through Suppression of the LKB1/AMPK Pathway,” Circulation Research
116, no. 2 (2015): 279–288, 10.1161/circresaha.116.304707.
</cite> [<a href="https://doi.org/10.1161/circresaha.116.304707" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25362209/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Circulation%20Research&amp;title=MicroRNA%E2%80%90451%20Exacerbates%20Lipotoxicity%20in%20Cardiac%20Myocytes%20and%20High%E2%80%90Fat%20Diet%E2%80%90Induced%20Cardiac%20Hypertrophy%20in%20Mice%20Through%20Suppression%20of%20the%20LKB1/AMPK%20Pathway&amp;author=Y.%20Kuwabara&amp;author=T.%20Horie&amp;author=O.%20Baba&amp;volume=116&amp;issue=2&amp;publication_year=2015&amp;pages=279-288&amp;pmid=25362209&amp;doi=10.1161/circresaha.116.304707&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0114">
<span class="label">114.</span><cite>
Feng B., Chen S., Gordon A. D., and Chakrabarti S., “miR‐146a Mediates Inflammatory Changes and Fibrosis in the Heart in Diabetes,” Journal of Molecular and Cellular Cardiology
105 (2017): 70–76, 10.1016/j.yjmcc.2017.03.002.
</cite> [<a href="https://doi.org/10.1016/j.yjmcc.2017.03.002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28279663/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Molecular%20and%20Cellular%20Cardiology&amp;title=miR%E2%80%90146a%20Mediates%20Inflammatory%20Changes%20and%20Fibrosis%20in%20the%20Heart%20in%20Diabetes&amp;author=B.%20Feng&amp;author=S.%20Chen&amp;author=A.%20D.%20Gordon&amp;author=S.%20Chakrabarti&amp;volume=105&amp;publication_year=2017&amp;pages=70-76&amp;pmid=28279663&amp;doi=10.1016/j.yjmcc.2017.03.002&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0115">
<span class="label">115.</span><cite>
Feng B., Liu J., Wang E., Su Z., and Chakrabarti S., “Endothelial Derived miRNA‐9 Mediated Cardiac Fibrosis in Diabetes and Its Regulation by ZFAS1,” PLoS One
17, no. 10 (2022): e0276076, 10.1371/journal.pone.0276076.
</cite> [<a href="https://doi.org/10.1371/journal.pone.0276076" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9565427/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36240130/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20One&amp;title=Endothelial%20Derived%20miRNA%E2%80%909%20Mediated%20Cardiac%20Fibrosis%20in%20Diabetes%20and%20Its%20Regulation%20by%20ZFAS1&amp;author=B.%20Feng&amp;author=J.%20Liu&amp;author=E.%20Wang&amp;author=Z.%20Su&amp;author=S.%20Chakrabarti&amp;volume=17&amp;issue=10&amp;publication_year=2022&amp;pages=e0276076&amp;pmid=36240130&amp;doi=10.1371/journal.pone.0276076&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0116">
<span class="label">116.</span><cite>
Sun X., Sit A., and Feinberg M. W., “Role of miR‐181 Family in Regulating Vascular Inflammation and Immunity,” Trends in Cardiovascular Medicine
24, no. 3 (2014): 105–112, 10.1016/j.tcm.2013.09.002.
</cite> [<a href="https://doi.org/10.1016/j.tcm.2013.09.002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3943593/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24183793/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Trends%20in%20Cardiovascular%20Medicine&amp;title=Role%20of%20miR%E2%80%90181%20Family%20in%20Regulating%20Vascular%20Inflammation%20and%20Immunity&amp;author=X.%20Sun&amp;author=A.%20Sit&amp;author=M.%20W.%20Feinberg&amp;volume=24&amp;issue=3&amp;publication_year=2014&amp;pages=105-112&amp;pmid=24183793&amp;doi=10.1016/j.tcm.2013.09.002&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0117">
<span class="label">117.</span><cite>
Moore A., Shindikar A., Fomison‐Nurse I., et al., “Rapid Onset of Cardiomyopathy in STZ‐Induced Female Diabetic Mice Involves the Downregulation of Pro‐Survival Pim‐1,” Cardiovascular Diabetology
13, no. 1 (2014): 68, 10.1186/1475-2840-13-68.
</cite> [<a href="https://doi.org/10.1186/1475-2840-13-68" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4073808/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24685144/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cardiovascular%20Diabetology&amp;title=Rapid%20Onset%20of%20Cardiomyopathy%20in%20STZ%E2%80%90Induced%20Female%20Diabetic%20Mice%20Involves%20the%20Downregulation%20of%20Pro%E2%80%90Survival%20Pim%E2%80%901&amp;author=A.%20Moore&amp;author=A.%20Shindikar&amp;author=I.%20Fomison%E2%80%90Nurse&amp;volume=13&amp;issue=1&amp;publication_year=2014&amp;pages=68&amp;pmid=24685144&amp;doi=10.1186/1475-2840-13-68&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0118">
<span class="label">118.</span><cite>
Yildirim S. S., Akman D., Catalucci D., and Turan B., “Relationship Between Downregulation of miRNAs and Increase of Oxidative Stress in the Development of Diabetic Cardiac Dysfunction: Junctin as a Target Protein of miR‐1,” Cell Biochemistry and Biophysics
67, no. 3 (2013): 1397–1408, 10.1007/s12013-013-9672-y.
</cite> [<a href="https://doi.org/10.1007/s12013-013-9672-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23723006/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell%20Biochemistry%20and%20Biophysics&amp;title=Relationship%20Between%20Downregulation%20of%20miRNAs%20and%20Increase%20of%20Oxidative%20Stress%20in%20the%20Development%20of%20Diabetic%20Cardiac%20Dysfunction:%20Junctin%20as%20a%20Target%20Protein%20of%20miR%E2%80%901&amp;author=S.%20S.%20Yildirim&amp;author=D.%20Akman&amp;author=D.%20Catalucci&amp;author=B.%20Turan&amp;volume=67&amp;issue=3&amp;publication_year=2013&amp;pages=1397-1408&amp;pmid=23723006&amp;doi=10.1007/s12013-013-9672-y&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0119">
<span class="label">119.</span><cite>
You P., Chen H., Han W., and Deng J., “miR‐200a‐3p Overexpression Alleviates Diabetic Cardiomyopathy Injury in Mice by Regulating Autophagy Through the FOXO3/Mst1/Sirt3/AMPK Axis,” PeerJ
11 (2023): e15840, 10.7717/peerj.15840.
</cite> [<a href="https://doi.org/10.7717/peerj.15840" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10506579/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37727684/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PeerJ&amp;title=miR%E2%80%90200a%E2%80%903p%20Overexpression%20Alleviates%20Diabetic%20Cardiomyopathy%20Injury%20in%20Mice%20by%20Regulating%20Autophagy%20Through%20the%20FOXO3/Mst1/Sirt3/AMPK%20Axis&amp;author=P.%20You&amp;author=H.%20Chen&amp;author=W.%20Han&amp;author=J.%20Deng&amp;volume=11&amp;publication_year=2023&amp;pages=e15840&amp;pmid=37727684&amp;doi=10.7717/peerj.15840&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0120">
<span class="label">120.</span><cite>
Ning S., Zhang S., and Guo Z., “MicroRNA‐494 Regulates High Glucose‐Induced Cardiomyocyte Apoptosis and Autophagy by PI3K/AKT/mTOR Signalling Pathway,” ESC Heart Fail
10, no. 2 (2023): 1401–1411, 10.1002/ehf2.14311.
</cite> [<a href="https://doi.org/10.1002/ehf2.14311" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10053280/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36772911/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=ESC%20Heart%20Fail&amp;title=MicroRNA%E2%80%90494%20Regulates%20High%20Glucose%E2%80%90Induced%20Cardiomyocyte%20Apoptosis%20and%20Autophagy%20by%20PI3K/AKT/mTOR%20Signalling%20Pathway&amp;author=S.%20Ning&amp;author=S.%20Zhang&amp;author=Z.%20Guo&amp;volume=10&amp;issue=2&amp;publication_year=2023&amp;pages=1401-1411&amp;pmid=36772911&amp;doi=10.1002/ehf2.14311&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0121">
<span class="label">121.</span><cite>
Costantino S., Paneni F., Luscher T. F., and Cosentino F., “MicroRNA Profiling Unveils Hyperglycaemic Memory in the Diabetic Heart,” European Heart Journal
37, no. 6 (2016): 572–576, 10.1093/eurheartj/ehv599.
</cite> [<a href="https://doi.org/10.1093/eurheartj/ehv599" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26553540/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=European%20Heart%20Journal&amp;title=MicroRNA%20Profiling%20Unveils%20Hyperglycaemic%20Memory%20in%20the%20Diabetic%20Heart&amp;author=S.%20Costantino&amp;author=F.%20Paneni&amp;author=T.%20F.%20Luscher&amp;author=F.%20Cosentino&amp;volume=37&amp;issue=6&amp;publication_year=2016&amp;pages=572-576&amp;pmid=26553540&amp;doi=10.1093/eurheartj/ehv599&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0122">
<span class="label">122.</span><cite>
Delfan M., Delphan M., Kordi M. R., et al., “High Intensity Interval Training Improves Diabetic Cardiomyopathy via miR‐1 Dependent Suppression of Cardiomyocyte Apoptosis in Diabetic Rats,” Journal of Diabetes and Metabolic Disorders
19, no. 1 (2020): 145–152, 10.1007/s40200-019-00485-0.
</cite> [<a href="https://doi.org/10.1007/s40200-019-00485-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7270284/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32550164/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Diabetes%20and%20Metabolic%20Disorders&amp;title=High%20Intensity%20Interval%20Training%20Improves%20Diabetic%20Cardiomyopathy%20via%20miR%E2%80%901%20Dependent%20Suppression%20of%20Cardiomyocyte%20Apoptosis%20in%20Diabetic%20Rats&amp;author=M.%20Delfan&amp;author=M.%20Delphan&amp;author=M.%20R.%20Kordi&amp;volume=19&amp;issue=1&amp;publication_year=2020&amp;pages=145-152&amp;pmid=32550164&amp;doi=10.1007/s40200-019-00485-0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0123">
<span class="label">123.</span><cite>
Hou J., Liang W. Y., Xiong S., et al., “Identification of Hub Genes and Potential ceRNA Networks of Diabetic Cardiomyopathy,” Scientific Reports
13, no. 1 (2023): 10258, 10.1038/s41598-023-37378-5.
</cite> [<a href="https://doi.org/10.1038/s41598-023-37378-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10290640/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37355664/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Scientific%20Reports&amp;title=Identification%20of%20Hub%20Genes%20and%20Potential%20ceRNA%20Networks%20of%20Diabetic%20Cardiomyopathy&amp;author=J.%20Hou&amp;author=W.%20Y.%20Liang&amp;author=S.%20Xiong&amp;volume=13&amp;issue=1&amp;publication_year=2023&amp;pages=10258&amp;pmid=37355664&amp;doi=10.1038/s41598-023-37378-5&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0124">
<span class="label">124.</span><cite>
Guo R. and Nair S., “Role of microRNA in Diabetic Cardiomyopathy: From Mechanism to Intervention,” Biochimica et Biophysica Acta (BBA)—Molecular Basis of Disease
1863, no. 8 (2017): 2070–2077, 10.1016/j.bbadis.2017.03.013.
</cite> [<a href="https://doi.org/10.1016/j.bbadis.2017.03.013" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5475364/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28344129/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biochimica%20et%20Biophysica%20Acta%20(BBA)%E2%80%94Molecular%20Basis%20of%20Disease&amp;title=Role%20of%20microRNA%20in%20Diabetic%20Cardiomyopathy:%20From%20Mechanism%20to%20Intervention&amp;author=R.%20Guo&amp;author=S.%20Nair&amp;volume=1863&amp;issue=8&amp;publication_year=2017&amp;pages=2070-2077&amp;pmid=28344129&amp;doi=10.1016/j.bbadis.2017.03.013&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0125">
<span class="label">125.</span><cite>
Ghosh N. and Katare R., “Molecular Mechanism of Diabetic Cardiomyopathy and Modulation of microRNA Function by Synthetic Oligonucleotides,” Cardiovascular Diabetology
17, no. 1 (2018): 43, 10.1186/s12933-018-0684-1.
</cite> [<a href="https://doi.org/10.1186/s12933-018-0684-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5863891/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29566757/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cardiovascular%20Diabetology&amp;title=Molecular%20Mechanism%20of%20Diabetic%20Cardiomyopathy%20and%20Modulation%20of%20microRNA%20Function%20by%20Synthetic%20Oligonucleotides&amp;author=N.%20Ghosh&amp;author=R.%20Katare&amp;volume=17&amp;issue=1&amp;publication_year=2018&amp;pages=43&amp;pmid=29566757&amp;doi=10.1186/s12933-018-0684-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0126">
<span class="label">126.</span><cite>
Hathaway Q. A., Pinti M. V., Durr A. J., Waris S., Shepherd D. L., and Hollander J. M., “Regulating microRNA Expression: At the Heart of Diabetes Mellitus and the Mitochondrion,” American Journal of Physiology—Heart and Circulatory Physiology
314, no. 2 (2018): H293–H310, 10.1152/ajpheart.00520.2017.
</cite> [<a href="https://doi.org/10.1152/ajpheart.00520.2017" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5867655/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28986361/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=American%20Journal%20of%20Physiology%E2%80%94Heart%20and%20Circulatory%20Physiology&amp;title=Regulating%20microRNA%20Expression:%20At%20the%20Heart%20of%20Diabetes%20Mellitus%20and%20the%20Mitochondrion&amp;author=Q.%20A.%20Hathaway&amp;author=M.%20V.%20Pinti&amp;author=A.%20J.%20Durr&amp;author=S.%20Waris&amp;author=D.%20L.%20Shepherd&amp;volume=314&amp;issue=2&amp;publication_year=2018&amp;pages=H293-H310&amp;pmid=28986361&amp;doi=10.1152/ajpheart.00520.2017&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0127">
<span class="label">127.</span><cite>
Yin Z. and Chen C., “Biological Functions and Clinical Prospects of Extracellular Non‐Coding RNAs in Diabetic Cardiomyopathy: An Updated Review,” Journal of Cardiovascular Translational Research
15, no. 3 (2022): 469–476, 10.1007/s12265-022-10217-0.
</cite> [<a href="https://doi.org/10.1007/s12265-022-10217-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35175553/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Cardiovascular%20Translational%20Research&amp;title=Biological%20Functions%20and%20Clinical%20Prospects%20of%20Extracellular%20Non%E2%80%90Coding%20RNAs%20in%20Diabetic%20Cardiomyopathy:%20An%20Updated%20Review&amp;author=Z.%20Yin&amp;author=C.%20Chen&amp;volume=15&amp;issue=3&amp;publication_year=2022&amp;pages=469-476&amp;pmid=35175553&amp;doi=10.1007/s12265-022-10217-0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0128">
<span class="label">128.</span><cite>
Jakubik D., Fitas A., Eyileten C., et al., “MicroRNAs and Long Non‐Coding RNAs in the Pathophysiological Processes of Diabetic Cardiomyopathy: Emerging Biomarkers and Potential Therapeutics,” Cardiovascular Diabetology
20, no. 1 (2021): 55, 10.1186/s12933-021-01245-2.
</cite> [<a href="https://doi.org/10.1186/s12933-021-01245-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7916283/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33639953/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cardiovascular%20Diabetology&amp;title=MicroRNAs%20and%20Long%20Non%E2%80%90Coding%20RNAs%20in%20the%20Pathophysiological%20Processes%20of%20Diabetic%20Cardiomyopathy:%20Emerging%20Biomarkers%20and%20Potential%20Therapeutics&amp;author=D.%20Jakubik&amp;author=A.%20Fitas&amp;author=C.%20Eyileten&amp;volume=20&amp;issue=1&amp;publication_year=2021&amp;pages=55&amp;pmid=33639953&amp;doi=10.1186/s12933-021-01245-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0129">
<span class="label">129.</span><cite>
Kariuki D., Aouizerat B. E., Asam K., et al., “MicroRNA Biomarkers Target Genes and Pathways Associated With Type 2 Diabetes,” Diabetes Research and Clinical Practice
203 (2023): 110868, 10.1016/j.diabres.2023.110868.
</cite> [<a href="https://doi.org/10.1016/j.diabres.2023.110868" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37543292/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes%20Research%20and%20Clinical%20Practice&amp;title=MicroRNA%20Biomarkers%20Target%20Genes%20and%20Pathways%20Associated%20With%20Type%202%20Diabetes&amp;author=D.%20Kariuki&amp;author=B.%20E.%20Aouizerat&amp;author=K.%20Asam&amp;volume=203&amp;publication_year=2023&amp;pages=110868&amp;pmid=37543292&amp;doi=10.1016/j.diabres.2023.110868&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0130">
<span class="label">130.</span><cite>
Ma X., Mei S., Wuyun Q., Zhou L., Sun D., and Yan J., “Epigenetics in Diabetic Cardiomyopathy,” Clinical Epigenetics
16, no. 1 (2024): 52, 10.1186/s13148-024-01667-1.
</cite> [<a href="https://doi.org/10.1186/s13148-024-01667-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10996175/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38581056/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clinical%20Epigenetics&amp;title=Epigenetics%20in%20Diabetic%20Cardiomyopathy&amp;author=X.%20Ma&amp;author=S.%20Mei&amp;author=Q.%20Wuyun&amp;author=L.%20Zhou&amp;author=D.%20Sun&amp;volume=16&amp;issue=1&amp;publication_year=2024&amp;pages=52&amp;pmid=38581056&amp;doi=10.1186/s13148-024-01667-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0131">
<span class="label">131.</span><cite>
Macvanin M. T., Gluvic Z., Radovanovic J., Essack M., Gao X., and Isenovic E. R., “Diabetic Cardiomyopathy: The Role of microRNAs and Long Non‐Coding RNAs,” Frontiers in Endocrinology
14 (2023): 1124613, 10.3389/fendo.2023.1124613.
</cite> [<a href="https://doi.org/10.3389/fendo.2023.1124613" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10025540/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36950696/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Frontiers%20in%20Endocrinology&amp;title=Diabetic%20Cardiomyopathy:%20The%20Role%20of%20microRNAs%20and%20Long%20Non%E2%80%90Coding%20RNAs&amp;author=M.%20T.%20Macvanin&amp;author=Z.%20Gluvic&amp;author=J.%20Radovanovic&amp;author=M.%20Essack&amp;author=X.%20Gao&amp;volume=14&amp;publication_year=2023&amp;pages=1124613&amp;pmid=36950696&amp;doi=10.3389/fendo.2023.1124613&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0132">
<span class="label">132.</span><cite>
Kopp F. and Mendell J. T., “Functional Classification and Experimental Dissection of Long Noncoding RNAs,” Cell
172, no. 3 (2018): 393–407, 10.1016/j.cell.2018.01.011.
</cite> [<a href="https://doi.org/10.1016/j.cell.2018.01.011" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5978744/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29373828/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell&amp;title=Functional%20Classification%20and%20Experimental%20Dissection%20of%20Long%20Noncoding%20RNAs&amp;author=F.%20Kopp&amp;author=J.%20T.%20Mendell&amp;volume=172&amp;issue=3&amp;publication_year=2018&amp;pages=393-407&amp;pmid=29373828&amp;doi=10.1016/j.cell.2018.01.011&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0133">
<span class="label">133.</span><cite>
Ma C., Luo H., Liu B., Li F., Tschope C., and Fa X., “Long Noncoding RNAs: A New Player in the Prevention and Treatment of Diabetic Cardiomyopathy?,” Diabetes/Metabolism Research and Reviews
34, no. 8 (2018): e3056, 10.1002/dmrr.3056.
</cite> [<a href="https://doi.org/10.1002/dmrr.3056" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30160026/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes/Metabolism%20Research%20and%20Reviews&amp;title=Long%20Noncoding%20RNAs:%20A%20New%20Player%20in%20the%20Prevention%20and%20Treatment%20of%20Diabetic%20Cardiomyopathy?&amp;author=C.%20Ma&amp;author=H.%20Luo&amp;author=B.%20Liu&amp;author=F.%20Li&amp;author=C.%20Tschope&amp;volume=34&amp;issue=8&amp;publication_year=2018&amp;pages=e3056&amp;pmid=30160026&amp;doi=10.1002/dmrr.3056&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0134">
<span class="label">134.</span><cite>
Pant T., Dhanasekaran A., Bai X., et al., “Genome‐Wide Differential Expression Profiling of lncRNAs and mRNAs Associated With Early Diabetic Cardiomyopathy,” Scientific Reports
9, no. 1 (2019): 15345, 10.1038/s41598-019-51872-9.
</cite> [<a href="https://doi.org/10.1038/s41598-019-51872-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6814824/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31653946/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Scientific%20Reports&amp;title=Genome%E2%80%90Wide%20Differential%20Expression%20Profiling%20of%20lncRNAs%20and%20mRNAs%20Associated%20With%20Early%20Diabetic%20Cardiomyopathy&amp;author=T.%20Pant&amp;author=A.%20Dhanasekaran&amp;author=X.%20Bai&amp;volume=9&amp;issue=1&amp;publication_year=2019&amp;pages=15345&amp;pmid=31653946&amp;doi=10.1038/s41598-019-51872-9&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0135">
<span class="label">135.</span><cite>
Meng L., Lin H., Huang X., Weng J., Peng F., and Wu S., “METTL14 Suppresses Pyroptosis and Diabetic Cardiomyopathy by Downregulating TINCR lncRNA,” Cell Death &amp; Disease
13, no. 1 (2022): 38, 10.1038/s41419-021-04484-z.
</cite> [<a href="https://doi.org/10.1038/s41419-021-04484-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8748685/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35013106/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell%20Death%20&amp;%20Disease&amp;title=METTL14%20Suppresses%20Pyroptosis%20and%20Diabetic%20Cardiomyopathy%20by%20Downregulating%20TINCR%20lncRNA&amp;author=L.%20Meng&amp;author=H.%20Lin&amp;author=X.%20Huang&amp;author=J.%20Weng&amp;author=F.%20Peng&amp;volume=13&amp;issue=1&amp;publication_year=2022&amp;pages=38&amp;pmid=35013106&amp;doi=10.1038/s41419-021-04484-z&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0136">
<span class="label">136.</span><cite>
Wang K., Lin Y., Shen H., Yu S., and Xu J., “LncRNA TUG1 Exacerbates Myocardial Fibrosis in Diabetic Cardiomyopathy by Modulating the microRNA‐145a‐5p/Cfl2 Axis,” Journal of Cardiovascular Pharmacology
81, no. 3 (2023): 192–202, 10.1097/fjc.0000000000001391.
</cite> [<a href="https://doi.org/10.1097/fjc.0000000000001391" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36450139/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Cardiovascular%20Pharmacology&amp;title=LncRNA%20TUG1%20Exacerbates%20Myocardial%20Fibrosis%20in%20Diabetic%20Cardiomyopathy%20by%20Modulating%20the%20microRNA%E2%80%90145a%E2%80%905p/Cfl2%20Axis&amp;author=K.%20Wang&amp;author=Y.%20Lin&amp;author=H.%20Shen&amp;author=S.%20Yu&amp;author=J.%20Xu&amp;volume=81&amp;issue=3&amp;publication_year=2023&amp;pages=192-202&amp;pmid=36450139&amp;doi=10.1097/fjc.0000000000001391&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0137">
<span class="label">137.</span><cite>
Gao L., Wang X., Guo S., et al., “LncRNA HOTAIR Functions as a Competing Endogenous RNA to Upregulate SIRT1 by Sponging miR‐34a in Diabetic Cardiomyopathy,” Journal of Cellular Physiology
234, no. 4 (2019): 4944–4958, 10.1002/jcp.27296.
</cite> [<a href="https://doi.org/10.1002/jcp.27296" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30216438/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Cellular%20Physiology&amp;title=LncRNA%20HOTAIR%20Functions%20as%20a%20Competing%20Endogenous%20RNA%20to%20Upregulate%20SIRT1%20by%20Sponging%20miR%E2%80%9034a%20in%20Diabetic%20Cardiomyopathy&amp;author=L.%20Gao&amp;author=X.%20Wang&amp;author=S.%20Guo&amp;volume=234&amp;issue=4&amp;publication_year=2019&amp;pages=4944-4958&amp;pmid=30216438&amp;doi=10.1002/jcp.27296&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0138">
<span class="label">138.</span><cite>
Zhuo C., Jiang R., Lin X., and Shao M., “LncRNA H19 Inhibits Autophagy by Epigenetically Silencing of DIRAS3 in Diabetic Cardiomyopathy,” Oncotarget
8, no. 1 (2017): 1429–1437, 10.18632/oncotarget.13637.
</cite> [<a href="https://doi.org/10.18632/oncotarget.13637" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5352066/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27903964/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Oncotarget&amp;title=LncRNA%20H19%20Inhibits%20Autophagy%20by%20Epigenetically%20Silencing%20of%20DIRAS3%20in%20Diabetic%20Cardiomyopathy&amp;author=C.%20Zhuo&amp;author=R.%20Jiang&amp;author=X.%20Lin&amp;author=M.%20Shao&amp;volume=8&amp;issue=1&amp;publication_year=2017&amp;pages=1429-1437&amp;pmid=27903964&amp;doi=10.18632/oncotarget.13637&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0139">
<span class="label">139.</span><cite>
Li X., Wang H., Yao B., Xu W., Chen J., and Zhou X., “lncRNA H19/miR‐675 Axis Regulates Cardiomyocyte Apoptosis by Targeting VDAC1 in Diabetic Cardiomyopathy,” Scientific Reports
6, no. 1 (2016): 36340, 10.1038/srep36340.
</cite> [<a href="https://doi.org/10.1038/srep36340" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5087087/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27796346/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Scientific%20Reports&amp;title=lncRNA%20H19/miR%E2%80%90675%20Axis%20Regulates%20Cardiomyocyte%20Apoptosis%20by%20Targeting%20VDAC1%20in%20Diabetic%20Cardiomyopathy&amp;author=X.%20Li&amp;author=H.%20Wang&amp;author=B.%20Yao&amp;author=W.%20Xu&amp;author=J.%20Chen&amp;volume=6&amp;issue=1&amp;publication_year=2016&amp;pages=36340&amp;pmid=27796346&amp;doi=10.1038/srep36340&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0140">
<span class="label">140.</span><cite>
Zhang M., Gu H., Chen J., and Zhou X., “Involvement of Long Noncoding RNA MALAT1 in the Pathogenesis of Diabetic Cardiomyopathy,” International Journal of Cardiology
202 (2016): 753–755, 10.1016/j.ijcard.2015.10.019.
</cite> [<a href="https://doi.org/10.1016/j.ijcard.2015.10.019" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26476026/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=International%20Journal%20of%20Cardiology&amp;title=Involvement%20of%20Long%20Noncoding%20RNA%20MALAT1%20in%20the%20Pathogenesis%20of%20Diabetic%20Cardiomyopathy&amp;author=M.%20Zhang&amp;author=H.%20Gu&amp;author=J.%20Chen&amp;author=X.%20Zhou&amp;volume=202&amp;publication_year=2016&amp;pages=753-755&amp;pmid=26476026&amp;doi=10.1016/j.ijcard.2015.10.019&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0141">
<span class="label">141.</span><cite>
de Gonzalo‐Calvo D., Kenneweg F., Bang C., et al., “Circulating long‐non Coding RNAs as Biomarkers of Left Ventricular Diastolic Function and Remodelling in Patients With Well‐Controlled Type 2 Diabetes,” Scientific Reports
6, no. 1 (2016): 37354, 10.1038/srep37354.
</cite> [<a href="https://doi.org/10.1038/srep37354" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5118808/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27874027/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Scientific%20Reports&amp;title=Circulating%20long%E2%80%90non%20Coding%20RNAs%20as%20Biomarkers%20of%20Left%20Ventricular%20Diastolic%20Function%20and%20Remodelling%20in%20Patients%20With%20Well%E2%80%90Controlled%20Type%202%20Diabetes&amp;author=D.%20de%20Gonzalo%E2%80%90Calvo&amp;author=F.%20Kenneweg&amp;author=C.%20Bang&amp;volume=6&amp;issue=1&amp;publication_year=2016&amp;pages=37354&amp;pmid=27874027&amp;doi=10.1038/srep37354&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0142">
<span class="label">142.</span><cite>
Zhou X., Zhang W., Jin M., Chen J., Xu W., and Kong X., “lncRNA MIAT Functions as a Competing Endogenous RNA to Upregulate DAPK2 by Sponging miR‐22‐3p in Diabetic Cardiomyopathy,” Cell Death &amp; Disease
8, no. 7 (2017): e2929, 10.1038/cddis.2017.321.
</cite> [<a href="https://doi.org/10.1038/cddis.2017.321" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5550866/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28703801/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell%20Death%20&amp;%20Disease&amp;title=lncRNA%20MIAT%20Functions%20as%20a%20Competing%20Endogenous%20RNA%20to%20Upregulate%20DAPK2%20by%20Sponging%20miR%E2%80%9022%E2%80%903p%20in%20Diabetic%20Cardiomyopathy&amp;author=X.%20Zhou&amp;author=W.%20Zhang&amp;author=M.%20Jin&amp;author=J.%20Chen&amp;author=W.%20Xu&amp;volume=8&amp;issue=7&amp;publication_year=2017&amp;pages=e2929&amp;pmid=28703801&amp;doi=10.1038/cddis.2017.321&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0143">
<span class="label">143.</span><cite>
Qi Y., Wu H., Mai C., et al., “LncRNA‐MIAT‐Mediated miR‐214‐3p Silencing is Responsible for IL‐17 Production and Cardiac Fibrosis in Diabetic Cardiomyopathy,” Frontiers in Cell and Developmental Biology
8 (2020): 243, 10.3389/fcell.2020.00243.
</cite> [<a href="https://doi.org/10.3389/fcell.2020.00243" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7174588/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32351959/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Frontiers%20in%20Cell%20and%20Developmental%20Biology&amp;title=LncRNA%E2%80%90MIAT%E2%80%90Mediated%20miR%E2%80%90214%E2%80%903p%20Silencing%20is%20Responsible%20for%20IL%E2%80%9017%20Production%20and%20Cardiac%20Fibrosis%20in%20Diabetic%20Cardiomyopathy&amp;author=Y.%20Qi&amp;author=H.%20Wu&amp;author=C.%20Mai&amp;volume=8&amp;publication_year=2020&amp;pages=243&amp;pmid=32351959&amp;doi=10.3389/fcell.2020.00243&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0144">
<span class="label">144.</span><cite>
Thomas A. A., Feng B., and Chakrabarti S., “ANRIL Regulates Production of Extracellular Matrix Proteins and Vasoactive Factors in Diabetic Complications,” American Journal of Physiology. Endocrinology and Metabolism
314, no. 3 (2018): E191–E200, 10.1152/ajpendo.00268.2017.
</cite> [<a href="https://doi.org/10.1152/ajpendo.00268.2017" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29118015/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=American%20Journal%20of%20Physiology.%20Endocrinology%20and%20Metabolism&amp;title=ANRIL%20Regulates%20Production%20of%20Extracellular%20Matrix%20Proteins%20and%20Vasoactive%20Factors%20in%20Diabetic%20Complications&amp;author=A.%20A.%20Thomas&amp;author=B.%20Feng&amp;author=S.%20Chakrabarti&amp;volume=314&amp;issue=3&amp;publication_year=2018&amp;pages=E191-E200&amp;pmid=29118015&amp;doi=10.1152/ajpendo.00268.2017&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0145">
<span class="label">145.</span><cite>
Devaux Y., Creemers E. E., Boon R. A., et al., “Circular RNAs in Heart Failure,” European Journal of Heart Failure
19, no. 6 (2017): 701–709, 10.1002/ejhf.801.
</cite> [<a href="https://doi.org/10.1002/ejhf.801" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28345158/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=European%20Journal%20of%20Heart%20Failure&amp;title=Circular%20RNAs%20in%20Heart%20Failure&amp;author=Y.%20Devaux&amp;author=E.%20E.%20Creemers&amp;author=R.%20A.%20Boon&amp;volume=19&amp;issue=6&amp;publication_year=2017&amp;pages=701-709&amp;pmid=28345158&amp;doi=10.1002/ejhf.801&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0146">
<span class="label">146.</span><cite>
Werfel S., Nothjunge S., Schwarzmayr T., Strom T. M., Meitinger T., and Engelhardt S., “Characterization of Circular RNAs in Human, Mouse and Rat Hearts,” Journal of Molecular and Cellular Cardiology
98 (2016): 103–107, 10.1016/j.yjmcc.2016.07.007.
</cite> [<a href="https://doi.org/10.1016/j.yjmcc.2016.07.007" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27476877/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Molecular%20and%20Cellular%20Cardiology&amp;title=Characterization%20of%20Circular%20RNAs%20in%20Human,%20Mouse%20and%20Rat%20Hearts&amp;author=S.%20Werfel&amp;author=S.%20Nothjunge&amp;author=T.%20Schwarzmayr&amp;author=T.%20M.%20Strom&amp;author=T.%20Meitinger&amp;volume=98&amp;publication_year=2016&amp;pages=103-107&amp;pmid=27476877&amp;doi=10.1016/j.yjmcc.2016.07.007&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0147">
<span class="label">147.</span><cite>
Tan W. L., Lim B. T., Anene‐Nzelu C. G., et al., “A Landscape of Circular RNA Expression in the Human Heart,” Cardiovascular Research
113, no. 3 (2017): 298–309, 10.1093/cvr/cvw250.
</cite> [<a href="https://doi.org/10.1093/cvr/cvw250" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28082450/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cardiovascular%20Research&amp;title=A%20Landscape%20of%20Circular%20RNA%20Expression%20in%20the%20Human%20Heart&amp;author=W.%20L.%20Tan&amp;author=B.%20T.%20Lim&amp;author=C.%20G.%20Anene%E2%80%90Nzelu&amp;volume=113&amp;issue=3&amp;publication_year=2017&amp;pages=298-309&amp;pmid=28082450&amp;doi=10.1093/cvr/cvw250&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0148">
<span class="label">148.</span><cite>
Wang K., Long B., Liu F., et al., “A Circular RNA Protects the Heart From Pathological Hypertrophy and Heart Failure by Targeting miR‐223,” European Heart Journal
37, no. 33 (2016): 2602–2611, 10.1093/eurheartj/ehv713.
</cite> [<a href="https://doi.org/10.1093/eurheartj/ehv713" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26802132/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=European%20Heart%20Journal&amp;title=A%20Circular%20RNA%20Protects%20the%20Heart%20From%20Pathological%20Hypertrophy%20and%20Heart%20Failure%20by%20Targeting%20miR%E2%80%90223&amp;author=K.%20Wang&amp;author=B.%20Long&amp;author=F.%20Liu&amp;volume=37&amp;issue=33&amp;publication_year=2016&amp;pages=2602-2611&amp;pmid=26802132&amp;doi=10.1093/eurheartj/ehv713&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0149">
<span class="label">149.</span><cite>
Dong S., Tu C., Ye X., et al., “Expression Profiling of Circular RNAs and Their Potential Role in Early‐Stage Diabetic Cardiomyopathy,” Molecular Medicine Reports
22, no. 3 (2020): 1958–1968, 10.3892/mmr.2020.11248.
</cite> [<a href="https://doi.org/10.3892/mmr.2020.11248" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7411360/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32705182/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Molecular%20Medicine%20Reports&amp;title=Expression%20Profiling%20of%20Circular%20RNAs%20and%20Their%20Potential%20Role%20in%20Early%E2%80%90Stage%20Diabetic%20Cardiomyopathy&amp;author=S.%20Dong&amp;author=C.%20Tu&amp;author=X.%20Ye&amp;volume=22&amp;issue=3&amp;publication_year=2020&amp;pages=1958-1968&amp;pmid=32705182&amp;doi=10.3892/mmr.2020.11248&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0150">
<span class="label">150.</span><cite>
Tang C. M., Zhang M., Huang L., et al., “CircRNA_000203 Enhances the Expression of Fibrosis‐Associated Genes by Derepressing Targets of miR‐26b‐5p, Col1a2 and CTGF, in Cardiac Fibroblasts,” Scientific Reports
7, no. 1 (2017): 40342, 10.1038/srep40342.
</cite> [<a href="https://doi.org/10.1038/srep40342" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5228128/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28079129/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Scientific%20Reports&amp;title=CircRNA_000203%20Enhances%20the%20Expression%20of%20Fibrosis%E2%80%90Associated%20Genes%20by%20Derepressing%20Targets%20of%20miR%E2%80%9026b%E2%80%905p,%20Col1a2%20and%20CTGF,%20in%20Cardiac%20Fibroblasts&amp;author=C.%20M.%20Tang&amp;author=M.%20Zhang&amp;author=L.%20Huang&amp;volume=7&amp;issue=1&amp;publication_year=2017&amp;pages=40342&amp;pmid=28079129&amp;doi=10.1038/srep40342&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0151">
<span class="label">151.</span><cite>
Zhou B. and Yu J. W., “A Novel Identified Circular RNA, circRNA_010567, Promotes Myocardial Fibrosis via Suppressing miR‐141 by Targeting TGF‐beta1,” Biochemical and Biophysical Research Communications
487, no. 4 (2017): 769–775, 10.1016/j.bbrc.2017.04.044.
</cite> [<a href="https://doi.org/10.1016/j.bbrc.2017.04.044" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28412345/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biochemical%20and%20Biophysical%20Research%20Communications&amp;title=A%20Novel%20Identified%20Circular%20RNA,%20circRNA_010567,%20Promotes%20Myocardial%20Fibrosis%20via%20Suppressing%20miR%E2%80%90141%20by%20Targeting%20TGF%E2%80%90beta1&amp;author=B.%20Zhou&amp;author=J.%20W.%20Yu&amp;volume=487&amp;issue=4&amp;publication_year=2017&amp;pages=769-775&amp;pmid=28412345&amp;doi=10.1016/j.bbrc.2017.04.044&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0152">
<span class="label">152.</span><cite>
Yuan Q., Sun Y., Yang F., et al., “CircRNA DICAR as a Novel Endogenous Regulator for Diabetic Cardiomyopathy and Diabetic Pyroptosis of Cardiomyocytes,” Signal Transduction and Targeted Therapy
8, no. 1 (2023): 99, 10.1038/s41392-022-01306-2.
</cite> [<a href="https://doi.org/10.1038/s41392-022-01306-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9992392/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36882410/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Signal%20Transduction%20and%20Targeted%20Therapy&amp;title=CircRNA%20DICAR%20as%20a%20Novel%20Endogenous%20Regulator%20for%20Diabetic%20Cardiomyopathy%20and%20Diabetic%20Pyroptosis%20of%20Cardiomyocytes&amp;author=Q.%20Yuan&amp;author=Y.%20Sun&amp;author=F.%20Yang&amp;volume=8&amp;issue=1&amp;publication_year=2023&amp;pages=99&amp;pmid=36882410&amp;doi=10.1038/s41392-022-01306-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0153">
<span class="label">153.</span><cite>
Yuan L., Wang T., Duan J., et al., “Expression Profiles and Bioinformatic Analysis of Circular RNAs in Db/Db Mice With Cardiac Fibrosis,” Diabetes, Metabolic Syndrome and Obesity
17 (2024): 2107–2120, 10.2147/dmso.s465588.</cite> [<a href="https://doi.org/10.2147/dmso.s465588" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11128257/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38799279/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes,%20Metabolic%20Syndrome%20and%20Obesity&amp;title=Expression%20Profiles%20and%20Bioinformatic%20Analysis%20of%20Circular%20RNAs%20in%20Db/Db%20Mice%20With%20Cardiac%20Fibrosis&amp;author=L.%20Yuan&amp;author=T.%20Wang&amp;author=J.%20Duan&amp;volume=17&amp;publication_year=2024&amp;pages=2107-2120&amp;pmid=38799279&amp;doi=10.2147/dmso.s465588&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0154">
<span class="label">154.</span><cite>
Yang Y., Yang H., and Yang C., “Circ‐AMOTL1 Enhances Cardiac Fibrosis Through Binding With EIF4A3 and Stabilizing MARCKS Expression in Diabetic Cardiomyopathy,” Cellular Signalling
111 (2023): 110853, 10.1016/j.cellsig.2023.110853.
</cite> [<a href="https://doi.org/10.1016/j.cellsig.2023.110853" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37586467/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cellular%20Signalling&amp;title=Circ%E2%80%90AMOTL1%20Enhances%20Cardiac%20Fibrosis%20Through%20Binding%20With%20EIF4A3%20and%20Stabilizing%20MARCKS%20Expression%20in%20Diabetic%20Cardiomyopathy&amp;author=Y.%20Yang&amp;author=H.%20Yang&amp;author=C.%20Yang&amp;volume=111&amp;publication_year=2023&amp;pages=110853&amp;pmid=37586467&amp;doi=10.1016/j.cellsig.2023.110853&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0155">
<span class="label">155.</span><cite>
Wang W., Zhang S., Xu L., et al., “Involvement of circHIPK3 in the Pathogenesis of Diabetic Cardiomyopathy in Mice,” Diabetologia
64, no. 3 (2021): 681–692, 10.1007/s00125-020-05353-8.
</cite> [<a href="https://doi.org/10.1007/s00125-020-05353-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33398455/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabetologia&amp;title=Involvement%20of%20circHIPK3%20in%20the%20Pathogenesis%20of%20Diabetic%20Cardiomyopathy%20in%20Mice&amp;author=W.%20Wang&amp;author=S.%20Zhang&amp;author=L.%20Xu&amp;volume=64&amp;issue=3&amp;publication_year=2021&amp;pages=681-692&amp;pmid=33398455&amp;doi=10.1007/s00125-020-05353-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0156">
<span class="label">156.</span><cite>
Shao Y., Li M., Yu Q., et al., “CircRNA CDR1as Promotes Cardiomyocyte Apoptosis Through Activating Hippo Signaling Pathway in Diabetic Cardiomyopathy,” European Journal of Pharmacology
922 (2022): 174915, 10.1016/j.ejphar.2022.174915.
</cite> [<a href="https://doi.org/10.1016/j.ejphar.2022.174915" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35339477/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=European%20Journal%20of%20Pharmacology&amp;title=CircRNA%20CDR1as%20Promotes%20Cardiomyocyte%20Apoptosis%20Through%20Activating%20Hippo%20Signaling%20Pathway%20in%20Diabetic%20Cardiomyopathy&amp;author=Y.%20Shao&amp;author=M.%20Li&amp;author=Q.%20Yu&amp;volume=922&amp;publication_year=2022&amp;pages=174915&amp;pmid=35339477&amp;doi=10.1016/j.ejphar.2022.174915&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0157">
<span class="label">157.</span><cite>
Yang F., Li A., Qin Y., et al., “A Novel Circular RNA Mediates Pyroptosis of Diabetic Cardiomyopathy by Functioning as a Competing Endogenous RNA,” Molecular Therapy Nucleic Acids
17 (2019): 636–643, 10.1016/j.omtn.2019.06.026.
</cite> [<a href="https://doi.org/10.1016/j.omtn.2019.06.026" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6700436/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31400606/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Molecular%20Therapy%20Nucleic%20Acids&amp;title=A%20Novel%20Circular%20RNA%20Mediates%20Pyroptosis%20of%20Diabetic%20Cardiomyopathy%20by%20Functioning%20as%20a%20Competing%20Endogenous%20RNA&amp;author=F.%20Yang&amp;author=A.%20Li&amp;author=Y.%20Qin&amp;volume=17&amp;publication_year=2019&amp;pages=636-643&amp;pmid=31400606&amp;doi=10.1016/j.omtn.2019.06.026&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0158">
<span class="label">158.</span><cite>
Shen M., Wu Y., Li L., Zhang L., Liu G., and Wang R., “CircMAP3K5 Promotes Cardiomyocyte Apoptosis in Diabetic Cardiomyopathy by Regulating miR‐22‐3p/DAPK2 Axis,” Journal of Diabetes
16, no. 1 (2024): e13471, 10.1111/1753-0407.13471.
</cite> [<a href="https://doi.org/10.1111/1753-0407.13471" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10809294/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37735821/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Diabetes&amp;title=CircMAP3K5%20Promotes%20Cardiomyocyte%20Apoptosis%20in%20Diabetic%20Cardiomyopathy%20by%20Regulating%20miR%E2%80%9022%E2%80%903p/DAPK2%20Axis&amp;author=M.%20Shen&amp;author=Y.%20Wu&amp;author=L.%20Li&amp;author=L.%20Zhang&amp;author=G.%20Liu&amp;volume=16&amp;issue=1&amp;publication_year=2024&amp;pages=e13471&amp;pmid=37735821&amp;doi=10.1111/1753-0407.13471&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0159">
<span class="label">159.</span><cite>
Jin G., Wang Q., Hu X., et al., “Profiling and Functional Analysis of Differentially Expressed Circular RNAs in High Glucose‐Induced Human Umbilical Vein Endothelial Cells,” FEBS Open Bio
9, no. 9 (2019): 1640–1651, 10.1002/2211-5463.12709.</cite> [<a href="https://doi.org/10.1002/2211-5463.12709" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6722901/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31369204/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=FEBS%20Open%20Bio&amp;title=Profiling%20and%20Functional%20Analysis%20of%20Differentially%20Expressed%20Circular%20RNAs%20in%20High%20Glucose%E2%80%90Induced%20Human%20Umbilical%20Vein%20Endothelial%20Cells&amp;author=G.%20Jin&amp;author=Q.%20Wang&amp;author=X.%20Hu&amp;volume=9&amp;issue=9&amp;publication_year=2019&amp;pages=1640-1651&amp;pmid=31369204&amp;doi=10.1002/2211-5463.12709&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0160">
<span class="label">160.</span><cite>
Zhang W. and Sui Y., “CircBPTF Knockdown Ameliorates High Glucose‐Induced Inflammatory Injuries and Oxidative Stress by Targeting the miR‐384/LIN28B Axis in Human Umbilical Vein Endothelial Cells,” Molecular and Cellular Biochemistry
471, no. 1–2 (2020): 101–111, 10.1007/s11010-020-03770-2.
</cite> [<a href="https://doi.org/10.1007/s11010-020-03770-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32524321/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Molecular%20and%20Cellular%20Biochemistry&amp;title=CircBPTF%20Knockdown%20Ameliorates%20High%20Glucose%E2%80%90Induced%20Inflammatory%20Injuries%20and%20Oxidative%20Stress%20by%20Targeting%20the%20miR%E2%80%90384/LIN28B%20Axis%20in%20Human%20Umbilical%20Vein%20Endothelial%20Cells&amp;author=W.%20Zhang&amp;author=Y.%20Sui&amp;volume=471&amp;issue=1%E2%80%932&amp;publication_year=2020&amp;pages=101-111&amp;pmid=32524321&amp;doi=10.1007/s11010-020-03770-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0161">
<span class="label">161.</span><cite>
Zhang M., Du G., Xie L., Xu Y., and Chen W., “Circular RNA HMGCS1 Sponges MIR4521 to Aggravate Type 2 Diabetes‐Induced Vascular Endothelial Dysfunction,” Elife
13 (2024): RP97267, 10.7554/elife.97267.
</cite> [<a href="https://doi.org/10.7554/elife.97267" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11377038/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39235443/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Elife&amp;title=Circular%20RNA%20HMGCS1%20Sponges%20MIR4521%20to%20Aggravate%20Type%202%20Diabetes%E2%80%90Induced%20Vascular%20Endothelial%20Dysfunction&amp;author=M.%20Zhang&amp;author=G.%20Du&amp;author=L.%20Xie&amp;author=Y.%20Xu&amp;author=W.%20Chen&amp;volume=13&amp;publication_year=2024&amp;pages=RP97267&amp;pmid=39235443&amp;doi=10.7554/elife.97267&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0162">
<span class="label">162.</span><cite>
Khan A. W., Paneni F., and Jandeleit‐Dahm K. A. M., “Cell‐Specific Epigenetic Changes in Atherosclerosis,” Clinical Science
135, no. 9 (2021): 1165–1187, 10.1042/cs20201066.
</cite> [<a href="https://doi.org/10.1042/cs20201066" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8314213/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33988232/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clinical%20Science&amp;title=Cell%E2%80%90Specific%20Epigenetic%20Changes%20in%20Atherosclerosis&amp;author=A.%20W.%20Khan&amp;author=F.%20Paneni&amp;author=K.%20A.%20M.%20Jandeleit%E2%80%90Dahm&amp;volume=135&amp;issue=9&amp;publication_year=2021&amp;pages=1165-1187&amp;pmid=33988232&amp;doi=10.1042/cs20201066&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0163">
<span class="label">163.</span><cite>
Laakso M., “Heart in Diabetes: A Microvascular Disease,” supplement, Diabetes Care
34, no. S2 (2011): S145–S149, 10.2337/dc11-s209.
</cite> [<a href="https://doi.org/10.2337/dc11-s209" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3632152/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21525446/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes%20Care&amp;title=Heart%20in%20Diabetes:%20A%20Microvascular%20Disease&amp;author=M.%20Laakso&amp;volume=34&amp;issue=S2&amp;publication_year=2011&amp;pages=S145-S149&amp;pmid=21525446&amp;doi=10.2337/dc11-s209&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0164">
<span class="label">164.</span><cite>
Coco C., Sgarra L., Potenza M. A., et al., “Can Epigenetics of Endothelial Dysfunction Represent the Key to Precision Medicine in Type 2 Diabetes Mellitus?,” International Journal of Molecular Sciences
20, no. 12 (2019): 2949, 10.3390/ijms20122949.
</cite> [<a href="https://doi.org/10.3390/ijms20122949" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6628049/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31212911/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=International%20Journal%20of%20Molecular%20Sciences&amp;title=Can%20Epigenetics%20of%20Endothelial%20Dysfunction%20Represent%20the%20Key%20to%20Precision%20Medicine%20in%20Type%202%20Diabetes%20Mellitus?&amp;author=C.%20Coco&amp;author=L.%20Sgarra&amp;author=M.%20A.%20Potenza&amp;volume=20&amp;issue=12&amp;publication_year=2019&amp;pages=2949&amp;pmid=31212911&amp;doi=10.3390/ijms20122949&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0165">
<span class="label">165.</span><cite>
Paneni F., Costantino S., Battista R., et al., “Adverse Epigenetic Signatures by Histone Methyltransferase Set7 Contribute to Vascular Dysfunction in Patients With Type 2 Diabetes Mellitus,” Circulation: Cardiovascular Genetics
8, no. 1 (2015): 150–158, 10.1161/circgenetics.114.000671.
</cite> [<a href="https://doi.org/10.1161/circgenetics.114.000671" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25472959/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Circulation:%20Cardiovascular%20Genetics&amp;title=Adverse%20Epigenetic%20Signatures%20by%20Histone%20Methyltransferase%20Set7%20Contribute%20to%20Vascular%20Dysfunction%20in%20Patients%20With%20Type%202%20Diabetes%20Mellitus&amp;author=F.%20Paneni&amp;author=S.%20Costantino&amp;author=R.%20Battista&amp;volume=8&amp;issue=1&amp;publication_year=2015&amp;pages=150-158&amp;pmid=25472959&amp;doi=10.1161/circgenetics.114.000671&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0166">
<span class="label">166.</span><cite>
Pepin M. E., Schiano C., Miceli M., et al., “The Human Aortic Endothelium Undergoes Dose‐Dependent DNA Methylation in Response to Transient Hyperglycemia,” Experimental Cell Research
400, no. 2 (2021): 112485, 10.1016/j.yexcr.2021.112485.
</cite> [<a href="https://doi.org/10.1016/j.yexcr.2021.112485" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8038422/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33515594/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Experimental%20Cell%20Research&amp;title=The%20Human%20Aortic%20Endothelium%20Undergoes%20Dose%E2%80%90Dependent%20DNA%20Methylation%20in%20Response%20to%20Transient%20Hyperglycemia&amp;author=M.%20E.%20Pepin&amp;author=C.%20Schiano&amp;author=M.%20Miceli&amp;volume=400&amp;issue=2&amp;publication_year=2021&amp;pages=112485&amp;pmid=33515594&amp;doi=10.1016/j.yexcr.2021.112485&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0167">
<span class="label">167.</span><cite>
Green H. L. H. and Brewer A. C., “Dysregulation of 2‐Oxoglutarate‐Dependent Dioxygenases by Hyperglycaemia: Does This Link Diabetes and Vascular Disease?,” Clinical Epigenetics
12, no. 1 (2020): 59, 10.1186/s13148-020-00848-y.
</cite> [<a href="https://doi.org/10.1186/s13148-020-00848-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7189706/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32345373/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clinical%20Epigenetics&amp;title=Dysregulation%20of%202%E2%80%90Oxoglutarate%E2%80%90Dependent%20Dioxygenases%20by%20Hyperglycaemia:%20Does%20This%20Link%20Diabetes%20and%20Vascular%20Disease?&amp;author=H.%20L.%20H.%20Green&amp;author=A.%20C.%20Brewer&amp;volume=12&amp;issue=1&amp;publication_year=2020&amp;pages=59&amp;pmid=32345373&amp;doi=10.1186/s13148-020-00848-y&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0168">
<span class="label">168.</span><cite>
Jabs M., Rose A. J., Lehmann L. H., et al., “Inhibition of Endothelial Notch Signaling Impairs Fatty Acid Transport and Leads to Metabolic and Vascular Remodeling of the Adult Heart,” Circulation
137, no. 24 (2018): 2592–2608, 10.1161/circulationaha.117.029733.
</cite> [<a href="https://doi.org/10.1161/circulationaha.117.029733" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29353241/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Circulation&amp;title=Inhibition%20of%20Endothelial%20Notch%20Signaling%20Impairs%20Fatty%20Acid%20Transport%20and%20Leads%20to%20Metabolic%20and%20Vascular%20Remodeling%20of%20the%20Adult%20Heart&amp;author=M.%20Jabs&amp;author=A.%20J.%20Rose&amp;author=L.%20H.%20Lehmann&amp;volume=137&amp;issue=24&amp;publication_year=2018&amp;pages=2592-2608&amp;pmid=29353241&amp;doi=10.1161/circulationaha.117.029733&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0169">
<span class="label">169.</span><cite>
Wang E., Chen S., Wang H., Chen T., and Chakrabarti S., “Non‐Coding RNA‐Mediated Endothelial‐to‐Mesenchymal Transition in Human Diabetic Cardiomyopathy, Potential Regulation by DNA Methylation,” Cardiovascular Diabetology
22, no. 1 (2023): 303, 10.1186/s12933-023-02039-4.
</cite> [<a href="https://doi.org/10.1186/s12933-023-02039-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10625293/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37924123/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cardiovascular%20Diabetology&amp;title=Non%E2%80%90Coding%20RNA%E2%80%90Mediated%20Endothelial%E2%80%90to%E2%80%90Mesenchymal%20Transition%20in%20Human%20Diabetic%20Cardiomyopathy,%20Potential%20Regulation%20by%20DNA%20Methylation&amp;author=E.%20Wang&amp;author=S.%20Chen&amp;author=H.%20Wang&amp;author=T.%20Chen&amp;author=S.%20Chakrabarti&amp;volume=22&amp;issue=1&amp;publication_year=2023&amp;pages=303&amp;pmid=37924123&amp;doi=10.1186/s12933-023-02039-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0170">
<span class="label">170.</span><cite>
Wang E., Wang H., and Chakrabarti S., “Endothelial‐to‐Mesenchymal Transition: An Underappreciated Mediator of Diabetic Complications,” Frontiers in Endocrinology
14 (2023): 1050540, 10.3389/fendo.2023.1050540.
</cite> [<a href="https://doi.org/10.3389/fendo.2023.1050540" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9911675/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36777351/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Frontiers%20in%20Endocrinology&amp;title=Endothelial%E2%80%90to%E2%80%90Mesenchymal%20Transition:%20An%20Underappreciated%20Mediator%20of%20Diabetic%20Complications&amp;author=E.%20Wang&amp;author=H.%20Wang&amp;author=S.%20Chakrabarti&amp;volume=14&amp;publication_year=2023&amp;pages=1050540&amp;pmid=36777351&amp;doi=10.3389/fendo.2023.1050540&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0171">
<span class="label">171.</span><cite>
Sathishkumar C., Prabu P., Balakumar M., et al., “Augmentation of Histone Deacetylase 3 (HDAC3) Epigenetic Signature at the Interface of Proinflammation and Insulin Resistance in Patients With Type 2 Diabetes,” Clinical Epigenetics
8, no. 1 (2016): 125, 10.1186/s13148-016-0293-3.
</cite> [<a href="https://doi.org/10.1186/s13148-016-0293-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5122206/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27904654/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clinical%20Epigenetics&amp;title=Augmentation%20of%20Histone%20Deacetylase%203%20(HDAC3)%20Epigenetic%20Signature%20at%20the%20Interface%20of%20Proinflammation%20and%20Insulin%20Resistance%20in%20Patients%20With%20Type%202%20Diabetes&amp;author=C.%20Sathishkumar&amp;author=P.%20Prabu&amp;author=M.%20Balakumar&amp;volume=8&amp;issue=1&amp;publication_year=2016&amp;pages=125&amp;pmid=27904654&amp;doi=10.1186/s13148-016-0293-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0172">
<span class="label">172.</span><cite>
Xu X., Friehs I., Zhong Hu T., et al., “Endocardial Fibroelastosis Is Caused by Aberrant Endothelial to Mesenchymal Transition,” Circulation Research
116, no. 5 (2015): 857–866, 10.1161/circresaha.116.305629.
</cite> [<a href="https://doi.org/10.1161/circresaha.116.305629" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4344885/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25587097/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Circulation%20Research&amp;title=Endocardial%20Fibroelastosis%20Is%20Caused%20by%20Aberrant%20Endothelial%20to%20Mesenchymal%20Transition&amp;author=X.%20Xu&amp;author=I.%20Friehs&amp;author=T.%20Zhong%20Hu&amp;volume=116&amp;issue=5&amp;publication_year=2015&amp;pages=857-866&amp;pmid=25587097&amp;doi=10.1161/circresaha.116.305629&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0173">
<span class="label">173.</span><cite>
Xu X., Tan X., Tampe B., et al., “Epigenetic Balance of Aberrant Rasal1 Promoter Methylation and Hydroxymethylation Regulates Cardiac Fibrosis,” Cardiovascular Research
105, no. 3 (2015): 279–291, 10.1093/cvr/cvv015.
</cite> [<a href="https://doi.org/10.1093/cvr/cvv015" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25616414/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cardiovascular%20Research&amp;title=Epigenetic%20Balance%20of%20Aberrant%20Rasal1%20Promoter%20Methylation%20and%20Hydroxymethylation%20Regulates%20Cardiac%20Fibrosis&amp;author=X.%20Xu&amp;author=X.%20Tan&amp;author=B.%20Tampe&amp;volume=105&amp;issue=3&amp;publication_year=2015&amp;pages=279-291&amp;pmid=25616414&amp;doi=10.1093/cvr/cvv015&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0174">
<span class="label">174.</span><cite>
Jordan N. P., Tingle S. J., Shuttleworth V. G., et al., “MiR‐126‐3p is Dynamically Regulated in Endothelial‐to‐Mesenchymal Transition During Fibrosis,” International Journal of Molecular Sciences
22, no. 16 (2021): 8629, 10.3390/ijms22168629.
</cite> [<a href="https://doi.org/10.3390/ijms22168629" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8395326/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34445337/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=International%20Journal%20of%20Molecular%20Sciences&amp;title=MiR%E2%80%90126%E2%80%903p%20is%20Dynamically%20Regulated%20in%20Endothelial%E2%80%90to%E2%80%90Mesenchymal%20Transition%20During%20Fibrosis&amp;author=N.%20P.%20Jordan&amp;author=S.%20J.%20Tingle&amp;author=V.%20G.%20Shuttleworth&amp;volume=22&amp;issue=16&amp;publication_year=2021&amp;pages=8629&amp;pmid=34445337&amp;doi=10.3390/ijms22168629&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0175">
<span class="label">175.</span><cite>
Patil N. S., Feng B., Su Z., Castellani C. A., and Chakrabarti S., “Circular RNA Mediated Gene Regulation in Chronic Diabetic Complications,” Scientific Reports
11, no. 1 (2021): 23766, 10.1038/s41598-021-02980-y.
</cite> [<a href="https://doi.org/10.1038/s41598-021-02980-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8660871/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34887449/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Scientific%20Reports&amp;title=Circular%20RNA%20Mediated%20Gene%20Regulation%20in%20Chronic%20Diabetic%20Complications&amp;author=N.%20S.%20Patil&amp;author=B.%20Feng&amp;author=Z.%20Su&amp;author=C.%20A.%20Castellani&amp;author=S.%20Chakrabarti&amp;volume=11&amp;issue=1&amp;publication_year=2021&amp;pages=23766&amp;pmid=34887449&amp;doi=10.1038/s41598-021-02980-y&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0176">
<span class="label">176.</span><cite>
Tuleta I. and Frangogiannis N. G., “Fibrosis of the Diabetic Heart: Clinical Significance, Molecular Mechanisms, and Therapeutic Opportunities,” Advanced Drug Delivery Reviews
176 (2021): 113904, 10.1016/j.addr.2021.113904.
</cite> [<a href="https://doi.org/10.1016/j.addr.2021.113904" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8444077/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34331987/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Advanced%20Drug%20Delivery%20Reviews&amp;title=Fibrosis%20of%20the%20Diabetic%20Heart:%20Clinical%20Significance,%20Molecular%20Mechanisms,%20and%20Therapeutic%20Opportunities&amp;author=I.%20Tuleta&amp;author=N.%20G.%20Frangogiannis&amp;volume=176&amp;publication_year=2021&amp;pages=113904&amp;pmid=34331987&amp;doi=10.1016/j.addr.2021.113904&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0177">
<span class="label">177.</span><cite>
Tao H., Shi P., Zhao X. D., Xuan H. Y., Gong W. H., and Ding X. S., “DNMT1 Deregulation of SOCS3 Axis Drives Cardiac Fibroblast Activation in Diabetic Cardiac Fibrosis,” Journal of Cellular Physiology
236, no. 5 (2021): 3481–3494, 10.1002/jcp.30078.
</cite> [<a href="https://doi.org/10.1002/jcp.30078" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32989761/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Cellular%20Physiology&amp;title=DNMT1%20Deregulation%20of%20SOCS3%20Axis%20Drives%20Cardiac%20Fibroblast%20Activation%20in%20Diabetic%20Cardiac%20Fibrosis&amp;author=H.%20Tao&amp;author=P.%20Shi&amp;author=X.%20D.%20Zhao&amp;author=H.%20Y.%20Xuan&amp;author=W.%20H.%20Gong&amp;volume=236&amp;issue=5&amp;publication_year=2021&amp;pages=3481-3494&amp;pmid=32989761&amp;doi=10.1002/jcp.30078&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0178">
<span class="label">178.</span><cite>
Tao H., Shi P., Xuan H. Y., and Ding X. S., “DNA Methyltransferase‐1 Inactivation of Androgen Receptor Axis Triggers Homocysteine Induced Cardiac Fibroblast Autophagy in Diabetic Cardiac Fibrosis,” Archives of Biochemistry and Biophysics
692 (2020): 108521, 10.1016/j.abb.2020.108521.
</cite> [<a href="https://doi.org/10.1016/j.abb.2020.108521" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32800775/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Archives%20of%20Biochemistry%20and%20Biophysics&amp;title=DNA%20Methyltransferase%E2%80%901%20Inactivation%20of%20Androgen%20Receptor%20Axis%20Triggers%20Homocysteine%20Induced%20Cardiac%20Fibroblast%20Autophagy%20in%20Diabetic%20Cardiac%20Fibrosis&amp;author=H.%20Tao&amp;author=P.%20Shi&amp;author=H.%20Y.%20Xuan&amp;author=X.%20S.%20Ding&amp;volume=692&amp;publication_year=2020&amp;pages=108521&amp;pmid=32800775&amp;doi=10.1016/j.abb.2020.108521&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0179">
<span class="label">179.</span><cite>
Che H., Wang Y., Li Y., et al., “Inhibition of microRNA‐150‐5p Alleviates Cardiac Inflammation and Fibrosis via Targeting Smad7 in High Glucose‐Treated Cardiac Fibroblasts,” Journal of Cellular Physiology
235, no. 11 (2020): 7769–7779, 10.1002/jcp.29386.
</cite> [<a href="https://doi.org/10.1002/jcp.29386" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31710102/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Cellular%20Physiology&amp;title=Inhibition%20of%20microRNA%E2%80%90150%E2%80%905p%20Alleviates%20Cardiac%20Inflammation%20and%20Fibrosis%20via%20Targeting%20Smad7%20in%20High%20Glucose%E2%80%90Treated%20Cardiac%20Fibroblasts&amp;author=H.%20Che&amp;author=Y.%20Wang&amp;author=Y.%20Li&amp;volume=235&amp;issue=11&amp;publication_year=2020&amp;pages=7769-7779&amp;pmid=31710102&amp;doi=10.1002/jcp.29386&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0180">
<span class="label">180.</span><cite>
Liu S., Li W., Xu M., Huang H., Wang J., and Chen X., “Micro‐RNA 21Targets Dual Specific Phosphatase 8 to Promote Collagen Synthesis in High Glucose‐Treated Primary Cardiac Fibroblasts,” Canadian Journal of Cardiology
30, no. 12 (2014): 1689–1699, 10.1016/j.cjca.2014.07.747.
</cite> [<a href="https://doi.org/10.1016/j.cjca.2014.07.747" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25418215/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Canadian%20Journal%20of%20Cardiology&amp;title=Micro%E2%80%90RNA%2021Targets%20Dual%20Specific%20Phosphatase%208%20to%20Promote%20Collagen%20Synthesis%20in%20High%20Glucose%E2%80%90Treated%20Primary%20Cardiac%20Fibroblasts&amp;author=S.%20Liu&amp;author=W.%20Li&amp;author=M.%20Xu&amp;author=H.%20Huang&amp;author=J.%20Wang&amp;volume=30&amp;issue=12&amp;publication_year=2014&amp;pages=1689-1699&amp;pmid=25418215&amp;doi=10.1016/j.cjca.2014.07.747&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0181">
<span class="label">181.</span><cite>
Shen J., Xing W., Liu R., Zhang Y., Xie C., and Gong F., “MiR‐32‐5p Influences High Glucose‐Induced Cardiac Fibroblast Proliferation and Phenotypic Alteration by Inhibiting DUSP1,” BMC Molecular Biology
20, no. 1 (2019): 21, 10.1186/s12867-019-0135-x.
</cite> [<a href="https://doi.org/10.1186/s12867-019-0135-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6704591/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31438862/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMC%20Molecular%20Biology&amp;title=MiR%E2%80%9032%E2%80%905p%20Influences%20High%20Glucose%E2%80%90Induced%20Cardiac%20Fibroblast%20Proliferation%20and%20Phenotypic%20Alteration%20by%20Inhibiting%20DUSP1&amp;author=J.%20Shen&amp;author=W.%20Xing&amp;author=R.%20Liu&amp;author=Y.%20Zhang&amp;author=C.%20Xie&amp;volume=20&amp;issue=1&amp;publication_year=2019&amp;pages=21&amp;pmid=31438862&amp;doi=10.1186/s12867-019-0135-x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0182">
<span class="label">182.</span><cite>
Wang X., Jin H., Jiang S., and Xu Y., “MicroRNA‐495 Inhibits the High Glucose‐Induced Inflammation, Differentiation and Extracellular Matrix Accumulation of Cardiac Fibroblasts Through Downregulation of NOD1,” Cellular and Molecular Biology Letters
23, no. 1 (2018): 23, 10.1186/s11658-018-0089-x.
</cite> [<a href="https://doi.org/10.1186/s11658-018-0089-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5941488/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29760746/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cellular%20and%20Molecular%20Biology%20Letters&amp;title=MicroRNA%E2%80%90495%20Inhibits%20the%20High%20Glucose%E2%80%90Induced%20Inflammation,%20Differentiation%20and%20Extracellular%20Matrix%20Accumulation%20of%20Cardiac%20Fibroblasts%20Through%20Downregulation%20of%20NOD1&amp;author=X.%20Wang&amp;author=H.%20Jin&amp;author=S.%20Jiang&amp;author=Y.%20Xu&amp;volume=23&amp;issue=1&amp;publication_year=2018&amp;pages=23&amp;pmid=29760746&amp;doi=10.1186/s11658-018-0089-x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0183">
<span class="label">183.</span><cite>
Yang F., Qin Y., Lv J., et al., “Silencing Long Non‐Coding RNA Kcnq1ot1 Alleviates Pyroptosis and Fibrosis in Diabetic Cardiomyopathy,” Cell Death &amp; Disease
9, no. 10 (2018): 1000, 10.1038/s41419-018-1029-4.
</cite> [<a href="https://doi.org/10.1038/s41419-018-1029-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6155223/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30250027/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell%20Death%20&amp;%20Disease&amp;title=Silencing%20Long%20Non%E2%80%90Coding%20RNA%20Kcnq1ot1%20Alleviates%20Pyroptosis%20and%20Fibrosis%20in%20Diabetic%20Cardiomyopathy&amp;author=F.%20Yang&amp;author=Y.%20Qin&amp;author=J.%20Lv&amp;volume=9&amp;issue=10&amp;publication_year=2018&amp;pages=1000&amp;pmid=30250027&amp;doi=10.1038/s41419-018-1029-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0184">
<span class="label">184.</span><cite>
Zhang Y., Zhang Y. Y., Li T. T., et al., “Ablation of Interleukin‐17 Alleviated Cardiac Interstitial Fibrosis and Improved Cardiac Function via Inhibiting Long Non‐Coding RNA‐AK081284 in Diabetic Mice,” Journal of Molecular and Cellular Cardiology
115 (2018): 64–72, 10.1016/j.yjmcc.2018.01.001.
</cite> [<a href="https://doi.org/10.1016/j.yjmcc.2018.01.001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29305939/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Molecular%20and%20Cellular%20Cardiology&amp;title=Ablation%20of%20Interleukin%E2%80%9017%20Alleviated%20Cardiac%20Interstitial%20Fibrosis%20and%20Improved%20Cardiac%20Function%20via%20Inhibiting%20Long%20Non%E2%80%90Coding%20RNA%E2%80%90AK081284%20in%20Diabetic%20Mice&amp;author=Y.%20Zhang&amp;author=Y.%20Y.%20Zhang&amp;author=T.%20T.%20Li&amp;volume=115&amp;publication_year=2018&amp;pages=64-72&amp;pmid=29305939&amp;doi=10.1016/j.yjmcc.2018.01.001&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0185">
<span class="label">185.</span><cite>
Peng T., Liu M., Hu L., et al., “LncRNA Airn Alleviates Diabetic Cardiac Fibrosis by Inhibiting Activation of Cardiac Fibroblasts via a m6A‐IMP2‐p53 Axis,” Biology Direct
17, no. 1 (2022): 32, 10.1186/s13062-022-00346-6.
</cite> [<a href="https://doi.org/10.1186/s13062-022-00346-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9670606/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36384975/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biology%20Direct&amp;title=LncRNA%20Airn%20Alleviates%20Diabetic%20Cardiac%20Fibrosis%20by%20Inhibiting%20Activation%20of%20Cardiac%20Fibroblasts%20via%20a%20m6A%E2%80%90IMP2%E2%80%90p53%20Axis&amp;author=T.%20Peng&amp;author=M.%20Liu&amp;author=L.%20Hu&amp;volume=17&amp;issue=1&amp;publication_year=2022&amp;pages=32&amp;pmid=36384975&amp;doi=10.1186/s13062-022-00346-6&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0186">
<span class="label">186.</span><cite>
Jia G., Hill M. A., and Sowers J. R., “Diabetic Cardiomyopathy: An Update of Mechanisms Contributing to This Clinical Entity,” Circulation Research
122, no. 4 (2018): 624–638, 10.1161/circresaha.117.311586.
</cite> [<a href="https://doi.org/10.1161/circresaha.117.311586" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5819359/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29449364/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Circulation%20Research&amp;title=Diabetic%20Cardiomyopathy:%20An%20Update%20of%20Mechanisms%20Contributing%20to%20This%20Clinical%20Entity&amp;author=G.%20Jia&amp;author=M.%20A.%20Hill&amp;author=J.%20R.%20Sowers&amp;volume=122&amp;issue=4&amp;publication_year=2018&amp;pages=624-638&amp;pmid=29449364&amp;doi=10.1161/circresaha.117.311586&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0187">
<span class="label">187.</span><cite>
Duan Y., Zhou B., Su H., Liu Y., and Du C., “miR‐150 Regulates High Glucose‐Induced Cardiomyocyte Hypertrophy by Targeting the Transcriptional Co‐Activator p300,” Experimental Cell Research
319, no. 3 (2013): 173–184, 10.1016/j.yexcr.2012.11.015.
</cite> [<a href="https://doi.org/10.1016/j.yexcr.2012.11.015" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23211718/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Experimental%20Cell%20Research&amp;title=miR%E2%80%90150%20Regulates%20High%20Glucose%E2%80%90Induced%20Cardiomyocyte%20Hypertrophy%20by%20Targeting%20the%20Transcriptional%20Co%E2%80%90Activator%20p300&amp;author=Y.%20Duan&amp;author=B.%20Zhou&amp;author=H.%20Su&amp;author=Y.%20Liu&amp;author=C.%20Du&amp;volume=319&amp;issue=3&amp;publication_year=2013&amp;pages=173-184&amp;pmid=23211718&amp;doi=10.1016/j.yexcr.2012.11.015&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0188">
<span class="label">188.</span><cite>
Raut S. K., Kumar A., Singh G. B., et al., “miR‐30c Mediates Upregulation of Cdc42 and Pak1 in Diabetic Cardiomyopathy,” Cardiovascular Therapeutics
33, no. 3 (2015): 89–97, 10.1111/1755-5922.12113.
</cite> [<a href="https://doi.org/10.1111/1755-5922.12113" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25781190/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cardiovascular%20Therapeutics&amp;title=miR%E2%80%9030c%20Mediates%20Upregulation%20of%20Cdc42%20and%20Pak1%20in%20Diabetic%20Cardiomyopathy&amp;author=S.%20K.%20Raut&amp;author=A.%20Kumar&amp;author=G.%20B.%20Singh&amp;volume=33&amp;issue=3&amp;publication_year=2015&amp;pages=89-97&amp;pmid=25781190&amp;doi=10.1111/1755-5922.12113&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0189">
<span class="label">189.</span><cite>
Shen E., Diao X., Wang X., Chen R., and Hu B., “MicroRNAs Involved in the Mitogen‐Activated Protein Kinase Cascades Pathway During Glucose‐Induced Cardiomyocyte Hypertrophy,” American Journal Of Pathology
179, no. 2 (2011): 639–650, 10.1016/j.ajpath.2011.04.034.
</cite> [<a href="https://doi.org/10.1016/j.ajpath.2011.04.034" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3157194/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21704010/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=American%20Journal%20Of%20Pathology&amp;title=MicroRNAs%20Involved%20in%20the%20Mitogen%E2%80%90Activated%20Protein%20Kinase%20Cascades%20Pathway%20During%20Glucose%E2%80%90Induced%20Cardiomyocyte%20Hypertrophy&amp;author=E.%20Shen&amp;author=X.%20Diao&amp;author=X.%20Wang&amp;author=R.%20Chen&amp;author=B.%20Hu&amp;volume=179&amp;issue=2&amp;publication_year=2011&amp;pages=639-650&amp;pmid=21704010&amp;doi=10.1016/j.ajpath.2011.04.034&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0190">
<span class="label">190.</span><cite>
Yang X., Li X., Lin Q., and Xu Q., “Up‐Regulation of microRNA‐203 Inhibits Myocardial Fibrosis and Oxidative Stress in Mice With Diabetic Cardiomyopathy Through the Inhibition of PI3K/Akt Signaling Pathway via PIK3CA,” Gene
715 (2019): 143995, 10.1016/j.gene.2019.143995.
</cite> [<a href="https://doi.org/10.1016/j.gene.2019.143995" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31336140/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Gene&amp;title=Up%E2%80%90Regulation%20of%20microRNA%E2%80%90203%20Inhibits%20Myocardial%20Fibrosis%20and%20Oxidative%20Stress%20in%20Mice%20With%20Diabetic%20Cardiomyopathy%20Through%20the%20Inhibition%20of%20PI3K/Akt%20Signaling%20Pathway%20via%20PIK3CA&amp;author=X.%20Yang&amp;author=X.%20Li&amp;author=Q.%20Lin&amp;author=Q.%20Xu&amp;volume=715&amp;publication_year=2019&amp;pages=143995&amp;pmid=31336140&amp;doi=10.1016/j.gene.2019.143995&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0191">
<span class="label">191.</span><cite>
Zhao F., Li B., Wei Y. Z., et al., “MicroRNA‐34a Regulates High Glucose‐Induced Apoptosis in H9c2 Cardiomyocytes,” Journal of Huazhong University of Science and Technology
33, no. 6 (2013): 834–839, 10.1007/s11596-013-1207-7.
</cite> [<a href="https://doi.org/10.1007/s11596-013-1207-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24337844/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Huazhong%20University%20of%20Science%20and%20Technology&amp;title=MicroRNA%E2%80%9034a%20Regulates%20High%20Glucose%E2%80%90Induced%20Apoptosis%20in%20H9c2%20Cardiomyocytes&amp;author=F.%20Zhao&amp;author=B.%20Li&amp;author=Y.%20Z.%20Wei&amp;volume=33&amp;issue=6&amp;publication_year=2013&amp;pages=834-839&amp;pmid=24337844&amp;doi=10.1007/s11596-013-1207-7&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0192">
<span class="label">192.</span><cite>
Shan Z. X., Lin Q. X., Deng C. Y., et al., “miR‐1/miR‐206 Regulate Hsp60 Expression Contributing to Glucose‐Mediated Apoptosis in Cardiomyocytes,” FEBS Letters
584, no. 16 (2010): 3592–3600, 10.1016/j.febslet.2010.07.027.
</cite> [<a href="https://doi.org/10.1016/j.febslet.2010.07.027" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20655308/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=FEBS%20Letters&amp;title=miR%E2%80%901/miR%E2%80%90206%20Regulate%20Hsp60%20Expression%20Contributing%20to%20Glucose%E2%80%90Mediated%20Apoptosis%20in%20Cardiomyocytes&amp;author=Z.%20X.%20Shan&amp;author=Q.%20X.%20Lin&amp;author=C.%20Y.%20Deng&amp;volume=584&amp;issue=16&amp;publication_year=2010&amp;pages=3592-3600&amp;pmid=20655308&amp;doi=10.1016/j.febslet.2010.07.027&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0193">
<span class="label">193.</span><cite>
Yu X. Y., Song Y. H., Geng Y. J., et al., “Glucose Induces Apoptosis of Cardiomyocytes via microRNA‐1 and IGF‐1,” Biochemical and Biophysical Research Communications
376, no. 3 (2008): 548–552, 10.1016/j.bbrc.2008.09.025.
</cite> [<a href="https://doi.org/10.1016/j.bbrc.2008.09.025" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18801338/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biochemical%20and%20Biophysical%20Research%20Communications&amp;title=Glucose%20Induces%20Apoptosis%20of%20Cardiomyocytes%20via%20microRNA%E2%80%901%20and%20IGF%E2%80%901&amp;author=X.%20Y.%20Yu&amp;author=Y.%20H.%20Song&amp;author=Y.%20J.%20Geng&amp;volume=376&amp;issue=3&amp;publication_year=2008&amp;pages=548-552&amp;pmid=18801338&amp;doi=10.1016/j.bbrc.2008.09.025&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0194">
<span class="label">194.</span><cite>
Zheng D., Ma J., Yu Y., et al., “Silencing of miR‐195 Reduces Diabetic Cardiomyopathy in C57BL/6 Mice,” Diabetologia
58, no. 8 (2015): 1949–1958, 10.1007/s00125-015-3622-8.
</cite> [<a href="https://doi.org/10.1007/s00125-015-3622-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4499474/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25994075/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabetologia&amp;title=Silencing%20of%20miR%E2%80%90195%20Reduces%20Diabetic%20Cardiomyopathy%20in%20C57BL/6%20Mice&amp;author=D.%20Zheng&amp;author=J.%20Ma&amp;author=Y.%20Yu&amp;volume=58&amp;issue=8&amp;publication_year=2015&amp;pages=1949-1958&amp;pmid=25994075&amp;doi=10.1007/s00125-015-3622-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0195">
<span class="label">195.</span><cite>
Zhuo X., Bai K., Wang Y., et al., “Long‐Chain Noncoding RNA‐GAS5/hsa‐miR‐138‐5p Attenuates High Glucose‐Induced Cardiomyocyte Damage by Targeting CYP11B2,” Bioscience Reports
41, no. 9 (2021), 10.1042/bsr20202232.</cite> [<a href="https://doi.org/10.1042/bsr20202232" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8485392/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33682891/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Bioscience%20Reports&amp;title=Long%E2%80%90Chain%20Noncoding%20RNA%E2%80%90GAS5/hsa%E2%80%90miR%E2%80%90138%E2%80%905p%20Attenuates%20High%20Glucose%E2%80%90Induced%20Cardiomyocyte%20Damage%20by%20Targeting%20CYP11B2&amp;author=X.%20Zhuo&amp;author=K.%20Bai&amp;author=Y.%20Wang&amp;volume=41&amp;issue=9&amp;publication_year=2021&amp;pmid=33682891&amp;doi=10.1042/bsr20202232&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0196">
<span class="label">196.</span><cite>
Zhu C., Zhang H., Wei D., and Sun Z., “Silencing lncRNA GAS5 Alleviates Apoptosis and Fibrosis in Diabetic Cardiomyopathy by Targeting miR‐26a/b‐5p,” Acta Diabetologica
58, no. 11 (2021): 1491–1501, 10.1007/s00592-021-01745-3.
</cite> [<a href="https://doi.org/10.1007/s00592-021-01745-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34091757/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Acta%20Diabetologica&amp;title=Silencing%20lncRNA%20GAS5%20Alleviates%20Apoptosis%20and%20Fibrosis%20in%20Diabetic%20Cardiomyopathy%20by%20Targeting%20miR%E2%80%9026a/b%E2%80%905p&amp;author=C.%20Zhu&amp;author=H.%20Zhang&amp;author=D.%20Wei&amp;author=Z.%20Sun&amp;volume=58&amp;issue=11&amp;publication_year=2021&amp;pages=1491-1501&amp;pmid=34091757&amp;doi=10.1007/s00592-021-01745-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0197">
<span class="label">197.</span><cite>
Simar D., Versteyhe S., Donkin I., et al., “DNA Methylation Is Altered in B and NK Lymphocytes in Obese and Type 2 Diabetic Human,” Metabolism
63, no. 9 (2014): 1188–1197, 10.1016/j.metabol.2014.05.014.
</cite> [<a href="https://doi.org/10.1016/j.metabol.2014.05.014" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24996265/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Metabolism&amp;title=DNA%20Methylation%20Is%20Altered%20in%20B%20and%20NK%20Lymphocytes%20in%20Obese%20and%20Type%202%20Diabetic%20Human&amp;author=D.%20Simar&amp;author=S.%20Versteyhe&amp;author=I.%20Donkin&amp;volume=63&amp;issue=9&amp;publication_year=2014&amp;pages=1188-1197&amp;pmid=24996265&amp;doi=10.1016/j.metabol.2014.05.014&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0198">
<span class="label">198.</span><cite>
Zhao J., Goldberg J., Bremner J. D., and Vaccarino V., “Global DNA Methylation Is Associated With Insulin Resistance: A Monozygotic Twin Study,” Diabetes
61, no. 2 (2012): 542–546, 10.2337/db11-1048.
</cite> [<a href="https://doi.org/10.2337/db11-1048" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3266395/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22210312/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes&amp;title=Global%20DNA%20Methylation%20Is%20Associated%20With%20Insulin%20Resistance:%20A%20Monozygotic%20Twin%20Study&amp;author=J.%20Zhao&amp;author=J.%20Goldberg&amp;author=J.%20D.%20Bremner&amp;author=V.%20Vaccarino&amp;volume=61&amp;issue=2&amp;publication_year=2012&amp;pages=542-546&amp;pmid=22210312&amp;doi=10.2337/db11-1048&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0199">
<span class="label">199.</span><cite>
Yang X., Wang X., Liu D., Yu L., Xue B., and Shi H., “Epigenetic Regulation of Macrophage Polarization by DNA Methyltransferase 3b,” Molecular Endocrinology
28, no. 4 (2014): 565–574, 10.1210/me.2013-1293.
</cite> [<a href="https://doi.org/10.1210/me.2013-1293" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3968399/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24597547/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Molecular%20Endocrinology&amp;title=Epigenetic%20Regulation%20of%20Macrophage%20Polarization%20by%20DNA%20Methyltransferase%203b&amp;author=X.%20Yang&amp;author=X.%20Wang&amp;author=D.%20Liu&amp;author=L.%20Yu&amp;author=B.%20Xue&amp;volume=28&amp;issue=4&amp;publication_year=2014&amp;pages=565-574&amp;pmid=24597547&amp;doi=10.1210/me.2013-1293&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0200">
<span class="label">200.</span><cite>
Raghuraman S., Donkin I., Versteyhe S., Barres R., and Simar D., “The Emerging Role of Epigenetics in Inflammation and Immunometabolism,” Trends in Endocrinology &amp; Metabolism
27, no. 11 (2016): 782–795, 10.1016/j.tem.2016.06.008.
</cite> [<a href="https://doi.org/10.1016/j.tem.2016.06.008" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27444065/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Trends%20in%20Endocrinology%20&amp;%20Metabolism&amp;title=The%20Emerging%20Role%20of%20Epigenetics%20in%20Inflammation%20and%20Immunometabolism&amp;author=S.%20Raghuraman&amp;author=I.%20Donkin&amp;author=S.%20Versteyhe&amp;author=R.%20Barres&amp;author=D.%20Simar&amp;volume=27&amp;issue=11&amp;publication_year=2016&amp;pages=782-795&amp;pmid=27444065&amp;doi=10.1016/j.tem.2016.06.008&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0201">
<span class="label">201.</span><cite>
Guzik T. J. and Cosentino F., “Epigenetics and Immunometabolism in Diabetes and Aging,” Antioxid Redox Signal
29, no. 3 (2018): 257–274, 10.1089/ars.2017.7299.
</cite> [<a href="https://doi.org/10.1089/ars.2017.7299" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6012980/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28891325/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Antioxid%20Redox%20Signal&amp;title=Epigenetics%20and%20Immunometabolism%20in%20Diabetes%20and%20Aging&amp;author=T.%20J.%20Guzik&amp;author=F.%20Cosentino&amp;volume=29&amp;issue=3&amp;publication_year=2018&amp;pages=257-274&amp;pmid=28891325&amp;doi=10.1089/ars.2017.7299&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0202">
<span class="label">202.</span><cite>
Zhou Y., Suo W., Zhang X., et al., “Targeting Epigenetics in Diabetic Cardiomyopathy: Therapeutic Potential of Flavonoids,” Biomedicine &amp; Pharmacotherapy
157 (2023): 114025, 10.1016/j.biopha.2022.114025.
</cite> [<a href="https://doi.org/10.1016/j.biopha.2022.114025" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36399824/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biomedicine%20&amp;%20Pharmacotherapy&amp;title=Targeting%20Epigenetics%20in%20Diabetic%20Cardiomyopathy:%20Therapeutic%20Potential%20of%20Flavonoids&amp;author=Y.%20Zhou&amp;author=W.%20Suo&amp;author=X.%20Zhang&amp;volume=157&amp;publication_year=2023&amp;pages=114025&amp;pmid=36399824&amp;doi=10.1016/j.biopha.2022.114025&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0203">
<span class="label">203.</span><cite>
Bartosova L., Horvath C., Galis P., et al., “Quercetin Alleviates Diastolic Dysfunction and Suppresses Adverse Pro‐Hypertrophic Signaling in Diabetic Rats,” Frontiers in Endocrinology
13 (2022): 1029750, 10.3389/fendo.2022.1029750.
</cite> [<a href="https://doi.org/10.3389/fendo.2022.1029750" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9772025/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36568083/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Frontiers%20in%20Endocrinology&amp;title=Quercetin%20Alleviates%20Diastolic%20Dysfunction%20and%20Suppresses%20Adverse%20Pro%E2%80%90Hypertrophic%20Signaling%20in%20Diabetic%20Rats&amp;author=L.%20Bartosova&amp;author=C.%20Horvath&amp;author=P.%20Galis&amp;volume=13&amp;publication_year=2022&amp;pages=1029750&amp;pmid=36568083&amp;doi=10.3389/fendo.2022.1029750&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0204">
<span class="label">204.</span><cite>
Devarshi P. P., Jones A. D., Taylor E. M., Stefanska B., and Henagan T. M., “Quercetin and Quercetin‐Rich Red Onion Extract Alter Pgc‐1alpha Promoter Methylation and Splice Variant Expression,” PPAR Research
2017 (2017): 3235693, 10.1155/2017/3235693.
</cite> [<a href="https://doi.org/10.1155/2017/3235693" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5278221/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28191013/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PPAR%20Research&amp;title=Quercetin%20and%20Quercetin%E2%80%90Rich%20Red%20Onion%20Extract%20Alter%20Pgc%E2%80%901alpha%20Promoter%20Methylation%20and%20Splice%20Variant%20Expression&amp;author=P.%20P.%20Devarshi&amp;author=A.%20D.%20Jones&amp;author=E.%20M.%20Taylor&amp;author=B.%20Stefanska&amp;author=T.%20M.%20Henagan&amp;volume=2017&amp;publication_year=2017&amp;pages=3235693&amp;pmid=28191013&amp;doi=10.1155/2017/3235693&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0205">
<span class="label">205.</span><cite>
Rawal S., Manning P., and Katare R., “Cardiovascular microRNAs: As Modulators and Diagnostic Biomarkers of Diabetic Heart Disease,” Cardiovascular Diabetology
13, no. 1 (2014): 44, 10.1186/1475-2840-13-44.
</cite> [<a href="https://doi.org/10.1186/1475-2840-13-44" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3976030/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24528626/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cardiovascular%20Diabetology&amp;title=Cardiovascular%20microRNAs:%20As%20Modulators%20and%20Diagnostic%20Biomarkers%20of%20Diabetic%20Heart%20Disease&amp;author=S.%20Rawal&amp;author=P.%20Manning&amp;author=R.%20Katare&amp;volume=13&amp;issue=1&amp;publication_year=2014&amp;pages=44&amp;pmid=24528626&amp;doi=10.1186/1475-2840-13-44&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0206">
<span class="label">206.</span><cite>
Makeyev E. V., Kolb V. A., and Spirin A. S., “Cell‐Free Immunology: Construction and in Vitro Expression of a PCR‐based Library Encoding a Single‐Chain Antibody Repertoire,” FEBS Letters
444, no. 2–3 (1999): 177–180, 10.1016/s0014-5793(99)00055-1.
</cite> [<a href="https://doi.org/10.1016/s0014-5793(99)00055-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10050754/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=FEBS%20Letters&amp;title=Cell%E2%80%90Free%20Immunology:%20Construction%20and%20in%20Vitro%20Expression%20of%20a%20PCR%E2%80%90based%20Library%20Encoding%20a%20Single%E2%80%90Chain%20Antibody%20Repertoire&amp;author=E.%20V.%20Makeyev&amp;author=V.%20A.%20Kolb&amp;author=A.%20S.%20Spirin&amp;volume=444&amp;issue=2%E2%80%933&amp;publication_year=1999&amp;pages=177-180&amp;pmid=10050754&amp;doi=10.1016/s0014-5793(99)00055-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0207">
<span class="label">207.</span><cite>
Deng J., Liao Y., Liu J., Liu W., and Yan D., “Research Progress on Epigenetics of Diabetic Cardiomyopathy in Type 2 Diabetes,” Frontiers in Cell and Developmental Biology
9 (2021): 777258, 10.3389/fcell.2021.777258.
</cite> [<a href="https://doi.org/10.3389/fcell.2021.777258" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8740193/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35004678/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Frontiers%20in%20Cell%20and%20Developmental%20Biology&amp;title=Research%20Progress%20on%20Epigenetics%20of%20Diabetic%20Cardiomyopathy%20in%20Type%202%20Diabetes&amp;author=J.%20Deng&amp;author=Y.%20Liao&amp;author=J.%20Liu&amp;author=W.%20Liu&amp;author=D.%20Yan&amp;volume=9&amp;publication_year=2021&amp;pages=777258&amp;pmid=35004678&amp;doi=10.3389/fcell.2021.777258&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0208">
<span class="label">208.</span><cite>
Zhang Q. and Cao X., “Epigenetic Regulation of the Innate Immune Response to Infection,” Nature Reviews Immunology
19, no. 7 (2019): 417–432, 10.1038/s41577-019-0151-6.</cite> [<a href="https://doi.org/10.1038/s41577-019-0151-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30918351/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature%20Reviews%20Immunology&amp;title=Epigenetic%20Regulation%20of%20the%20Innate%20Immune%20Response%20to%20Infection&amp;author=Q.%20Zhang&amp;author=X.%20Cao&amp;volume=19&amp;issue=7&amp;publication_year=2019&amp;pages=417-432&amp;pmid=30918351&amp;doi=10.1038/s41577-019-0151-6&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0209">
<span class="label">209.</span><cite>
Zhang L., Lu Q., and Chang C., “Epigenetics in Health and Disease,” Advances in Experimental Medicine and Biology
1253 (2020): 3–55, 10.1007/978-981-15-3449-2_1.
</cite> [<a href="https://doi.org/10.1007/978-981-15-3449-2_1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32445090/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Advances%20in%20Experimental%20Medicine%20and%20Biology&amp;title=Epigenetics%20in%20Health%20and%20Disease&amp;author=L.%20Zhang&amp;author=Q.%20Lu&amp;author=C.%20Chang&amp;volume=1253&amp;publication_year=2020&amp;pages=3-55&amp;pmid=32445090&amp;doi=10.1007/978-981-15-3449-2_1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0210">
<span class="label">210.</span><cite>
Guo Y., Zou J., Xu X., et al., “Short‐Chain Fatty Acids Combined With Intronic DNA Methylation of HIF3A: Potential Predictors for Diabetic Cardiomyopathy,” Clinical Nutrition
40, no. 6 (2021): 3708–3717, 10.1016/j.clnu.2021.04.007.
</cite> [<a href="https://doi.org/10.1016/j.clnu.2021.04.007" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34130016/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clinical%20Nutrition&amp;title=Short%E2%80%90Chain%20Fatty%20Acids%20Combined%20With%20Intronic%20DNA%20Methylation%20of%20HIF3A:%20Potential%20Predictors%20for%20Diabetic%20Cardiomyopathy&amp;author=Y.%20Guo&amp;author=J.%20Zou&amp;author=X.%20Xu&amp;volume=40&amp;issue=6&amp;publication_year=2021&amp;pages=3708-3717&amp;pmid=34130016&amp;doi=10.1016/j.clnu.2021.04.007&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0211">
<span class="label">211.</span><cite>
Copier C. U., Leon L., Fernandez M., Contador D., and Calligaris S. D., “Circulating miR‐19b and miR‐181b Are Potential Biomarkers for Diabetic Cardiomyopathy,” Scientific Reports
7, no. 1 (2017): 13514, 10.1038/s41598-017-13875-2.
</cite> [<a href="https://doi.org/10.1038/s41598-017-13875-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5647433/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29044172/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Scientific%20Reports&amp;title=Circulating%20miR%E2%80%9019b%20and%20miR%E2%80%90181b%20Are%20Potential%20Biomarkers%20for%20Diabetic%20Cardiomyopathy&amp;author=C.%20U.%20Copier&amp;author=L.%20Leon&amp;author=M.%20Fernandez&amp;author=D.%20Contador&amp;author=S.%20D.%20Calligaris&amp;volume=7&amp;issue=1&amp;publication_year=2017&amp;pages=13514&amp;pmid=29044172&amp;doi=10.1038/s41598-017-13875-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0212">
<span class="label">212.</span><cite>
Leopold J. A. and Loscalzo J., “Emerging Role of Precision Medicine in Cardiovascular Disease,” Circulation Research
122, no. 9 (2018): 1302–1315, 10.1161/circresaha.117.310782.
</cite> [<a href="https://doi.org/10.1161/circresaha.117.310782" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6021027/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29700074/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Circulation%20Research&amp;title=Emerging%20Role%20of%20Precision%20Medicine%20in%20Cardiovascular%20Disease&amp;author=J.%20A.%20Leopold&amp;author=J.%20Loscalzo&amp;volume=122&amp;issue=9&amp;publication_year=2018&amp;pages=1302-1315&amp;pmid=29700074&amp;doi=10.1161/circresaha.117.310782&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0213">
<span class="label">213.</span><cite>
Gadd D. A., Hillary R. F., McCartney D. L., et al., “Epigenetic Scores for the Circulating Proteome as Tools for Disease Prediction,” eLife
11 (2022): e71802, 10.7554/elife.71802.
</cite> [<a href="https://doi.org/10.7554/elife.71802" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8880990/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35023833/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=eLife&amp;title=Epigenetic%20Scores%20for%20the%20Circulating%20Proteome%20as%20Tools%20for%20Disease%20Prediction&amp;author=D.%20A.%20Gadd&amp;author=R.%20F.%20Hillary&amp;author=D.%20L.%20McCartney&amp;volume=11&amp;publication_year=2022&amp;pages=e71802&amp;pmid=35023833&amp;doi=10.7554/elife.71802&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0214">
<span class="label">214.</span><cite>
Hathaway Q. A., Roth S. M., Pinti M. V., et al., “Machine‐Learning to Stratify Diabetic Patients Using Novel Cardiac Biomarkers and Integrative Genomics,” Cardiovascular Diabetology
18, no. 1 (2019): 78, 10.1186/s12933-019-0879-0.
</cite> [<a href="https://doi.org/10.1186/s12933-019-0879-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6560734/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31185988/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cardiovascular%20Diabetology&amp;title=Machine%E2%80%90Learning%20to%20Stratify%20Diabetic%20Patients%20Using%20Novel%20Cardiac%20Biomarkers%20and%20Integrative%20Genomics&amp;author=Q.%20A.%20Hathaway&amp;author=S.%20M.%20Roth&amp;author=M.%20V.%20Pinti&amp;volume=18&amp;issue=1&amp;publication_year=2019&amp;pages=78&amp;pmid=31185988&amp;doi=10.1186/s12933-019-0879-0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0215">
<span class="label">215.</span><cite>
Sweaad W. K., Stefanizzi F. M., Chamorro‐Jorganes A., Devaux Y., Emanueli C., and Eu‐Cca C. A., “Relevance of N6‐Methyladenosine Regulators for Transcriptome: Implications for Development and the Cardiovascular System,” Journal of Molecular and Cellular Cardiology
160 (2021): 56–70, 10.1016/j.yjmcc.2021.05.006.
</cite> [<a href="https://doi.org/10.1016/j.yjmcc.2021.05.006" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33991529/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Molecular%20and%20Cellular%20Cardiology&amp;title=Relevance%20of%20N6%E2%80%90Methyladenosine%20Regulators%20for%20Transcriptome:%20Implications%20for%20Development%20and%20the%20Cardiovascular%20System&amp;author=W.%20K.%20Sweaad&amp;author=F.%20M.%20Stefanizzi&amp;author=A.%20Chamorro%E2%80%90Jorganes&amp;author=Y.%20Devaux&amp;author=C.%20Emanueli&amp;volume=160&amp;publication_year=2021&amp;pages=56-70&amp;pmid=33991529&amp;doi=10.1016/j.yjmcc.2021.05.006&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0216">
<span class="label">216.</span><cite>
Lin L. C., Liu Z. Y., Yang J. J., Zhao J. Y., and Tao H., “m6A Epitranscriptomic Modification in Diabetic Microvascular Complications,” Trends in Pharmacological Sciences
44, no. 12 (2023): 991–1008, 10.1016/j.tips.2023.09.013.</cite> [<a href="https://doi.org/10.1016/j.tips.2023.09.013" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39492320/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Trends%20in%20Pharmacological%20Sciences&amp;title=m6A%20Epitranscriptomic%20Modification%20in%20Diabetic%20Microvascular%20Complications&amp;author=L.%20C.%20Lin&amp;author=Z.%20Y.%20Liu&amp;author=J.%20J.%20Yang&amp;author=J.%20Y.%20Zhao&amp;author=H.%20Tao&amp;volume=44&amp;issue=12&amp;publication_year=2023&amp;pages=991-1008&amp;pmid=39492320&amp;doi=10.1016/j.tips.2023.09.013&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0217">
<span class="label">217.</span><cite>
Karagianni K., Bibi A., Made A., et al., “Recommendations for Detection, Validation, and Evaluation of RNA Editing Events in Cardiovascular and Neurological/Neurodegenerative Diseases,” Molecular Therapy Nucleic Acids
35, no. 1 (2024): 102085, 10.1016/j.omtn.2023.102085.
</cite> [<a href="https://doi.org/10.1016/j.omtn.2023.102085" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10772297/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38192612/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Molecular%20Therapy%20Nucleic%20Acids&amp;title=Recommendations%20for%20Detection,%20Validation,%20and%20Evaluation%20of%20RNA%20Editing%20Events%20in%20Cardiovascular%20and%20Neurological/Neurodegenerative%20Diseases&amp;author=K.%20Karagianni&amp;author=A.%20Bibi&amp;author=A.%20Made&amp;volume=35&amp;issue=1&amp;publication_year=2024&amp;pages=102085&amp;pmid=38192612&amp;doi=10.1016/j.omtn.2023.102085&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0218">
<span class="label">218.</span><cite>
Li P., Qin D., Chen T., et al., “Dysregulated Rbfox2 Produces Aberrant Splicing of Ca(V)1.2 Calcium Channel in Diabetes‐Induced Cardiac Hypertrophy,” Cardiovascular Diabetology
22, no. 1 (2023): 168, 10.1186/s12933-023-01894-5.
</cite> [<a href="https://doi.org/10.1186/s12933-023-01894-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10324275/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37415128/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cardiovascular%20Diabetology&amp;title=Dysregulated%20Rbfox2%20Produces%20Aberrant%20Splicing%20of%20Ca(V)1.2%20Calcium%20Channel%20in%20Diabetes%E2%80%90Induced%20Cardiac%20Hypertrophy&amp;author=P.%20Li&amp;author=D.%20Qin&amp;author=T.%20Chen&amp;volume=22&amp;issue=1&amp;publication_year=2023&amp;pages=168&amp;pmid=37415128&amp;doi=10.1186/s12933-023-01894-5&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0219">
<span class="label">219.</span><cite>
Nutter C. A., Jaworski E. A., Verma S. K., et al., “Dysregulation of RBFOX2 Is an Early Event in Cardiac Pathogenesis of Diabetes,” Cell Reports
15, no. 10 (2016): 2200–2213, 10.1016/j.celrep.2016.05.002.
</cite> [<a href="https://doi.org/10.1016/j.celrep.2016.05.002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4899142/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27239029/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell%20Reports&amp;title=Dysregulation%20of%20RBFOX2%20Is%20an%20Early%20Event%20in%20Cardiac%20Pathogenesis%20of%20Diabetes&amp;author=C.%20A.%20Nutter&amp;author=E.%20A.%20Jaworski&amp;author=S.%20K.%20Verma&amp;volume=15&amp;issue=10&amp;publication_year=2016&amp;pages=2200-2213&amp;pmid=27239029&amp;doi=10.1016/j.celrep.2016.05.002&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0220">
<span class="label">220.</span><cite>
Nicholls S. J., Schwartz G. G., Buhr K. A., et al., “Apabetalone and Hospitalization for Heart Failure in Patients Following an Acute Coronary Syndrome: A Prespecified Analysis of the BETonMACE Study,” Cardiovascular Diabetology
20, no. 1 (2021): 13, 10.1186/s12933-020-01199-x.
</cite> [<a href="https://doi.org/10.1186/s12933-020-01199-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7791841/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33413345/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cardiovascular%20Diabetology&amp;title=Apabetalone%20and%20Hospitalization%20for%20Heart%20Failure%20in%20Patients%20Following%20an%20Acute%20Coronary%20Syndrome:%20A%20Prespecified%20Analysis%20of%20the%20BETonMACE%20Study&amp;author=S.%20J.%20Nicholls&amp;author=G.%20G.%20Schwartz&amp;author=K.%20A.%20Buhr&amp;volume=20&amp;issue=1&amp;publication_year=2021&amp;pages=13&amp;pmid=33413345&amp;doi=10.1186/s12933-020-01199-x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0221">
<span class="label">221.</span><cite>
Mattick J. S., Amaral P. P., Carninci P., et al., “Long Non‐coding RNAs: Definitions, Functions, Challenges and Recommendations,” Nature Reviews Molecular Cell Biology
24, no. 6 (2023): 430–447, 10.1038/s41580-022-00566-8.
</cite> [<a href="https://doi.org/10.1038/s41580-022-00566-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10213152/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36596869/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature%20Reviews%20Molecular%20Cell%20Biology&amp;title=Long%20Non%E2%80%90coding%20RNAs:%20Definitions,%20Functions,%20Challenges%20and%20Recommendations&amp;author=J.%20S.%20Mattick&amp;author=P.%20P.%20Amaral&amp;author=P.%20Carninci&amp;volume=24&amp;issue=6&amp;publication_year=2023&amp;pages=430-447&amp;pmid=36596869&amp;doi=10.1038/s41580-022-00566-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0222">
<span class="label">222.</span><cite>
Schorderet P. and Duboule D., “Structural and Functional Differences in the Long Non‐Coding RNA Hotair in Mouse and Human,” PLoS Genetics
7, no. 5 (2011): e1002071, 10.1371/journal.pgen.1002071.
</cite> [<a href="https://doi.org/10.1371/journal.pgen.1002071" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3102750/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21637793/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20Genetics&amp;title=Structural%20and%20Functional%20Differences%20in%20the%20Long%20Non%E2%80%90Coding%20RNA%20Hotair%20in%20Mouse%20and%20Human&amp;author=P.%20Schorderet&amp;author=D.%20Duboule&amp;volume=7&amp;issue=5&amp;publication_year=2011&amp;pages=e1002071&amp;pmid=21637793&amp;doi=10.1371/journal.pgen.1002071&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0223">
<span class="label">223.</span><cite>
Tao L., Huang X., Xu M., et al., “Value of Circulating miRNA‐21 in the Diagnosis of Subclinical Diabetic Cardiomyopathy,” Molecular and Cellular Endocrinology
518 (2020): 110944, 10.1016/j.mce.2020.110944.
</cite> [<a href="https://doi.org/10.1016/j.mce.2020.110944" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32717421/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Molecular%20and%20Cellular%20Endocrinology&amp;title=Value%20of%20Circulating%20miRNA%E2%80%9021%20in%20the%20Diagnosis%20of%20Subclinical%20Diabetic%20Cardiomyopathy&amp;author=L.%20Tao&amp;author=X.%20Huang&amp;author=M.%20Xu&amp;volume=518&amp;publication_year=2020&amp;pages=110944&amp;pmid=32717421&amp;doi=10.1016/j.mce.2020.110944&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="dmrr70081-bib-0224">
<span class="label">224.</span><cite>
Sopic M., Stopa V., and Devaux Y., “Leveraging Epitranscriptomics for Cardiovascular Disease Theranostics,” European Heart Journal
45, no. 13 (2024): 1098–1100, 10.1093/eurheartj/ehad852.
</cite> [<a href="https://doi.org/10.1093/eurheartj/ehad852" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38190430/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=European%20Heart%20Journal&amp;title=Leveraging%20Epitranscriptomics%20for%20Cardiovascular%20Disease%20Theranostics&amp;author=M.%20Sopic&amp;author=V.%20Stopa&amp;author=Y.%20Devaux&amp;volume=45&amp;issue=13&amp;publication_year=2024&amp;pages=1098-1100&amp;pmid=38190430&amp;doi=10.1093/eurheartj/ehad852&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>Data sharing is not applicable to this article as no new data were created or analyzed in this study.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Diabetes/Metabolism Research and Reviews are provided here courtesy of <strong>Wiley</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1002/dmrr.70081"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/DMRR-41-e70081.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (2.8 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12365466/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12365466/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12365466%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12365466/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12365466/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12365466/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40831067/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12365466/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40831067/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12365466/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12365466/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="x8aio8MWi7GEe3dJ7xddTP38mSEG4bXOBux9RbUOchD1GwFlegRxFo93Iy60KkpL">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
